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 ABSTRACT 
The cell wall is essential for fungal survival in natural environments. Galactofuranose 
(Galf) decorates certain carbohydrates and lipids of Aspergillus cell wall, is absent in humans 
and appears to play a role in fungal cell wall maturation. Previous studies in our lab showed 
that deletion of any of three sequential-acting genes (ugeA, ugmA, and ugtA) of Galf pathway 
caused substantially reduced growth and spore production.  
Two genes upstream of the Galf pathway, galD and galE are essential for galactose 
metabolism in many systems including the budding yeast, Saccharomyces cerevisiae. 
Interestingly, characterization of galD and galE in A. nidulans using cell and molecular 
techniques showed that unlike yeast, neither of these genes was essential for growth at 
physiological pH 7.5. Nevertheless for each case, their expressions were up-regulated by 
growth on galactose, revealing the relative complexity of galactose metabolism in A. nidulans. 
Our study also showed that repression of the three sequentially acting Galf pathway genes by 
conditional promoters phenocopied previously characterized deletion morphology. Using 
anti-Galf (L10) we also showed that deletion and repression of these genes caused no Galf in 
the hyphal wall. Gene deletion or repression also increased sensitivity to the wall-targeting 
drug, caspofungin. Related results from qPCR showed that deletion or repression of ugmA 
increased gene expression of α-glucan synthase agsB and decreased that of β-glucan synthase 
fksA.  Therefore, Galf is non-essential but important for many aspects of Aspergillus growth, 
sporulation, and wall maturation.  
Aspergillosis, the most common airborne systemic fungal disease, is typically caused 
by Aspergillus fumigatus. Several A.  fumigatus UgmA (AfUgmA) mutants with altered 
enzyme activity due to single amino acid changes were used to assess their effect on growth 
and wall composition in A. nidulans. Wild type AfugmA complemented the phenotypic 
defects in an A. nidulans ugmA∆ strain, consistent with these two genes being homologous. 
The AfUgmA crystal structure has been solved, and the in vitro enzymatic effects of specific 
mutations in the enzyme active site have been published. AfUgmA mutated strains with 
reduced activity in vitro impaired A. nidulans growth in a manner substantially similar to gene 
deletion and gene down-regulation. Site directed mutagenesis showed that AfUgmA residues 
R182 and R327 were critical for Galf generation both in vivo and in vitro. This supports 
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previous results showing that UgmA is essential for Galf biosynthesis. Using fluorescent latex 
beads, we showed that reduction of wall Galf increased hyphal surface adhesion. Consistent 
with qPCR studies, immunofluorescence and ELISA results showed that loss or absence of 
Galf increased wall α-glucan but reduced wall β-glucan. Galf is important for wall surface 
integrity and for maintaining dynamic co-ordination with other pathways. To begin to assess 
this dynamic co-ordination, Tandem Affinity Purification (TAP) tagging combined with 
LC-MS/MS was used to identify the interacting partners of UgmA. Our results showed that 
UgmA interacted with proteins that are involved in cytoskeleton generation, osmotic 
adaptation, and cell signalling pathway. Further study will help us to understand the dynamic 
coordination of Galf biosynthesis pathway with other wall carbohydrate polymers for 
Aspergillus wall formation.  
In summary, my thesis results have clearly shown that Galf plays important roles in 
Aspergillus growth, and wall surface integrity. We also showed that Galf deficient strains are 
hypersensitive to wall-targeting drugs, indicating that Galf biosynthesis pathway could be 
potential target for combination therapy. The Galf pathway also maintained a dynamic 
co-ordination with alpha-glucan and beta-glucan carbohydrate pathways. Future study may 
include developing an inhibitor against UgmA and exploring the relationship of Galf pathway 
with alpha-glucan and beta-glucan carbohydrate pathways. 
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CHAPTER 1 
           Introduction 
This thesis consists of six chapters. Chapter 1 includes a general introduction about 
fungi and the genus Aspergillus, galactose metabolism, cell wall composition, Aspergillus 
infection, antifungal drugs, and the galactofuranose (Galf) biosynthesis pathway. Chapter 2 
describes the roles of GalD and GalE in Aspergillus galactose metabolism. Chapter 3 explains 
the roles of Galf biosynthesis enzymes in fungal growth, drug sensitivity, and their 
relationship with major cell wall carbohydrate biosynthesis pathways. Chapter 4 explores how 
modification of Galf leads to changes in Aspergillus cell wall composition and hyphal surface 
adhesion. Chapter 5 reveals potential interacting partners of A. nidulans UDP-galactopyranose 
mutase using a proteomic approach. Chapter 6 includes a discussion about overall research 
results in terms of their importance in understanding the complexity of galactose metabolism, 
contribution of Galf in fungal growth, drug sensitivity, cell wall modification and co-
ordination of Galf with other carbohydrate pathways and ends with a discussion about the 
possibility for anti-Galf drug as a part of a combination therapy and future directions. 
 
1.1 Fungal Biology 
Fungi are heterotrophic eukaryotic organisms that are distinct from both plants and 
animals. Today, fungi are grouped in their own taxonomic kingdom, the Mycota, which is 
estimated to consist of 3.5 to 5.1 million species (O’ Brien et al., 2005; Taylor et al., 2010; 
Blackwell, 2011), although only ~97,000 have been formally described (Kirk et al., 2008; 
Blackwell, 2011). Based on recent comprehensive phylogenetic classification, the Mycota 
contains seven phyla, the Microsporidia, Chytridiomycota, Blastocladiomycota, 
Neocallimastigomycota, Glomeromycota (includes the traditional phylum Zygomycota), 
Ascomycota, and Basidiomycota (Hibbett et al., 2007). Together, the Ascomycota and 
Basidiomycota represent the subkingdom Dikarya (Hibbett et al., 2007). 
Like animals, fungi lack chloroplasts and so are heterotrophic organisms, and as such 
they require organic compounds as energy sources. Unlike plant cell walls that contain 
cellulose, fungal cell walls contain chitin microfibrils. In general, fungi can propagate in a 
sexual or asexual way by producing spores. The sexual form of fungi is known as the 
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teleomorph and the asexual form is the anamorph (Kirk et al 2008). Fungi typically have 
haploid nuclei. Fungi can be multicellular filamentous (moulds), macroscopic filamentous 
fungi that form large fruiting bodies (mushroom), or single celled microscopic yeasts. Some 
fungi are dimorphic, so that they are able to switch between unicellular and multicellular 
forms at different life cycle stages (e.g. Candida) (Osiewacz, 2002).  
Fungi are diverse in regard to ecological contribution and biological function. Overall, 
fungi are abundant worldwide and perform essential roles in ecosystems (Barr and Aust, 
1994; Newbound et al., 2010). Many fungi are excellent scavengers in nature, breaking down 
dead vegetable material (particularly cellulose and lignin) into simpler compounds (Rambold 
et al., 2013).  
Some fungi are used as a source of food, such as mushrooms and truffles, and others 
including yeasts are used in industrial fermentation processes to produce wine, beer, as well 
as to produce some useful biochemicals such as antibiotics and enzymes (Bennett, 1998). 
Some species form symbiotic relationships with plants (Rodriguez and Redman, 2008), which 
are essential for their survival in terrestrial environments. However, other fungi are 
detrimental to plants, animals and humans (Monk and Goffeau, 2008; Cannon et al., 2009). 
Some fungi can cause serious plant diseases (e.g. Magnaporthe oryzae causing rice blast 
disease), that results in the loss of billions of dollars worth of crops each year. Some fungi 
cause animal diseases and/or human disease (Gould, 2011). They are also used as 
experimental organisms to study metabolic pathways, growth and development, and cell 
division because they are eukaryotes, and are relatively closely related to animals (van der 
Klei and Veenhuis, 2006).  
The filamentous fungi (moulds) are different from the unicellular yeasts in their 
cellular organization and growth (Deacon, 1997). They are composed of long tubular cells 
called hyphae that exhibit tip localized growth (Kaminskyj and Heath, 1996). Hyphae can be 
septate (cross walls) or aseptate (no cross walls) depending on their taxonomic group. The 
hyphae grow and branch until they form a network of threadlike cells called a colony or 
mycelium. Some of the hyphal branches grow into the air and differentiate to produce asexual 
spores called conidia. Macroscopic filamentous fungi also grow by producing a mycelium in a 
nutrient substrate that can be below ground or within a plant. These fungi differ from moulds 
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(which typically are asexual) because they produce large macroscopic fruiting bodies that 
hold the sexual spores. Major groups of septate fungi are the Ascomycetes (e.g. Aspergillus 
and Candida) and the Basidiomycetes (e.g. Cryptococcus). The hyphal cells of septate 
filamentous fungi can be uninucleate or multinucleate (Todd et al 2007a&b; Wearing et al 
2010). 
The genus Aspergillus is a group of filamentous ascomycetes that include ~250 
species. These are typically aerobic, but can be facultative anaerobes. Aspergillus species 
have septate hyphae and characteristic arrangement of conidia on the conidiophore (Fig 1.1). 
Colonies appear in 1 to 2 d depending on growth temperature; by 5 d they may cover an entire 
Petri plate. For many filamentous fungi including Aspergillus, the predominant life cycle 
stage is asexual (Fig. 1.1) (Wearing, 2010). Aspergillus has a tremendous impact on public 
health, both beneficially as the workhorse of industrial applications and negatively as plant 
and human pathogens (Dagenais and Keller, 2009). For example, A. fumigatus is a deadly 
pathogen of immunocompromised patients; A. flavus is an agriculturally dangerous toxin 
producer; A. niger and A. oryzae are used in industrial processes (Kapoor et al., 1999; Erjavec 
et al 2009). A. nidulans is widely used as a model system to a wide array of biological 
processes (Todd et al 2007a). 
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Figure 1.1: Life cycle of Aspergillus nidulans, which grows as haploid vegetative 
filamentous hyphae following germination of uninucleate conidia or binucleate ascospores. 
Asexual cycle: a-c) germination and hyphal growth leads to the formation of a vegetative 
colony. d) At the onset of spore development, a stalk forms, then e) swells at its tip to form 
the vesicle. This produces two layers of cells: f) metulae, and g) phialides. In wild type 
A. nidulans, each metula produces a pair of phialides. h) Mature phialides produce chains of 
uninucleate spores. Parasexual cycle: Hyphae from two individuals may fuse to form a 
heterokaryon, and nuclei in a heterokaryon or a homokaryon may fuse to form a diploid. 
Hyphae differentiate by asexual development, as above. Sexual Cycle: as growth proceeds, 
sexual development produces nurse cells called Hülle cells and closed fruiting bodies 
(cleistothecia) containing sexual ascospores within asci. Simplified from Todd et al. (2007b).  
 
1.2 Galactose metabolism in fungi   
Galactose metabolism via the Leloir pathway (named after the 1970 Nobel laureate 
Luis Leloir) is conserved from bacteria through humans (Ross et al. 2004). Galactose itself 
cannot be used directly for glycolysis. Before it can enter the glycolytic pathway, galactose 
must be converted via galactose-1-phosphate into glucose-1-phosphate (Sellick et al. 2008). 
The enzymes of the Leloir pathway are galactokinase (GalE), galactose-1-phosphate 
uridylyltransferase (GalD), and UDP-glucose/galactose-4-epimerase (UGE) (Christacos et al 
2000), which mediate this conversion. Leloir enzymes have attracted significant research 
attention because of their important metabolic roles. For example, defects in the human 
enzymes galactokinase or galactose-1-phosphate-uridylyltransferase causes diseases called 
galactosemias (Holden et al, 2003; Timson 2005). The galactose metabolism and 
galactofuranose biosynthesis pathways are illustrated together in Fig 2.1 of Chapter 2. In the 
first step of conversion, galactose is phosphorylated by GalE to produce 
galactose-1-phosphate. In the next round of the transfer reaction, GalD interconverts glucose- 
or galactose-1-phosphate to their UDP conjugates and releases glucose-1-phosphate. Once 
released, glucose-1-phosphate is converted to glucose-6-phosphate and can enter the 
glycolytic pathway to generate energy. UDP-glucose is a substrate for UGE (UgeA), which 
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can potentially be processed into UDP-galactofuranose (UDP-Galf) by UDP-galactopyranose 
mutase (UGM, UgmA) in fungi (El-Ganiny 2008, 2010).  
In fungi, galactose can be used for energy generation (catabolism), and for fungal wall 
glycan synthesis (anabolism) (Fekete et al, 2004). The Leloir pathway has been extensively 
studied in the yeasts Saccharomyces cerevisiae and Kluyveromyces lactis (Bhat & Murthy 
2001; Rubio-Texeira 2005). All of the Leloir genes are essential for growth on D-galactose in 
these yeast systems (Slepak et al. 2005, Seiboth et al 2008). Although the Leloir pathway 
appears to be the main D-galactose degrading route in Aspergillus, alternative or additional 
galactose metabolism pathways via galactitol, sorbitol and fructose (Elorza, 1971) and 
fructose-6-phosphate and sorbose-6-phosphate have been proposed in A. nidulans (Fekete et 
al. 2004). Flipphi et al. (2009) hypothesized that galactitol can also be epimerized to 
D-tagatose via L-sorbose, which might be catabolized via D-sorbitol and D-fructose to 
D-fructose-6-phosphate. A non-phosphorolytic pathway for D-galactose utilization has been 
reported for A. niger (Elshafei & Abdel-Fatah 2001) but neither the genes nor the proteins 
have been identified. Similarly, Hypocrea jecorina strain with deleted galE was able to grow 
on D-galactose (Seiboth et al. 2004). Therefore, galactose metabolism is more complex in 
filamentous fungi than in yeast (Slot and Rokas, 2010).  
 
1.3 Fungal cell wall structure  
Formation of an outer protective cell wall layer is crucial for the survival and growth 
of fungi and to establish host-pathogen interaction as well (Latgé, 2007; Cummings and 
Doering, 2009). In filamentous fungi, wall formation is also an integral part of hyphal 
extension (Read, 2011). The fungal cell wall also protects cells from mechanical injury, 
prevents osmotic lysis, and provides passive protection against the ingress of potentially 
harmful macromolecules. Due to the importance of cell walls for fungal growth and host 
invasion, and the lack of conservation with animal cell components, the cell wall is a good 
source of potential antifungal targets (Aimanianda and Latgé, 2010).   
Although wall composition varies with fungal species, generally fungal walls are 
composed of glucans, chitin and/or chitosan, mannans and/or galactomannans, and 
glycoproteins (Free, 2013). Up to 90 % of wall components are polysaccharides (Latgé 2007). 
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These can be divided in two groups, depending on their solubility in alkali (Bernard and 
Latgé, 2001). The alkali-insoluble polysaccharides are thought to be located close to plasma 
membrane and are primarily composed of β-1,3-glucans, chitin and galactomannan (Latgé 
2010).  The alkali soluble polysaccharides are present in the entire cell wall; especially in the 
outer face and are mainly composed of α-(1,3)-glucans with some galactomannan (Bernard 
and Latgé, 2001; Latgé 2010). In most fungi, two covalently cross-linked polysaccharides, 
β-(1,3)-glucan and chitin, form the core wall structure that is responsible for structural 
integrity and shape of the cell (Latgé, 2007). This glucan–chitin complex is covalently bound 
to other polysaccharides, the composition of which varies among fungi.   
β-glucans are ~40% of the mass of the Aspergillus wall (Gastebois et al 2009; Free, 
2013). A variety of β-glucans, including β-1,3-glucan, β-1,6-glucan, mixed β-1,3-/β-1,4-
glucan have been identified in fungal cell walls (Free, 2013). The β-1,3-glucan is the major 
glucan (Fig 1.2) and is synthesized by β-1,3-glucan synthase, a well-characterized plasma 
membrane-associated enzyme with multiple transmembrane domains that form a channel 
through which newly synthesised glucan polymers are extruded into the cell wall space (Klis 
et al., 2006; Lesage & Bussey, 2006). Each of A. nidulans, A. fumigatus, Cryptococcus 
neoformans, Neurospora crassa, and C. albicans have a single β-1,3-glucan synthase, called 
FKS1 (Thompson et al., 1999; Beauvais et al., 2001) or in A. nidulans, FksA. Saccharomyces 
cerevisiae has three glucan synthase genes, but FKS1 functions as a major β-1,3-glucan 
synthase during vegetative growth in yeast (Klis et al., 2006; Lesage & Bussey, 2006).  
Alpha-1,3-glucans (Fig 1.2) are synthesized by plasma membrane-associated alpha 
glucan synthases (AGS), which extrude newly formed linear glucan polymers through the 
plasma membrane into the cell wall space. Recent evidence suggested that α-(1,3)-glucan is 
present in the outermost layer of the fungal hyphal and conidial wall  (Claverie-Martin et al 
1988; Rappleye et al 2007). Although α-glucan is not essential for most fungi 
(Schizosaccharomyces pombe being the single exception, Hochstenbach et al., 1998), 
α-glucan can contribute to virulence for some pathogenic fungi (Rappleye et al 2007, Reese et 
al., 2007; Fujikawa et al., 2012), cell morphology (Reese and Doering, 2003; Cortés et al., 
2012), cell wall integrity (Fujioka et al., 2007). Aspergillus fumigatus has three α-1,3-glucan 
synthases (AGS1, AGS2, AGS3), and two of these have been shown to participate in the 
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synthesis of α-1,3-glucan. Yoshimi et al. (2013) and He et al. (2014) recently described 
A. nidulans AgsA and AgsB as α-glucan synthases, with AgsB as the major α-glucan 
synthase. 
Chitin is a relatively minor yet structurally important component of the fungal wall. 
Yeast species generally have 1–2 % chitin, mostly associated with cytokinesis scars, whereas 
chitin can comprise up to 15 % of the cell wall mass in filamentous fungi (Free 2013). In both 
yeasts and filamentous fungi, chitin microfibrils have an enormous tensile strength, covalently 
bind with β-1,3-glucan, and significantly contribute to the overall integrity of the cell wall 
(Latgé 2007). Chitin is synthesized by plasma membrane-associated chitin synthases (CHS). 
All characterized fungi have CHS and most have multiple genes encoding CHS. 
Saccharomyces cerevisiae has three genes that encode CHS (Cabib et al 2001), C. albicans 
has four (Munro et al., 2003). Both A. nidulans and A. fumigatus have seven CHS, which 
contribute to hyphal wall integrity, differentiation and tip growth (Horiuchi, 2009).  
Galactomannan is a polysaccharide composed of a mannan core structure with 
galactose (galactopyranose or galactofuranose; Fig 1.2) side chains, is also commonly found 
in the wall of Aspergillus and some other species, but not in Candida (Fontaine et al. 2000). 
In A. fumigatus, the galactomannan is either covalently attached to β-1,3-glucans of the cell 
wall (Fig. 1.2) or linked to the plasma membrane via a GPI anchor (Costachel et al. 2005). 
Galactofuranose, a minor cell wall component, has been reported to be present in the wall of 
many pathogenic fungi and comprise around 5 % of the dry weight of A. fumigatus (Lamarre 
2009). Typically, Galf has been described to occur in galactomannan as side chains with 
repeating β-1,5-Galf units that are β-3,6 linked to the mannose backbone (Fig. 1.2) (Latgé et 
al. 1994).   
Fungal cell walls also contain glycoproteins, some of which are covalently linked into 
the cell wall matrix (Cheng 2011; Free 2013). Cell wall glycoproteins are synthesized by 
ER-associated ribosomes and extruded into the lumen of the ER. Glycoproteins can be 
attached to the cell membrane either via transmembrane domains or via a 
glycosylphosphatidylinositol (GPI) anchor (Cheng, 2011; Free, 2013). As the cell wall 
proteins are processed within the ER and Golgi apparatus, O-linked glycosylation occurs 
(addition of mannans or galactomannan) and the N-linked oligosaccharides are further 
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processed to generate high-mannan outer chain structures (in S. cerevisiae, C. albicans) or 
N-linked galactomannans (S. pombe, A. fumigatus, N. crassa) (Free, 2013).  
In summary, the details of fungal cell wall composition and structure are still a very 
complicated puzzle; each element plays a role on its own as well as in concert with the others 
in the functioning of this structure. Loss of any of these cell wall components (glucans, chitin, 
mannans, galactomannans, and glycoproteins) can dramatically affect the growth, 
morphology, and viability of the fungus, demonstrating that all of these components are 
needed for the formation of a normally functional cell wall.  
 
 
Figure 1.2: Cartoon showing the chemical structures of some fungal wall 
sugars, linkage of β-1,3 glucan, alpha-1, 3 glucan and glycoconjugation of Galf.  
A. chemical structures of glucose, galactopyranose, galactofuranose, mannose.  
B. Beta-1,3-linkages in β-glucan and alpha-1,3-linkages in α-glucan.  
C. Glyconjugation of Galf with galactomannans.   
 
1.4 Galactofunaose in fungal cell walls: 
Despite decades of effort to characterize the composition and architecture of fungal 
cell walls (Bartnicki-Garcia, 1968; Bowman et al 2006; de Groot et al 2009) many details still 
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remain poorly understood. For example, recent evidence has shown that cell wall composition 
can be remodeled following environmental change, and altering certain minor wall 
components can cause major phenotype effects (Levin, 2005; Fujioka et al 2007; Levin, 2011) 
(Chapter 3 and references therein). Galactofuranose (Galf) decorates certain wall 
carbohydrates and lipids (Lamarre et al., 2009). The six-member ring form, galactopyranose 
(Galp) (Fig 1.2) is abundant in mammals (Pedersen et al 2003; Richards et al 2009). In 
contrast, the five-member ring form galactofuranose (Galf) (Fig 1.2), detected in many 
pathogenic microorganisms is absent in higher eukaryotes including humans (Pedersen et al 
2003; Richards et al 2009; Lamarre et al., 2009).  Galf is important for survival or virulence of 
many pathogenic microorganisms including bacteria, protozoa and some fungi (Beverley et al 
2005; Kleczka et al 2007; Schmalhorst et al 2008; Lamarre et al., 2009). Since Galf is absent 
from higher eukaryotes and is involved in growth or virulence of many bacteria and fungi, the 
enzymes involved in the biosynthesis of Galf are considered to be an attractive drug targets 
(Pan et al 2001, Pedersen 2003).  
Interestingly, the presence of Galf is restricted to bacteria (Köplin et al 1997; Leone et 
al 2010), protozoa (Oppenheimer et al 2011), fungi (El-Ganiny et al., 2008; Latgé, 2009; 
Tefsen et al., 2012) as well as certain algae (Cordeiro et al 2008), archaea (Eichler and 
Adams, 2005), and invertebrates (Ma et al 2010). Galf is essential in Mycobacterium 
tuberculosis, making Galf biosynthesis a drug target against mycobacteria (Scherman et al 
2003). Galf is also found as glycoconjugates on the cell surface of Leishmania and 
Trypanosoma and shown to be important in parasite-cell interaction (MacRae et al., 2006; 
Kleczka et al., 2007).  
In fungi, Galf has been found in pathogenic Penicillium, Histoplasma, Cryptococcus 
and Aspergillus species (Barr et al, 1984; Latgé, 1994; Vaishnav et al 1998) and is considered 
to be an important component of a variety of cell surface glycoconjugates and glycans (Barr et 
al. 1984; El-Ganiny 2008; Lamarre 2009; Shibata and Okawa 2011). In contrast, yeast-like 
fungi belonging to the Taphrinomycotina and Saccharomycotina subphyla within the 
Ascomycota such as Saccharomyces cerevisiae, Schizosaccharomyces pombe, Candida 
albicans, Pichia pastoris do not have wall Galf (Tefsen et al 2012).  
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 In A. fumigatus walls (Fig. 1.3), Galf is said to account for about 5 % of the total wall 
dry weight (Lamarre et al., 2009; Free et al 2013) and is reported to be part of galactomannans 
(Fig 1.3), glycoproteins, sphingolipids and lipophosphogalactomannans (Latgé, 2009). The 
presence of Galf in A. fumigatus improves cell integrity and reduces adhesion to mammalian 
epithelial and endothelial surfaces by masking underlying mannan structures (Lamarre et al., 
2009).  In A. nidulans, deletion of Galf results in severe defects: 500-fold reduction in hyphal 
growth rate and colony sporulation; aberrant cell shape; soft walls with abnormally sticky 
surfaces (El-Ganiny et al, 2008, 2010; Afroz et al. 2011). Galf is also important for normal 
adherent properties of cell wall in A. nidulans (Paul et al. 2011).  
Nevertheless, Galf is not essential for any fungi studied to date. However, its presence 
is important for cell wall growth, maturation and integrity. Although the effects of Galf are 
observed to vary with the organism, generally Galf deficient strains are hypersensitive to 
wall-targeting drugs and exhibit a constitutive osmotic stress phenotype that could be partially 
remediated by growing on 1 M sucrose (El-Ganiny et al. 2008). Gauwerky et al. (2009) and 
Aimanianda & Latgé (2010) suggest that these non-essential wall components have the 
potential to be useful anti-fungal drug targets.  
 
 
Figure 1.3:  Fungal cell wall organization and targets for antifungal 
therapy. Some parts of this image were modified from Gastebois et al. 2009. 
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1.5 Aspergillus nidulans as a model system  
Aspergillus species have both positive and negative impacts on humanity. Aspergillus 
nidulans is one of the most thoroughly characterized fungi with respect to genetics and cell 
biology. Aspergillus hyphae are septate and their cells are haploid and multinucleate. 
However, A. nidulans asexual spores are uninucleate (Todd et al 2007). Aspergillus nidulans 
is important because it is closely related to a large number of other Aspergillus species of 
industrial and medical significance e.g., A. niger, A. oryzae, A. flavus, and A. fumigatus and 
serves as a model for their biology (Todd et al 2007). Research on A. nidulans has made many 
contributions to the understanding of spore development, cell cycle regulation, cell polarity 
generation and maintenance, gene regulation, secondary metabolism, and signalling (Osmani 
et al., 1988; Timberlake, 1990; Momany, 2002; Yu & Keller, 2005).  
There are several advantages that make A. nidulans an excellent experimental model 
system. Aspergillus nidulans has a well-characterized, conventional genetic system unlike 
most Aspergillus species, which are asexual or have cryptic sexual cycles (Fig 1.1) (Todd et 
al., 2007 a&b). The A. nidulans sexual cycle is readily induced so this species is easily 
manipulated using classical and molecular genetics (Todd et al., 2007a). It undergoes 
DNA-mediated transformation, and genes from other Aspergillus species typically function in 
A. nidulans. It grows rapidly as a filamentous fungus on solid or in liquid media under a 
variety of nutritional conditions (Todd et al, 2007a). Aspergillus nidulans is homothallic, 
which means that any two strains can be mated directly. Aspergillus species are normally 
haploid, but can also be induced to grow as a heterokaryon or a vegetative diploid (Fig. 1.1). 
Aspergillus produces both asexual spores (conidia) and sexual spores (ascospores) (Todd et al 
2007b). Aspergillus nidulans is relatively safer [less infective to humans] than A. fumigatus 
and most other Aspergillus species (de Aguirre et al., 2004). Analysis of cell wall sugars of 
A. fumigatus and A. nidulans showed that both fungi have overall similar wall sugar 
composition (Guest and Momany, 2000).  
The genomes of A. nidulans, A. fumigatus, and several other Aspergillus species have 
been sequenced (Galagan et al., 2005; Wortman et al., 2009). The size of the A. nidulans 
genome is relatively small, about 31 Mb (available on the Broad Institute: 
http://www.broadinstitute.org/scientific-community/science/projects/fungal-genome-
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initiative/fungal-genome-initiative). It has eight well-marked chromosomes containing an 
estimated 11,000–12,000 genes. Approximately 900 genes have been identified in A. nidulans 
by conventional matings; 432 have been mapped to locus, and 254 are cloned and sequenced 
(according to Broad Institute data). There are several extensively curated comparative 
databases of many Aspergillus species and easy-to-use web-based tools for accessing, 
analyzing and exploring these data which accelerate Aspergillus research (Rokas et al., 2007; 
Arnaud et al., 2010). Altogether, studies in A. nidulans contribute significantly to 
understanding fundamental biological principles and are relevant for biotechnology and 
industrial applications, as well as human, animal and plant fungal pathogenesis. 
 
1.6 Aspergillus infection 
Fungi cause a wide range of illnesses in humans, from minor skin conditions to 
life-threatening invasive disease. Generally, fungal infections can be categorized into groups 
such as superficial and systemic. Superficial infections affect the surface of the body, the skin, 
mucous membrane, the nails, and the hair. These include ringworm, athlete's foot, and yeast 
infections (Ho and Cheng, 2010). A systemic fungal infection is caused either by an 
opportunistic organism that attacks a person with a weakened immune system (opportunistic 
infection), or by an invasive organism that is common in a specific geographic area, such as 
Coccidioides immitus and Histoplasma capsulatum (Bradsher, 1996; Erjavec et al., 2009; 
Welsh et al., 2012). Unlike superficial infections, human systemic fungal infections are an 
increasing threat (Fisher et al., 2012), particularly due to improved medical technology 
leading to larger populations of immune-compromised people. The most common 
opportunistic fungal infections that affect people are candidiasis, aspergillosis, and 
cryptococcosis. Clinically, candidiasis and aspergillosis account for between 80-90 % of 
systemic fungal infections in immunocompromised and hospitalized patients (Onnis et al 
2009).  
Aspergillus is second to Candida as a cause of invasive or systemic fungal infections 
(Erjavec et al., 2009). Aspergillus is usually acquired in hospital, mainly by intensive care 
patients (Heinemann et al 2004). Mortality is 50-100 % even with treatment (van der Woude 
et al 2004). Although there is a great number of Aspergillus species, Aspergillus fumigatus is 
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the primary causative agent of human infections followed by A. flavus, A. terreus, A. niger, 
and the model organism, A. nidulans (Dagenais and Keller, 2009). Aspergillus fumigatus is 
one of the most common airborne spore-producing fungi in the world (Perfect and Casadevall, 
2006). Its conidia production is prolific, and so human respiratory tract exposure is almost 
constant, (Perfect and Casadevall, 2006) because their concentration in the air is high, 
approximately 1- 100 conidia per m
3
 (Latgé, 2001). Depending on the immune status of the 
host, A. fumigatus can cause a spectrum of diseases ranging from the infection in the sinus, 
airway, or lung tissues in immunocompetent persons to acute invasive aspergillosis in 
immunocompromised patients (Latgé, 1999).  
The exact mechanism for A. fumigatus pathogenicity is not yet identified. However, it 
has been speculated that A. fumigatus virulence is directly correlated with its specific 
biological characteristics: the small size of the conidia (2–3 μm), rapid mycelial growth at 
37 °C, and minimum nutritional requirements (Latgé, 1999). In addition, production of 
secondary metabolites and toxins and the presence of ‘pathogenicity islands’ in genome that 
contain genes that code for one or more virulence factors, such as adhesins and toxins are also 
considered as pathogenic determinants of A. fumigatus (Fedorova et al. 2008). 
The frequent use of anti-fungal drugs (particularly use of azoles in agriculture), 
immunosuppressive agents after organ transplantation, cancer chemotherapy, hematological 
malignancies, chronic granulomatous disease, advanced AIDS, and advances in surgery have 
caused a dramatic increase in the number of immunocompromised individuals who are more 
susceptible to Aspergillus infections (Perfect and Casadevall, 2006). The primary route of 
human infection is by inhalation of airborne conidia, followed by conidial deposition in the 
bronchioles or alveolar spaces.  The lungs are the most common site of Aspergillus infection 
(Latgé, 1999). If the conidia can overcome the immune defence mechanisms in the lung, they 
germinate and produce a compact vegetative mycelium that invades the lung tissues (Latgé, 
1999, 2001). The virulence of A. fumigatus can then be caused either by the production of 
fungal proteins that promote mycelial growth into the lung parenchyma or by structural 
features of the conidia that confer resistance to the host’s antifungal mechanisms (Latgé, 
2001).  
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In immunocompromised individuals, the incidence of invasive infection can easily be 
50 % of patients, with a morbidity rate of ≥50 % (Denning, 1998). Late diagnosis and 
relatively poor knowledge about fungal pathogenicity and virulence factors result in 60-90 % 
mortality rate in humans (Tekaia and Latgé, 2005). In sum, the number of 
immunocompromised individuals is increasing which lead to increase in Aspergillus infection. 
However, as described below, very few antifungal drugs are available to treat these infections. 
 
1.7 Antifungal drugs and fungal resistance:  
Effective treatment for fungal infection has become an increasing concern as the 
frequency of fungal infection increases due to increased numbers of immuocompromised 
patients (Sheppard et al 2004). Fortunately, over the last few decades, a few potent antifungals 
and the increasing use of combination therapy have improved our ability to fight 
life-threatening fungal disease. However, the number of available antifungal drugs is very 
limited. Moreover, few drugs meet the criteria of an ideal antifungal agent such as broad 
spectrum of activity, low host toxicity, flexible routes of administration, and reasonable cost 
(Chapman et al., 2008). Finding such an ideal target is always complicated due to the 
underlying biochemical similarities between humans and fungi (Aimanianda and Latgé, 
2010). In addition, resistance to antifungal treatment can occur. A general schematic diagram 
of fungal cell and its drug targets is given in Fig. 1.3. 
Existing antifungal drugs are grouped into classes according to their targets. The 
newest class of antifungals (~2005) is the echinocandins that target fungal wall biosynthesis 
(Fig 1.3). Echinocandins bind non-competitively to the catalytic subunit of β-1,3-glucan 
synthases (Fks). Fks are membrane protein complexes that are responsible for the synthesis of 
cell wall β-1,3-glucans (Walker et al., 2010). Inhibition of Fks leads to disruption of the 
structure of the growing cell wall, resulting in osmotic instability and death in susceptible 
fungal species (Bowman et al., 2002). Among the numerous semisynthetic echinocandins 
developed in the last decades, caspofungin (trade name: Cancidas, Merck and Co.), 
micafungin (trade name: Mycamine, Astellas Pharmaceuticals) and anidulafungin (trade 
name: Eraxis, Pfizer Pharmaceuticals) are Food and Drug Administration (FDA)-approved 
(Goswami et al., 2012).  As they show good fungicidal (Candida spp.) or fungistatic 
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(Aspergillus spp.) activity against the most important human pathogenic fungi including 
azole-resistant strains, they are an important addition to the antifungal armamentarium 
(Bowman, 2002). However, echinocandins are not effective against C. neoformans or 
non-Aspergillus moulds. Because β-1,3-glucan synthases do not exist in mammalian cells, 
human toxicity associated with echinocandins is limited (Gauwerky et al., 2009).  However 
they must be administered by injection (Kauffman and Carver, 2008). Evidence of acquired 
resistance against echinocandins has already been reported in Candida (Lee et al. 2012). All 
the echinocandin-resistant Candida isolates tested to date harbored Fks mutations and had 
increased chitin content (Lee et al. 2012).  In the case of A. fumigatus, the introduction of 
point mutations within the fks1 gene caused elevated MEC values (Gardiner et al. 2005; 
Rocha et al. 2007). In addition, over-expression of the fks gene as well as increases in chitin 
synthesis (Gardiner et al. 2005; Arendrup et al 2008) might also be responsible for the 
emerging resistance in these filamentous fungus pathogens. 
Cell membrane targeting antifungals either bind directly to ergosterol (polyenes) or 
inhibit ergosterol biosynthesis (azoles, allylamines) (Fig 1.4). Ergosterol is the main sterol 
component of the fungal cell membrane. Ergosterol is chemically similar to human 
cholesterol, and this similarity may result in toxicity in human treatment.  
The polyenes bind irreversibly to ergosterol and disrupt the fungal plasma membrane 
that results in increased membrane permeability, the leakage of the cytoplasmic ion contents 
and ultimately death of the fungal cell (Bolard, 1986; reviewed by Sanglad 2011). Thus, the 
polyenes are fungicidal. Nystatin was the first polyene drug to be used clinically. It is active 
against Candida and Aspergillus. However, nystatin can only be used topically due to 
problems with its solubilisation in injectable solvents, as well as its human toxicity 
(Carrillo-Munoz et al., 1999). Amphotericin B is a polyene that was developed shortly after 
nystatin (~1956). It has a broad spectrum of activity, and is used successfully to treat various 
yeasts and mould infections (Gallis et al., 1990).  Acquired resistance to amphotericin B is 
often associated with alteration of membrane lipids, especially sterols. Recently, C. albicans 
clinical isolates resistant to amphotericin B were described that lacked ergosterol and 
accumulated other sterols (Chau et al 2005; Martel et al., 2010).  
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Azoles are the best-studied class of antifungal drugs (Sheehan et al., 1999). In 
addition, azoles are widely used as agricultural fungicides to control plant fungal diseases 
(Verweij et al., 2009). Azoles are generally recognized as fungistatic agents at clinically 
achievable concentrations. However, recent in vitro studies with itraconazole and 
voriconazole demonstrated fungicidal activity against conidial suspensions of A. fumigatus 
and several other Aspergillus species at concentrations below those attained with 
recommended dosages (Manavathu et al., 1998). Azole antifungal agents used in medicine are 
categorized as imidazoles (ketoconazole, miconazole, clotrimazole) or triazoles (fluconazole, 
itraconazole, posaconazole, voriconazole, and ravuconazole). Azoles target a cytochrome P450 
enzyme, lanosterol 14α-demethylase, (referred to as Erg11p in yeast). This is the product of 
the ERG11 gene as a common cellular target in yeast or moulds (Zhang et al., 2007). The use 
of imidazoles is limited to treating superficial mycoses due to their human toxicity (Zhang et 
al., 2007). In general, the triazoles are relatively safe, even when used for prolonged periods, 
although they can cause liver toxicity (Spanakis et al., 2006). Yeasts or filamentous fungi can 
use several mechanisms to become resistant to azole antifungal agents such as up-regulation 
of ABC-transporter genes, multidrug transporter genes, alterations in cellular target 
(Erg11/Cyp41), and biofilm formation (reviewed by Sanglad, 2011). In general azoles are 
relatively safer than the drugs that target DNA synthesis (see below), however, host toxicity 
and evolving resistance limit their application in humans. 
The allylamines inhibit an early stage of ergosterol biosynthesis by binding the 
enzyme squalene epoxidase (Fig 1.3). Terbinafine is the only allylamine in clinical use for 
subcutaneous infections. Terbinafine has good in vitro activity against Aspergillus spp., 
Fusarium spp. and other filamentous fungi but has variable activity against yeasts (Petranyi et 
al., 1987). Terbinafine may cause gastrointestinal upset and transient elevation of liver 
enzymes (Gauwerky et al., 2009).  
Other agents, including flucytosine (5-fluorocytosine; 5-FC) and griseofulvin target 
nucleic acid biosynthesis and mitosis respectively (Carrillo-Muñoz et al., 2006; Cannon et al., 
2009). In the cell, 5-FC belongs to the class of pyrimidine analogues. It is converted into the 
metabolically active nucleoside analogue 5-fluorouracil, which inhibits RNA and DNA 
synthesis. 5-FC is not usually administered as a single agent because of rapid development of 
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resistance (Barchiesi et al., 2000). It is therefore used mainly in combination with other 
agents, particularly amphotericin B for treatment of Candida species and C. neoformans 
infections (Barchiesi et al., 2000). Resistance may occur due to the deficiency or lack of 
enzymes implicated in the metabolism of 5-FC, or resistance may be due to the deregulation 
of the pyrimidine biosynthetic pathway, in which products can compete with the fluorinated 
metabolites of 5-FC (Bossche et al., 1994). 
Overall, although the arsenal of antifungals has expanded, currently available drugs do 
not meet the increasing requirements of managing infection in complex patient populations. In 
addition, no single class of antifungal is effective against all invasive mycoses, and some are 
highly selective. Besides emerging resistance, there are other problems associated with 
current antifungal therapies such as host toxicity and narrow activity spectra. The problems 
associated with current antifungal drugs require the development of new antifungals for 
clinical therapy. 
 
1.8 The Galf biosynthesis pathway and its possibility to be a drug target in Aspergillus 
Biosynthesis of Galf-containing glycoconjugates requires enzymes for the synthesis of 
activated sugar donors and transporters that ensure substrate availability in the proper cellular 
compartment(s). Enzymes in the Galf pathway have been well studied in prokaryotes (Weston 
et al., 1998; Mikusova et al., 2006). These include UDP-galactopyranose mutase (UGM) that 
catalyzes the inter-conversion between UDP-Galp and UDP-Galf (Weston et al., 1998) and 
galactofuranosyl transferase(s) that transfer Galf moieties from UDP-Galf to glycoconjugate 
molecules (Belanova et al., 2008).  
In eukaryotes including fungi, Galf biosynthesis and incorporation in the cell wall is a 
multistep process that is summarized in Fig 1.4. In Aspergillus, it starts with the synthesis of 
nucleotide-sugar donor UDP-Galp (Fig 1.4). UDP-Galp is generated by the epimerization of 
UDP-glucose by UDP-glucose-4-epimerase (UGE), as well as by the salvage of galactose (Fig 
2.1 in Chapter 2). In many organisms, galactose salvage occurs via the Leloir pathway, which 
includes GalE and GalD and provides a unique means for cells to use galactose as a carbon 
and energy source (Fekete et al, 2004). UDP-Galf is produced directly from UDP-Galp by 
UDP-galactopyranose mutase (UgmA) (El-Ganiny et al 2008). UDP-Galf is then transported 
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into the lumen of the Golgi by UgtA (Afroz et al 2011). Finally, the enzyme Galf transferase 
is responsible for transferring Galf from transported UDP-galactofuranose (Galf) to the 
respective glycoconjugate molecules (Fig 1.4).  
In A. fumigatus walls, Galf is reported to be part of four different molecules including 
galactomannans, glycoproteins, several sphingolipids, and lipophosphogalactomannan (Latgé, 
2009). Based on the likely Galf-containing structures (Latgé, 2009), it is expected that 
multiple putative galactofuranosyl (Galf) transferases contribute to the synthesis of the 
different glycoconjugates. Finally, all glycoconjugates are transported to the cell surface from 
where they are eventually transferred to the cell wall, or released into the extracellular space. 
Galf transferases that incorporate Galf into glycoconjugates have been identified in bacteria 
and protozoa, and most recently in fungi (Komachi et al., 2013). 
 
Figure 1.4: Predicted model for Galf biosynthesis and its deposition to cell wall. 
UDP-Glu; uridine diphosphate-glucose, UGE; UDP-glucose-4-epimerase, UDP-Galp; 
UDP-Galactopyranose, UGM; UDP-galactopyranose mutase; UDP-Galf; UDP-
galactofuranose, UGT; UDP-galactofuranose transporter, Galf-Transferase; 
galactofuranose transferase, Galf; galactofuranose. 
 
1.8.1 Galactokinase (GalE) and galactose-1-phosphate uridylyltransferase (GalD) 
Galactose is transported and phosphorylated by GalE to form galactose-1-phosphate. 
In the next round of the transfer reaction, GalD interconverts glucose- or 
galactose-1-phosphate to their UDP conjugates. Both of these steps are highly conserved in 
species ranging from bacteria to humans (Holden et al., 2003). In addition, both use the Leloir 
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pathway for D-galactose metabolism and therefore, all genes are essential for growth on D-
galactose (Slepak et al. 2005, reviewed in Seiboth et al 2007).  
GalE is essential for galactose metabolism in S. cerevisiae (Slepak et al. 2005). GalD 
is also essential for S. cerevisiae growth on galactose (Slepak et al. 2005) and for galactose 
metabolism in Kluyveromyces lactis (Dickson and Riley 1989). Although GalD and GalE 
appear to be the main D-galactose degrading enzymes in Aspergillus, alternative or additional 
galactose metabolism pathways via galactitol, sorbitol and fructose have been proposed in 
A. nidulans (Elorza, 1971; Fekete et al. 2004).  
 
1.8.2 UDP-glucose-4-epimerase (Uge): 
The catalytic conversion of UDP-galactopyranose from UDP-glucose by 
UDP-glucose/galactose 4-epimerase (UGE/Gal10) is a step in the Leloir pathway of galactose 
metabolism. This step is highly conserved in species ranging from bacteria to humans 
(Holden et al., 2003). Loss of Uge (called GalE in humans) activity causes a metabolic 
disorder called galactosemia (Openo et al., 2006). In some species, this step may be the only 
mechanism for providing galactose to the cell in the absence of an external source (Singh et 
al., 2007). Some fungi including C. neoformans, S. pombe and some Aspergillus species have 
two genes that both encode functional UDP-glucose/galactose epimerases (Moyrand, 2008; 
Suzuki et al., 2009), whereas some other fungi (e.g. C. albicans) have only one (Singh et al., 
2007). C. albicans glucose  galactose-4-epimerase was found to be essential for growth on 
galactose. In C. neoformans, Uge1 is essential for capsule formation and virulence, whereas 
Uge2 is necessary for the cells to utilize galactose as a carbon source at 30 ºC but is not 
required for virulence (Moyrand et al., 2008). Mutations of Uge (GalE) in S. cerevisiae cause 
galactose sensitivity: the mutants cease growth in response to trace quantities of galactose, 
even in the presence of other carbon sources (Wasilenko and Fridovich-Keil, 2006). In A. 
nidulans, the ugeA deleted strain is viable on glucose but has reduced growth and sporulation 
(El-Ganiny 2010). In the protozoan, Trypanosoma brucei, galactose metabolism mediated by 
Uge (called GalE) is essential for parasite growth and survival (Roper et al., 2002).  
Trypanosoma brucei Uge is a validated drug target for African sleeping sickness. 
Some inhibitors of T. brucei Uge were identified by screening a small library of natural 
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products and commercially available compounds. Unfortunately, these inhibitors showed a 
small degree of selectivity between human and Trypanosoma enzymes (Urbaniak et al., 
2006). Although Uge is highly conserved amongst diverse organisms, it may be possible to 
find compounds that selectively inhibit its function in specific organisms. However, UgeA is 
not essential in any Aspergillus species, unlike Trypanosoma (Roper et al., 2002), so selection 
pressures to overcome a future potential therapeutic compound might be reduced. 
 
1.8.3 UDP-galactopyranose mutase (Ugm) 
The cytosolic enzyme Ugm is the key enzyme in the Galf biosynthesis pathway. Ugm 
is responsible for interconversion of UDP-Galp and UDP-Galf. The gene encoding Ugm (also 
called GlfA in A. fumigatus) has been identified and characterized in several eukaryotes, 
including L. major, T. cruzi, Caenorhabaditis elegans, A. fumigatus, A. nidulans, and A. niger 
(Beverley et al. 2005; Kleczka et al. 2007; Damveld et al. 2008; El-Ganiny et al. 2008; 
Schmalhorst et al. 2008; Novelli et al. 2009). Ugm in different systems has been shown to be 
important for survival, growth, and  or pathogenicity. Deletion of ugm from Mycobacterium 
tuberculosis showed that it was essential for growth and survival (Pan et al., 2001). Targeted 
replacement of glf in L. major (the causative agent of leishmaniasis) caused attenuation of 
virulence (Kleczka et al., 2007). Deletion of glf-1 from the nematode C. elegans caused a 
significant late embryonic and larval lethality due to defective surface coat formation (Novelli 
et al., 2009). Deletion of ugmA in A. fumigatus, A. nidulans, and A. niger revealed the 
corresponding knock-out strains were all completely lacking in Galf and exhibited marked 
alterations to their cell wall and growth (Damveld et al. 2008; Lamarre et al 2009). 
Additionally, infection of mice by Ugm deletion strains of either L. major or A. fumigatus 
showed significant attenuation to virulence (Kleczka et al 2007; Schmalhorst et al 2008). 
A. niger has two genes that encode putative UDP-galactopyranose mutase (ugmA & ugmB). 
Damveld et al. (2008) had shown that A. niger strains with defective ugmA homologues had 
impaired colony growth and increased wall α-glucan content. 
The crystal structure of Escherichia coli Ugm was described in 2001 (Sanders et al., 
2001), followed by the crystal structures of UGM from M. tuberculosis and K. pneumoniae 
(Beis et al., 2005). Although the sequence conservation between prokaryotic and eukaryotic 
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Ugms is low (15–20 %), a number of features are conserved, including the presence of FAD 
(van Straaten et al, 2011). Recently, the crystal structure of A. fumigatus Ugm has been solved 
(van Straaten et al, 2011). Despite low sequence identity with known prokaryotic Ugms, the 
overall fold is largely conserved.  Fungal Ugms function as homotetramers (van Straaten et al, 
2011), whereas L. major Ugm functions as a monomer (Oppenheimer et al. 2011) and hence 
both differ from the dimeric bacterial Ugms. 
Considering the fact that Ugm is critical for microbial growth and virulence and is not 
found in humans, Ugm is an attractive target for drug discovery (Oppenheimer et al 2011). 
Several inhibitors of bacterial UGM have been reported (Dykhuizen et al., 2008), but no 
inhibitor has been developed that is effective against fungal Ugm. Notably, UgmA is not 
essential in either of these Aspergillus species, unlike several pathogenic bacteria, so selection 
pressure to overcome a future potential therapeutic compound might be reduced.  
 
1.8.4 UDP-Galf transporter 
Many nucleotide sugars are synthesized in the cytosol and then translocated to the 
lumen of Golgi or ER by the action of the nucleotide-sugar transporters (NSTs) (Handford et 
al., 2006). NSTs are integral proteins typically with six to ten transmembrane domains 
(Handford et al., 2006). They occur in all eukaryotes and frequently are located in the 
membrane of the Golgi apparatus, an organelle in the endomembrane system where the 
biosynthesis of glycoconjugates and polysaccharides occurs. Glycosylation requires a sugar 
donor that typically is a nucleoside diphosphate sugar (NDP-sugar) or nucleoside 
monophosphate sugar (Reyes and Orellana, 2008).  
 UDP-Galf is a nucleotide diphosphate sugar, which is synthesized in the cytosol and 
so must be translocated into a membrane-bound organelle prior to incorporation into 
glycoconjugates. Interestingly, an UDP-Galf transporter (GlfB/UgtA) seems to be presented 
in all filamentous fungi of the subphylum Pezizomycotina and is directly adjacent or in close 
proximity to the GlfA/UgmA gene, which encodes the UGM (Tefsen et al 2012). However, 
until now UDP-Galf transporter (GlfB) has only been characterized in A. fumigatus and 
A. nidulans. In both species, ugtA/glfB is adjacent to the glfA/ugmA and both transporters 
localized to the Golgi equivalent (Engel et al. 2009; Afroz et al 2011). Analysis of 
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glycoproteins, glycolipids and galactomannans of the A. fumigatus glfB knockout strain 
revealed that none of these compounds contain Galf moieties. The deletion or repression of 
the UDP-Galf transporter (UgtA) in A. nidulans impaired growth and sporulation and 
increased drug sensitivity (Afroz et al 2011). AfglfB restored wild type growth in the 
AnugtA∆ strain, showing that these genes have homologous function (Afroz et al 2011). 
 In summary, the UDP-Galf transporter actively translocates the nucleotide sugar 
UDP-Galf from cytosol into Golgi equivalent in fungi. To our knowledge UDP-Galf 
transporter has only been studied in A. fumigatus and A. nidulans. Moreover, UDP-Galf 
specific transporter is absent in animals. Notably, the ugtA∆ strain showed significantly more 
sensitive to Caspofungin (Afroz et al., 2011), suggesting that drugs that could be developed to 
target the Galf biosynthesis pathway have potential for combination therapy. 
 
1.8.5 Galactofuranosyl transferases 
Galf exists as glycoconjugates in microbial cell wall. The enzyme galactofuranosyl 
transferase (Galf transferase) is responsible for transferring Galf from UDP-Galf to the 
respective glycoconjugate molecules (Chen and Okayama, 1988). These glycosylation steps 
take place in one or more compartments of the endomembrane system. Generally it involves 
in transferring monosacchararides to proteins, lipids or carbohydrates to produce 
glycoconjugates. To better understand the role of individual Galf-containing glycoconjugates 
in cell wall biosynthesis or pathogenesis, it is necessary to identify and characterize the Galf 
transferases that catalyze the addition of Galf from UDP-Galf to the respective acceptor 
substrates.  
Several Galf transferases have been identified in prokaryotes, such as WbbI in E. coli 
that performs β-1,6-coupling of Galf to α-glucose (Wing et al. 2006) and WbbO in 
K. pneumoniae that couples Galf in a β-1,3-linkage to Galp (Guan et al. 2001). Two 
galactofuranosyl transferases were identified in Mycobacterium, GlfT1 (Rv3782) and GlfT2 
(Rv3808c) (Belanova et al., 2008). GlfT1 initiates the first step of galactan synthesis, whereas 
GlfT2 is a bifunctional enzyme responsible for the majority of galactan polymerization 
(Szczepina et al., 2010). LPG1 is the only putative Galf transferase described in L. major,  
(Novozhilova and Bovin, 2010). Many glycosyltransferases have been identified in fungi 
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including glucan synthases, chitin synthases, and mannosyltransferases (Klutts et al., 2006). 
However, until now only one putative Galf specific transferase (GfsA) has been reported in 
Aspergillus nidulans and Aspergillus fumigatus (Komachi et al, 2013). Disruption of gfsA 
reduced binding of β-Galf-specific antibody EB-A2 to galactomannoproteins (Komachi et al, 
2013). Galf transferases are considered as a potential anti-microbial drug target. Some 
inhibitors have already been synthesized against Galf transferases and proven to be potent 
drugs against Mycobacterium (Peltier et al., 2010).  
 In sum, all the enzymes in the Galf pathway are important but not essential for fungal 
for normal growth, sporulation and wall maturation. Therefore, none of these enzymes in Galf 
biosynthesis pathway itself have the potential to be an antifungal drug target. However, 
considering Galf-lacking strains had substantially reduced growth and hypersensitivity to 
caspofungin, anti-Galf drugs (once created) may be useful in combination with existing 
antifungal drugs. Combination therapy is already in use to combat fungal infection. For 
example, it has been shown that toxicity of amphotericin B can be reduced in combination 
with echinocandins (Mihu et al., 2010). Use of flucytosine in combination with many other 
drugs helps in preventing the rapid development of resistance (Johnson et al., 2004). 
Altogether, considering the emergence of resistance against antifungal drugs and the high rate 
of mortality from fungal infections, there is a pressing need for new therapeutic options. Use 
of combination therapy, especially anti-Galf drugs in combination with echinocandins may 
overcome both emergence resistance and infection problems. 
 
1. 9. Summary 
Systemic fungal infection is life threatening, especially for immunocompromised 
patients. Treatment of fungal infections is challenging because fungi share many metabolic 
pathways with mammals. In addition, due to emerging drug resistance, current antifungals are 
losing effectiveness. Therefore, new therapeutic approaches, including antifungal agents with 
novel mechanisms of action, are urgently needed. The cell wall is essential for fungal survival 
in natural environments. Polysaccharides and glycoconjugates are significant components of 
fungal walls. They form an interface between cells or organisms and their environment, 
enabling cell–cell interactions and signaling events. Due to the importance of cell walls for 
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fungal growth and host invasion, and the lack of conservation with animal cell components, 
the cell wall is expected to be a good source of potential antifungal targets.  
 Galf decorates certain carbohydrates and lipids, comprises about 5 % of the 
Aspergillus fumigatus cell wall, and may play a role in systemic aspergillosis. In the 
filamentous fungus, A. nidulans, galactokinase (GalE) mediates galactose phosphorylation to 
galactose-1-phosphate. Galactose-1-phosphate uridylyltransferase (GalD) interconverts 
glucose- or galactose-1-phosphate to their UDP conjugates. UDP-glucose is a substrate for 
UDP-galactose-4-epimerase (UgeA) to create UDP-galactopyranose, which can potentially be 
processed into UDP-Galf by UDP-galactopyranose mutase (UgmA). Galf is transported into 
the Golgi by the UDP-Galf transporter (UgtA) and eventually   deposited as galactofuranose 
(Galf) in the cell wall as a Galf glycoconjugate.  
During my research, I characterized the function of enzymes that involve in galactose 
metabolism and Galf biosynthesis using gene deletion strategy, and by controlling gene 
expression with regulatable promoters to compare the effects of gene repression and 
induction. Phenotype characterization of the deleted strains in comparison to the wild type 
strain used fluorescence microscopy, scanning electron microscopy (SEM), and transmission 
electron microscopy (TEM). Gene product localization used green fluorescent protein (GFP) 
tagging, and Galf localization used immunofluorescence microscopy. To assess whether 
Galf-targeting compounds (once created) might be useful for combination therapy, I assessed 
the sensitivity of the Galf-defective strains to commercially available antifungal drugs. I also 
studied how modification of A. nidulans Galf leads to changes in cell wall α-glucan and 
β-glucan content, hyphal surface adhesion using immunofluorescence, ELISA, and a 
fluorescence bead assay. Interacting partners of UgmA were revealed using tandem affinity 
purification and LC-MS analysis. 
 
1.10. Outline and objectives  
My thesis consists of six Chapters. The first chapter is the general introduction. 
Chapters 2-5 contain four manuscripts that discuss the roles of GalD and GalE in galactose 
metabolism (Chapter 2), roles of enzymes (UgmA, UgeA, UgtA) of Galf biosynthesis 
pathway in fungal growth, drug sensitivity, and relationship with other major carbohydrate 
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biosynthesis pathways (Chapter 3), how modification of Galf leads to changes in cell wall 
composition, hyphal surface adhesion and response to antifungal drugs (Chapter 4), and 
revealing the interacting partner of A. nidulans UgmA using a proteomic approach (Chapter 
5). My roles in these manuscripts are described on the first page of each chapter. In the final 
chapter of my thesis (Chapter 6), I discuss my overall research results in terms of their 
importance in understanding the complexity of galactose metabolism in Aspergillus spp., 
contribution of Galf in fungal growth, development, drug sensitivity, cell wall modification 
and co-ordination Galf with other carbohydrate pathways. The final section of Chapter 6 
discusses the possibility for anti-Galf drug as a part of a combination therapy and future 
directions. 
 
My thesis work is based on following objectives,  
1. Exploring the biological roles of galactose metabolism enzymes in the model filamentous 
fungi Aspergillus nidulans. 
Hypothesis: The A. nidulans strains that lack galactose metabolism enzymes will be 
unable to grow when galactose is the sole carbon source. 
2. Exploring the roles of Galf-defective strains in wall maturation and sensitivity to available 
antifungal drugs. 
Hypothesis: Galf deletion/repressed A. nidulans strains will have a wall defect that will 
make them more sensitive to wall-targeting agents. 
3. Assessing how modification of UDP-galactopyranose mutase activity leads to changes in A. 
nidulans cell wall α-glucan and β-glucan content, hyphal surface adhesion and response 
to antifungal drugs. 
Hypothesis: Aspergillus nidulans strains lacking UgmA or hosting mutated UgmA will 
have significantly altered carbohydrate content in their cell wall compared to the wild 
type strain. These UgmA defective strains will also have less or no Galf in their cell wall.  
4. Revealing the interacting partner of Aspergillus nidulans UgmA using tandem affinity 
purification (TAP). 
Hypothesis: UgmA is part of a protein complex in A. nidulans that likely includes UgeA, 
UgtA, and members of α-glucan and beta-glucan metabolism. 
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      CHAPTER 2  
 
Aspergillus galactose metabolism is more complex than that of Saccharomyces: the story 
of GalD
GAL7
 and GalE
GAL1 
 
This Chapter studies the biological roles of two enzymes in galactose metabolism 
pathway, GalD
GAL7
 and GalE
GAL1
. The manuscript has been published as “Aspergillus 
galactose metabolism is more complex than that of Saccharomyces: the story of 
GalD
GAL7
 and GalE
GAL1” in Botany 91(7): 467-477 by Md. Kausar Alam and Susan 
Kaminskyj, 2013. 
 
This Chapter was based on our hypothesis “the strains that lack galactose metabolism 
enzymes will be unable to grow when galactose is the sole carbon source”. The objectives of 
the research in this Chapter were 
1. To identify putative GalD and GalE in A. nidulans  
2. To explore the biological roles of galactose metabolism enzymes in A. nidulans 
3. To investigate the effects of galD and galE deletion on colony growth, hyphal 
morphogenesis, drug senstivity and cell wall ultrastructure. 
4. To determine the subcellular localization of A. nidulans GalD and GalE 
 
My contribution in this Paper: This project was the first project of my program. I started 
with identification of Aspergillus nidulans GalD
GAL7
 and GalE
GAL1
. I performed all the 
experiments including: designing primers for gene deletion, confirming the deletion, GFP 
tagging, characterization of GalD
GAL7
 and GalE
GAL1
 strains using confocal, SEM and TEM, 
Immunolocalization of Galf in wild type and GalD
GAL7
 and GalE
GAL1
 strains, complementing 
GalD
GAL7
 and GalE
GAL1
 strain defects using S. cerevisiae GAL7 and GAL1, drug sensitivity 
study. I did the statistical analysis of the data and the editing of the final figures. I wrote the 
first draft of the manuscript. Professor Susan Kaminskyj and I worked together to revise this 
draft prior to submission.  We also worked together on the revision. 
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Abstract 
Saccharomyces cerevisiae GAL1 (galactokinase) generates galactose-1-phosphate; 
GAL7 (galactose-1-phosphate uridylyltransferase) transfers UDP between galactose and 
glucose and their respective sugar-1-phosphate conjugates; each is essential on galactose. 
Aspergillus nidulans ANID_04957 has 41% amino acid sequence identity with GAL1; 
ANID_06182 has 50% sequence identity with GAL7. Aspergillus nidulans GalE 
(galactokinase) and GalD (galactose-1-phosphate uridylyltransferase) names are consistent 
with prior studies. The galDΔ and galD5 strains did not grow on minimal medium galactose 
(MM-Gal) at pH4.5, but did on MM glucose; both grew on MM-Gal at pH7.5. The galE∆ and 
galE9 strains grew on MM-Gal at both pH levels. Complemented galDΔ:ScGAL7 and 
galEΔ:ScGAL1 strains demonstrated functional homology. Both galD5 and galE9 alleles 
were truncated. Both galDΔ and galEΔ produced wild type conidiophores on MM-Glu, but 
few spores; sporulation was lower on MM-Gal pH7.5. GalD-GFP and GalE-GFP were 
cytosolic, and more intense on MM-Gal than MM-Glu, consistent with qRT-PCR. 
Galactofuranose immunolocalization in galDΔ walls was wildtype on MM-Glu, low on MM-
Gal pH7.5, and absent on MM-Gal pH4.5. The galDΔ and galEΔ strains were more sensitive 
to Caspofungin and to Itraconazole on MM-Gal pH7.5. GalD and GalE are functionally 
homologous to S. cerevisiae GAL7 and GAL1, respectively, supporting their being other 
routes for galactose metabolism in Aspergillus. A. nidulans galactose metabolism is more 
complex than S. cerevisiae 
 
Key words: Aspergillus nidulans, galactose, galactose-1-phosphate uridylyltransferase, 
galactokinase, GAL7, GAL1. 
 
Abbreviations: MM-Glu, Minimal medium containing 1 % glucose; MM-Gal, minimal 
medium containing 1 % galactose; GalD, galactose-1-phosphate uridylyltransferase; GalE, 
galactokinase;  
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2. 1. Introduction 
Galactose metabolism is conserved from bacteria through humans (Christacos et al. 
2000; Ross et al. 2004). Galactose itself cannot be used directly for glycolysis. Before it can 
enter the Embden-Meyerhof glycolytic pathway, galactose must be converted via galactose-1-
phosphate into glucose-1-phosphate (Sellick et al. 2008). The enzymes of the Leloir pathway 
are responsible for this conversion. The Leloir pathway enzymes for galactose metabolism are 
galactokinase, galactose-1-phosphate uridylyltransferase, and UDP-glucose/galactose-4-
epimerase (Holden et al. 2003). These enzymes are named differently in different systems.  
To avoid confusion, names for orthologous genes in Aspergillus, Saccharomyces, Escherichia 
and Human are included in Figure 2.1. The Leloir pathway is also summarized in Figure 2.1. 
In humans, mutations in any Leloir enzyme can produce clinical deficiencies in 
galactose metabolism known as galactosemias (Holden et al. 2003; Timson et al. 2005). 
Mutations in human galactokinase and galactose-1-phosphate uridylyltransferase produce 
galactosemia types I & II respectively (Holden et al. 2003; Timson et al. 2005). Symptoms 
begin within a few days of birth, and progress to poor growth and mental retardation, 
cataracts, and potentially fatal accumulations of galactose in tissues. Treatment requires a diet 
free of lactose and high-galactose foods such as celery and stone fruits. More than 130 
different mutations in human galactose-1-phosphate uridylyltransferase have been mapped to 
the E. coli GALT crystal structure (Wedekind et al. 2004) and correlated with their clinical 
outcomes (Elsas and Lai, 1998).  
Saccharomyces cerevisiae galactose-1-phosphate uridylyltransferase (GAL7) and 
galactokinase (GAL1) were characterized by Slepak et al. (2005), who described them as 
having pivotal roles in S. cerevisiae growth and metabolism. An S. cerevisiae strain deleted 
for GAL7 (gal7∆) ceased growth after 0.2 % galactose was added to the yeast extract-glycerol 
broth in which it had been growing exponentially. The full effect of growth inhibition by 
galactose in gal7∆ cells required ~4 h, during which they accumulated galactose-1-phosphate 
(Slepak et al. 2005). Using RT-PCR and gene expression profiling, they also showed that 
during ‘galactose intoxication’ RNA and ribosome biogenesis were down-regulated and 
inositol biosynthesis was up-regulated, suggesting that galactose-1-phosphate accumulation 
had multiple adverse effects. Slepak et al. (2005) also showed that unlike gal7∆, in gal1∆ the 
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addition of 0.2 % galactose did not prevent growth. Both the presence of galactose and the 
absence of glucose are required for induction of galactose metabolism enzymes (Timson, 
2007). 
The biological function of galactokinase (GalE) and galactose-1-phosphate 
uridylyltransferase (GalD) have not been fully characterized in Aspergillus. Roberts (1963, 
1970) described some roles of mutant alleles of these enzymes in galactose metabolism, and 
Fekete et al. (2004) explored the enzymatic role of galactokinase in Aspergillus nidulans.  
The Aspergillus nidulans Leloir pathway enzymes UDP-glucose/galactose-4-
epimerase (ugeA) (El-Ganiny et al. 2010) and UDP-galactopyranose mutase (ugmA) 
(El-Ganiny et al. 2008) are required for wild type hyphal morphogenesis and spore 
development, and have similar deletion phenotypes. Consistent with their role in generating 
galactofuranose (Galf) residues for the cell wall, strains without UgeA or UgmA both lack 
wall Galf and have similar defects in hyphal wall architecture (Paul et al. 2011). Deletion of 
the UDP- Galf transporter, UgtA that acted downstream of UgmA has a similar effect (Afroz 
et al. 2011). Here, we characterize deletion strains for A. nidulans galactokinase and glucose-
1-phosphate uridylyltransferase, which function immediately upstream of UgeA, and compare 
them to partially described mutant alleles of these enzymes from earlier studies (Roberts, 
1970). 
 
2. 2. Methods 
2. 2.1. Cultures and growth conditions 
Strains, plasmids and primers used in this study are listed in Table S1. Aspergillus 
nidulans strains were grown as described in El-Ganiny et al. (2008) using media described in 
Kaminskyj (2001), and supplemented for nutritional markers as required. Minimal medium 
contained 1 % glucose or 1 % galactose (MM-Glu or MM-Gal, respectively), plus nitrate salts 
and trace elements. MM-Gal containing 70 mM NaNO3 was called MMN. MM-Gal 
containing 70 mM ammonium tartrate as the N-source was called MMA. Complete medium 
(CM) was MM amended with 0.4 % peptides (0.2 % peptone, 0.1 % casamino acids, 0.1 % 
yeast extract) and vitamin solution. The morphometric analysis, expression, and drug studies 
used MM-Gal containing nitrate at pH 7.5. 
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2. 2.2. Strain construction and validation  
Protoplasting followed procedures in Osmani et al. (2006). Protoplast storage is 
described in El-Ganiny et al. (2010). Gene knockout, complementation, GFP-tagging, and 
cDNA construction is described in El-Ganiny et al. (2008, 2010), and Afroz et al. (2011). 
Confirmation of gene manipulation used genomic DNA from putative transformant strains as 
a template for PCR with combinations of primers as shown Suppl Table S1 and Figs. S1-S6. 
Spore genomic DNA was extracted using the microwave procedure described in Alam et al. 
(in press). cDNAs were cloned into pCR4-TOPO, and sequenced using a Genetic Analyzer 
(Applied Biosystems). 
 
2. 2.3. Complementation of galDΔ with S. cerevisiae GAL7 and galEΔ with S. cerevisiae 
GAL1 
GAL7 and GAL1 were amplified from S. cerevisiae genomic DNA. A construct 
consisting of GAL7, the selectable marker AfpyroA, and 1 kb flanking regions of the galD 
coding sequence, was created using fusion PCR and introduced into the galD strain. 
ScGAL1 was introduced in the galE strain as described for GAL7. Strains were validated 
using PCR (described above) and morphometry on MM-Gal (described below). 
 
2. 2.4. Strain morphometry  
Colony and hyphal characteristics of the galD∆, galD5, galE∆, and galE9 strains were 
quantified using procedures described in El-Ganiny et al. (2008). Colony growth was 
compared for strains inoculated as 5 µL drops containing 5000 spores, and incubated for 2 d 
at 28 ºC. For fluorescence microscopy, freshly harvested conidia were grown on coverslips 
for 16 h at 28 ºC in liquid MM-Glu or MM-Gal (with nitrate, pH 7.5), fixed in formalin, 
stained with 0.4 μg/mL Hoechst 33258 (for nuclei) and 0.2 μg/mL Calcofluor (for cell walls). 
Samples were imaged by confocal fluorescence microscopy using a Zeiss META510 and a 
63×, N.A. 1.2 multi-immersion objective, and 405 nm excitation.  
 Hyphal width (at septa) and basal cell length (distance between adjacent septa) were 
measured for 30 cells per strain, and nuclei were counted in those cells. Morphometry data 
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(Table 2.1) are mean ± standard error of the mean. The number of branches in the apical 100 
μm was counted for hyphae grown on MM-Glu and MM-Gal.  
Spores harvested from colonies that appeared to have developed from single spores after 3 d 
at 28 °C were used to estimate number produced per colony, as previously described by 
El-Ganiny et al. (2008). Sporulation rate for strain and media combinations are expressed 
with respect to wild type on MM-Glu (100 %), which was 5 x 10
8
 spores per colony. Spore 
germination counted germlings produced by defined numbers of conidia inoculated on three 
replicate plates after 24 h at 28 ºC; for galDΔ on galactose, germination was assessed after 48 
h at 28 ºC.  
Cell wall thickness was measured on TEM cross-sections of hyphae where the cell 
membrane was crisply in focus (10 hyphae, 2 or 3 measurements each) as described in Afroz 
et al. 2011. ANOVA tests were used to assess the statistical significance of differences using 
GraphPad (Prism Software). 
 
2. 2.5. Scanning and transmission electron microscopy  
SEM followed procedures in El-Ganiny et al. (2010) for colonies grown for 3 d at 
28 ºC on dialysis tubing laid on selective media. TEM examined hyphae grown for 16 h on 
dialysis tubing (Afroz et al. 2011) laid on MM agar.  
 
2. 2.6. Galf immunolocalization, GalD and GalE localization  
Hyphal wall Galf content was assessed using immunolocalization following 
procedures in El-Ganiny et al. (2008) and examined using confocal fluorescence microscopy. 
Monoclonal anti-Galf antibody L10 was a gift of Prof. Frank Ebel (Univ Munich). Primary 
antisera were used at full strength; TRITC-conjugated goat-antimouse was used at 1:10 
dilution. GalD-GFP and GalE-GFP localization, under the control of their wild type 
promoters, was examined in growing hyphae using confocal fluorescence microscopy. 
Controls included samples with no primary antibody, or no secondary antibody. These 
produced no fluorescent signal. Within each fluorescence-based study, imaging parameters 
were kept constant to permit comparison. 
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2. 2.7. Quantitative real time PCR (qRT-PCR)  
Total RNA was extracted from wild type strain AAE1 that had been grown for 16 h at 
37 ºC on MM-Glu or MM-Glycerol, or MM-Gal (nitrate, pH 7.5), using an RNeasy plus mini-
kit (Qiagen). One microgram of total RNA was used for cDNA synthesis using a Quantitect 
Reverse Transcription Kit (Qiagen). To quantify galD and galE expression, we used 2-step 
qRT-PCR (QuantiTect® SYBR Green PCR kit; Qiagen) and an iQ5 real-time PCR detection 
system (Bio-Rad). Conditions: one cycle at 95 ºC for 10 min, 40 cycles of  95 ºC for 30 s, 60 
ºC for 1 min and 72 ºC for 1 min. Data were analyzed using the thermocycler-associated 
software. The galD and galE expression was normalized using actA (Upadhyay & Shaw, 
2008). Following amplification, melting curves for the products were generated to ensure that 
each represented homogenous species.  
 
2. 2.8. Antifungal susceptibility testing 
Drug sensitivity of galDΔ, galEΔ and wild type strains was compared using a disc 
diffusion assay (Afroz et al. 2011). Strains were grown for two rounds on the test media 
before being used for drug sensitivity studies, to compensate for potential spore dowry effects.  
For this test, 1 x 10
7
 spores were mixed into 20 mL of 50 ºC MM agar and immediately 
poured in 9 cm Petri plates. After the medium had solidified, sterile 6 mm paper discs were 
placed on the agar surface. Anti-fungal drug stock solutions were micro-pipetted onto 
individual disks: 20 mg/mL Caspofungin® in water, 20 mg/mL Itraconazole® in water, or 
10 mg/mL Calcofluor White in 25 mM KOH (Hill et al. 2006). Solvent control studies with 
DMSO and 50 % ethanol showed no zone of inhibition. The plates were incubated at 30 ºC 
and assessed after 48 h (Kiraz et al. 2009).    
The radius of the zone of inhibition was calculated as  
[diameter with no visible growth (mm) – disk diameter] / 2. 
For each biological replicate, two measurements at orthogonal axes were taken for 
each disk on each plate. Four plates (biological replicates) were assessed for each strain and 
medium combination, and each experiment was repeated. These data were used for statistical 
analysis (ANOVA). Data are presented as indexed values for galDΔ and galEΔ on MM–Glu 
or MM-Gal with respect to wild type on MM–Glu or MM-Gal. Mean ± SE of two 
 34 
 
measurements for each of three biological replicates were used for statistical analysis (not 
shown). 
2. 3. Results 
2. 3.1. Identification and characterization of Aspergillus nidulans GalD and GalE  
              Saccharomyces cerevisiae GAL7 and GAL1 encode galactose-1-phosphate 
uridylyltransferase and galactokinase, respectively (Broach, 1979). BLAST analysis of the 
primary amino acid sequences of S. cerevisiae GAL7 and GAL1 using 
http://www.broadinstitute.org/annotation/genome/aspergillus_group/Blast.html showed that 
A. nidulans ANID_06182.1 had 50 % sequence identity with GAL7 and A. nidulans 
ANID_04957.1 had 41 % sequence identity with GAL1. These had been annotated as a 
galactose-1-phosphate uridylyltransferase and a galactokinase, respectively. We named 
ANID_06182 as GalD and ANID_04957 as GalE, to be consistent with Roberts (1963, 1970). 
Reactions mediated by A. nidulans GalD and GalE (this paper), UgeA (El-Ganiny et al. 
2010), and UgmA (El-Ganiny et al. 2008) are shown in Fig. 2.1 Aspergillus nidulans GalD 
had 80-85 % amino acid sequence identity with A. clavatus, A. flavus, A. fumigatus, A. niger, 
A. oryzae and A. terreus orthologues, 43 % with Homo sapiens GALT, and 46 % with 
Escherichia coli GALT. Aspergillus nidulans GalE had 80-85 % amino acid sequence identity 
with A. clavatus, A. flavus, A. fumigatus, A. oryzae and A. terreus orthologues, and 38 % with 
Homo sapiens GALK.   
 We replaced the ANID_06182 coding sequence in the nkuA∆ strain A1149 with A. 
fumigatus pyroA, creating strain galDΔ. We replaced ANID_04957, also in A1149, with A. 
fumigatus pyrG creating strain galEΔ. Conidia produced by each type of primary transformant 
were able to form colonies on MM-Glu that lacked pyridoxine or pyrimidine, respectively 
(Osmani et al. 2006). Thus, neither GalD
 
nor GalE was essential for growth on glucose.  
 
2. 3.2. Aspergillus nidulans galD∆, galD5, galE∆ and galE9 phenotypes   
             Hyphal morphometry, sporulation, and germination data for wild type and deletion 
strains grown on glucose and galactose are provided in 2. 1. The galD∆ and galD5 strains 
strain did not form colonies on MMN-Gal or MMA-Gal at pH4.5, but did at pH7.5 (Fig. 2.2). 
Roberts (1970) suggested that Leloir pathway enzymes have optimal function at pH 4-6.5, and 
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that alternative pathways are available at higher pH, that is, >7. We compared the growth of 
all the deleted and mutant strains at pH 4.5 and pH 7.5 to determine whether our galD and 
galE deletion strains would phenocopy the galD and galE mutants that were described in 
Roberts (1970). Phenotypes of galD5 strains, A212 and A213 were similar to galD∆ (Fig. 
2.2).  
               Unlike the S. cerevisiae GAL7Δ strain, galactose was not toxic for A. nidulans 
galD∆. The galEΔ strain grew and sporulated on both MMN-Gal and MMA-Gal at both 
pH4.5 and pH7.5. The colony size of galE9 strain was similar to galEΔ on MM-Gal (nitrate) 
at pH7.5 and pH4.5. We compared the ability of wild type, galDΔ, and galEΔ strains to grow 
on a variety of substrates (Fig. 2.3). The wild type, galDΔ and galEΔ strains all grew on MM 
containing glucose, galactose, or glycerol as sole carbon sources (Fig. 2.3A), but their colony 
phenotypes differed. On glucose and glycerol, galDΔ and galEΔ strains gave wild type 
colonies (Fig. 2.3A). We have also grown deleted strains on MM containing both glucose and 
galactose (data not shown). On MM-Glu+Gal, both deleted strains grew like wild type, which 
means glucose is able to repress the galactose-associated phenotype. 
 Sporulation of the galD∆ and galE∆ strains were reduced about 10-fold on MM-Glu 
and 100-fold on MM-Gal compared to the wild type strain (Table 2.1, Fig. 2.2). The hyphae 
of galD∆ and galE∆ strains grown on MM-Gal were slightly wider than on MM-Glu, and 
their near-apical regions were highly branched (Table 2.1; Fig. 2.3B). The galD∆ strain was 
unable to form colonies on galactose at pH 4.5 which indicates that GalD is extremely 
important for A. nidulans growth at that pH. In contrast, the galE∆ strain formed sparse 
colonies on MMN-Gal and MMA-Gal at both pH 4.5 and pH 7.5, as did the galE9 strain, 
A214 (Fig 2.2) which indicates that GalE plays a less important role than GalD in A. nidulans 
galactose metabolism. 
 We generated a [ugeA∆, galDΔ] double deletion strain since these enzymes were 
expected to share substrate pools. [galDΔ, ugeA∆] strain grown on MM-Glu had compact 
colonies that resembled those of ugeA∆ strain grown on MM-Glu (El-Ganiny et al. 2010). 
However, on MM-Gal, the [galDΔ, ugeA∆] strain failed to grow (Fig. 2.3A). Previously, 
El-Ganiny et al. (2010) showed that ugeAΔ germination and growth was negligible on 
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galactose. Therefore, we did not find any significant difference between ugeA single mutant 
and [galDΔ, ugeA∆] double mutant.  
            SEM of wild type (Figs. 2.4A, B), galDΔ (Figs. 2.4C-F), and galEΔ (Figs. 2.4G, H) 
strains showed that all of them sporulated better on MM-Glu (Figs. 2.4A, C, E, G) than MM-
Gal (Figs. B, D, F, H) consistent with results in Table 2.1. For galDΔ on glucose there were 
both small wild type conidiophores (Fig. 2.4C) as well as structures that appeared to be 
swollen conidiophore vesicles that failed to produce metulae (arrows in Fig. 2.4E). The inset 
in Fig. 2.4E (Fig 2.4e) shows these naked conidiophore vesicles at higher magnification. On 
galactose, the galDΔ strain produced some metulae and phialides, but these were misshapen 
and produced few spores (Fig. 2.4 D). The galEΔ strain grown on glucose produced small 
conidiophores with metulae and some phialides (Fig. 2.4G), whereas on galactose the galEΔ 
strain typically arrested with metulae (Fig. 2.4 H). The galDΔ arrest stage corresponds to 
stage D and the galEΔ arrest to stage E according to Martinelli and Clutterbuck (1971).  
 Germination of wild type spores was similar on glucose and galactose, as expected, 
but this was not the case for galDΔ and galEΔ strains. Germination of galDΔ and galEΔ 
spores was somewhat lower than wild type on glucose, but on galactose it was reduced (15 %; 
galEΔ) or highly reduced (1 %; galDΔ) (Table 2.1).  
 El-Ganiny et al. (2010) showed that hyphal walls of the ugeAΔ strain grown on 
glucose were twice as thick as wild type and had a poorly consolidated outer layer. Using 
TEM we found that galDΔ hyphal walls had a poorly consolidated outer layer reminiscent of 
ugeAΔ, and had a wall thickness similar to ugeAΔ (Table 2.1; Fig. S9; El-Ganiny et al. 2010). 
The galEΔ hyphal walls also resembled those of galDΔ on both galactose and glucose (Table 
2.1, Fig. S9).  
 Together, these analyses showed that both galDΔ and galEΔ strains had defects at 
multiple stages. The most severe were for galD∆ on galactose at pH 4.5, but defects were also 
notable on galactose at pH 7.5. In contrast, we did not any find severe growth defects for 
galEΔ strain on galactose at either pH 4.5 or pH 7.5.  
 
2. 3.3. Aspergillus nidulans galD and galE complementation with Saccharomyces cerevisiae 
GAL7 and GAL1 
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 We generated galD∆:GAL7 and galE∆:GAL1 strains to test for functional 
complementation of the A. nidulans and S. cerevisiae uridylyl transferase and galactokinase 
orthologues respectively. The wild type, galDΔ:GAL7 and galEΔ:GAL1 strains all produced 
wild type colonies on galactose, glucose, and glycerol (Fig. 2.3A), and as well the 
complemented strains had a wild type hyphal phenotype (Fig. 2.3C). Thus, S. cerevisiae 
GAL7 and GAL1 were able to restore the loss of A. nidulans galD and galE at the colony and 
cellular level, respectively, showing that they are functionally homologous. We refer to them 
as GalD
GAL7
 and GalE
GAL1
. 
2. 3.4. Comparison of wild type, galD, and galE cDNA with galD5 and galE9   
The ANID_04957 (galE) coding sequence was predicted to contain three introns and 
ANID_06182 (galD) to contain two introns. We confirmed the length and position of these 
introns by comparison with the genomic sequence on the Broad Institute. The galD5 mutation 
had a single nucleotide change at base 628 in A212 and A213 (both G  T) that inserted a 
stop codon at amino acid 210 of this 384-residue protein (Fig. S10). The galE9 mutation had 
conservative mutation, D69E, and near the 3’ end had a single base pair insertion at position 
1477. This frame shift altered the residues beginning at 480 from …LTEEYYL… to 
…RRRSAIstop at residue 493 of this 524-residue protein (Fig. S11).  
 
2. 3.5. Localization of GalD and GalE in Aspergillus nidulans  
 GalD and GalE were each C-terminal tagged with green fluorescent protein (GFP) 
under the control of their endogenous promoters. Both strains were morphologically wild 
type, suggesting that these constructs were fully functional. Both GalD-GFP and GalE-GFP 
confocal fluorescence patterns were cytosolic and did not show obvious longitudinal gradients 
(Fig. 2.5 A-D). Both the GalD-GFP and GalE-GFP fluorescence intensities were noticeably 
higher in germlings following overnight growth on MM-Gal (Fig. 2.5B, D) compared to 
MM-Glu (Fig. 2.5A, C). We quantified the relative fluorescence intensity using Zeiss LSM 
510 region of interest (ROI) software. Increased fluorescence intensity in cells grown on MM-
Gal (Fig. 2.5E) suggested there should be a comparable increase in galD and galE expression 
assessed by qRT-PCR when grown on MM-Gal.  
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 Wild type colonies were grown for 16 h in liquid MM-Glu, MM-Glycerol and MM-
Gal. RNA was extracted from them so that the relative galD and galE expression could be 
quantified using qRT-PCR in comparison to actin (actA). Compared to actA, expression of 
galD on MM-Gal was 10.6-fold more than on MM-Glu (Fig. 2.5F); expression of galE on 
MM-Gal was 6.5-fold more than on MM-Glu (Fig. 2.5F). We did not find any significant 
change in galD and galE expression on MM-glycerol compared to MM-Glu. This suggests 
that the expression of GalD-GFP and GalE-GFP is 6 to 10 times lower when glucose or 
glycerol is the carbon than when galactose is the carbon source   
 
2. 3.6. Galactofuranose immunolocalization 
Galf was immunolocalized in hyphal walls of wild type, galDΔ and galEΔ hyphae 
grown on MM-Glu and MM-Gal at pH 7.5 and at pH 4.5. Galf levels were similar in wild type 
hyphae grown on MM-Glu, MM-Gal pH 4.5 and MM-Gal pH 7.5 (Fig. 2.6A- C). The galDΔ 
hyphal walls on MM-Glu (Fig. 2.6D) had a more intense Galf signal than on MM-Gal at pH 
7.5 (Fig. 2.6E). A clump of spores without visible signal was observed in the galDΔ strain 
germlings on MM-Gal at pH 4.5 (Fig. 2.6F). Galf immunolocalization in galEΔ hyphal walls 
was similar to wildtype on MM-Glu and MM-Gal at pH 4.5 and pH 7.5. Thus, GalD appears 
to contribute to Galf biosynthesis, but onlywhen galactose is sole carbon source. In contrast, 
galEΔ does not appear to contribute to Galf biosynthesis at either pH. 
 
2. 3.7 Sensitivity to antifungal compounds 
 The sensitivity of wild type, galDΔ and galEΔ strains to antifungal compounds used a 
disc-diffusion assay. The radius of the zone of inhibition provided quantitative visual 
information. We compared Calcofluor White that binds to fungal walls, Caspofungin that 
inhibits beta-glucan synthase, and Itraconazole that inhibits ergosterol synthesis. Sensitivity is 
presented as an index compared to wild type on the same medium, so that values greater than 
1.0 indicate drug hypersensitivity. Statistical analysis of the raw data and comparison to 
sensitivity indices showed that a difference of >0.2 in index value correlated with statistical 
significance. Representative plates from this study are shown in Fig. 2.7, with quantitative 
results presented in Table 2.1B.  
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 The wild type strain had similar sensitivity to Caspofungin and Itraconazole on MM-
Glu and MM-Gal (Fig. 2.7), but was more sensitive to Calcofluor White on MM-Gal. The 
galDΔ and galEΔ strains were significantly more sensitive to all three drugs when grown on 
MM-Gal than MM-Glu (Table 2.1B).   
2. 4.  Discussion 
Aspergillus nidulans GalD (galactose-6-phosphate uridylyltransferase) and GalE 
(galactokinase) are functionally homologous to S. cerevisiae GAL7 and GAL1, respectively. 
The galDΔ:GAL7 and galEΔ:GAL1 complemented strains had wild type colony and hyphal 
phenotype when grown on MM-Gal.  
GAL7 is essential for S. cerevisiae growth on galactose (Slepak et al. 2005) and for 
galactose metabolism in Kluyveromyces lactis (Dickson & Riley, 1989). However, GalD
GAL7
 
is only essential for A. nidulans when grown on MM-Gal at pH 4.5. At pH 4.5 the galDΔ 
strain grown on galactose was severely impaired at all stages from germination to colony 
development. In contrast, there was limited growth and sporulation at pH 7.5.  
GAL1 is essential for galactose metabolism in yeast (Dickson & Riley, 1989). Unlike 
GAL1, GalE
GAL1
 was not essential for A. nidulans growth on MM-Gal. For A. nidulans galDΔ 
and galEΔ strains, galactose adversely affected germination, conidiophore initiation, and 
metulae, phialide, and spore formation. Taken together, the A. nidulans Leloir enzymes 
GalD
GAL7
 and GalE
GAL1 
play multiple but not essential roles in A. nidulans growth and 
development. The galDΔ and galEΔ strains provide insights into their function that would not 
be possible in a species where they were essential. Identifying products that interact with 
GalD and GalE will help clarify their roles in galactose fungal metabolism. 
Aspergillus nidulans galD5 and galE9 mutant strains were unable to grow on MM 
galactose containing nitrate below pH 6, but could grow on complete medium (CM) with 
galactose (Roberts, 1970); CM has peptides as well as nitrate. Fekete et al. (2004) reported 
that an A. nidulans galE∆ strain they called EFES2 could grow on galactose in the presence of 
ammonium tartrate. We confirmed these observations and showed that GalD was 
all-but-essential for germination and growth on MM-Gal at pH 4.5, but not at pH 7.5, whereas 
GalE was important but not essential under any condition in this study. Ammonium tartrate 
(we used 70 mM) is also a carbon source, but likely an insignificant level. galD5 and galE9 
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encode C-terminal truncations of the transferase and kinase, respectively and in addition the 
C-terminus of the galE9 product had altered polarity and charge. Our data are consistent with 
previous results, and point to the C-termini of GalD
GAL7
 and GalE
GAL1
 being important for 
function. Roberts (1963) also reported that galactose auxotrophs were more common than 
those of fructose, maltose, or sorbitol, which suggests that galactose-derived compounds such 
as Galf are relatively more important. Galf is a cell wall component that is important for 
growth and wall maturation in A. nidulans (El-Ganiny et al. 2010, Afroz et al. 2011). 
The Leloir pathway appears to be the main D-galactose degrading route in Aspergillus, 
but alternative or additional galactose metabolism pathways have been reported. Aspergillus 
nidulans galactose metabolism pathways via galactitol, sorbitol and fructose (Elorza & Arst, 
1971) and fructose-6-phosphate and sorbose-6-phosphate (Fekete et al. 2004) have been 
proposed. Flipphi et al. (2009) hypothesized that galactitol can also be epimerized to D-
tagatose via L-sorbose, with subsequent cleavage into two glycolytic triose-phosphates.  None 
of these pathways describe the fate of D-sorbose, but perhaps L-sorbose is catabolized via D-
sorbitol and D-fructose to D-fructose-6-phosphate (Flipphi et al. 2009). In Saccharomyces, d-
fructose-6-phosphate can be converted to N-acetyl glucosamine, which is a substrate for chitin 
synthesis (Milewski et al. 2006).  This alternative pathway is led by formation of galactitol by 
aldose reductase. Aldose reductase requires NADPH. Therefore, it is possible that aldose 
reductase is inactive when nitrite is the sole N source because both nitrate and nitrite 
reductases require NADPH and have high affinity (Bhushan et al. 2002).  
GalD-GFP and GalE-GFP are cytosolic, did not show obvious longitudinal gradients. 
GalD-GFP and GalE-GFP fluorescence was significantly higher for cells germinated on MM-
Gal than MM-Glu consistent with qRT-PCR showing ten-fold higher galD and six-fold higher 
galE expression on MM-Gal than MM-Glu. GalD-GFP and GalE-GFP fluorescence levels are 
similarly consistent with results from S. cerevisiae where the Leloir pathway genes showed 
higher levels of expression induced by galactose (Lohr et al. 1995). Higher galD and galE 
expression on galactose correlated with lower germination, growth, and sporulation, 
consistent with but less severe than the galactose effect on S. cerevisiae. 
GalE-GFP fluorescence distribution was even, whereas in S. cerevisiae GAL7-GFP 
localization is clumped (Christacos et al. 2000). The S. cerevisiae Leloir pathway enzymes 
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have been proposed to form multi-enzyme complexes (Abadjieva et al. 2001; Kindzelskii et 
al. 2004). Unlike in Saccharomyces, pronounced galactose toxicity has not been reported in 
Aspergillus and their Leloir pathways genes are not clustered. Slot and Rokas (2010) suggest 
that gene clustering may correlate with Leloir pathway defects that produce toxic 
intermediates.  
Galf was immunodetectable when the wild type and galEΔ strains were grown on 
MM-Glu or MM-Gal. Galf was also detectable when the galDΔ strain was grown on MM-
Glu. The Galf content of galDΔ grown on MM-Gal pH 7.5 was low, and Galf was 
undetectable on MM-Gal at pH 4.5. Taken together, this suggests that GalD but not GalE has 
a direct role in Galf biosynthesis. Deletion of UgeA and UgmA led to loss of hyphal wall Galf 
(El-Ganiny et al. 2008 & 2010). The [galDΔ, ugeAΔ] strain was able to germinate on MM-
Gal, and grew on MM-Glu and MM-glycerol, again suggesting that A. nidulans has additional 
metabolic pathways leading to energy generation and wall glycan biosynthesis. Growth on 
MM-Glu or MM-Gal resulted in hyphal walls of the galDΔ and galEΔ mutants 50% thicker 
than the cells walls of the wild type, comparable to ugeAΔ strains (El-Ganiny et al. 2010; Paul 
et al. 2011). Also like the ugeAΔ strain, the galDΔ hyphal walls accumulated extraneous 
material when grown in liquid culture, which has been seen previously (El-Ganiny et al. 2008; 
Lamarre et al. 2009; El-Ganiny et al. 2010; Afroz et al. 2011; Paul et al. 2011). Galf residues 
are found in galactomannans, glycoproteins, lipophosphogalactomannans and sphingolipids 
(Lamarre et al. 2009), where they may have multiple roles in cell wall structure and cell wall 
surface adhesion. High spatial resolution chemical analysis of fungal cell walls (Gough & 
Kaminskyj, 2010; Prusinkiewicz et al. 2012) and atomic force microscopy (Paul et al. 2011) 
may be able to detect differences in composition consistent with these changes. 
The galDΔ and galEΔ strains were more sensitive than wild type to Calcofluor White 
when grown on galactose than glucose, suggesting their walls were somehow different 
(maybe weaker) than those of wild type. The galDΔ and galEΔ strains were also more 
sensitive to Caspofungin and to Itraconazole when grown on galactose, both of which act in 
the cytoplasm and must transit the cell wall. We had comparable results on CM (not shown), 
showing that GalD-related drug sensitivity was also repeatable in complex medium. It may be 
possible to find compounds that would inhibit GalD function without affecting human GALT. 
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However, these would not be useful by themselves given the diversity of nutrients available in 
a host organism. 
In conclusion, we have shown that A. nidulans GalD
GAL7
 and GalE
GAL1
 play several 
roles in A. nidulans growth and sporulation. GalD
GAL7 
is essential for growth on galactose 
medium at pH 4.5, whereas GalE
GAL1 
appears to be dispensable. The galDΔ and galEΔ 
sporulation phenotypes arrest at different stages, so likely their products have additional 
metabolic functions. GalD and GalE expression are upregulated by growth on galactose, but 
germination and sporulation of galDΔ and galEΔ was suppressed on galactose. The galDΔ 
and galEΔ strains were significantly more sensitive than wild type to antifungal agents on 
galactose-containing media. Characterization of phenotypes related to the roles of GalD
GAL7 
and GalE
GAL1 
reveals the complexity of galactose metabolism in A. nidulans, and that 
functional homology does not ensure homologous function in different systems. 
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Table 2.1. Characteristics of Aspergillus nidulans wild type, galD∆ and galE∆ strains on 
minimal medium supplemented with nitrate at pH 7.5, containing 1 % glucose or 1 % 
galactose. 
A. Fungal morphometry
 a
 
Strain:    Wild type  galD∆            galE∆  
Growth medium:            Glucose       Galactose Glucose        Galactose      Glucose         Galactose 
Hyphal width (µm)
               
2.4 ± 0.0        2.2 ± 0.3 2.3 ± 0.1
 
        2.6 ± 0.3
   
      2.3 ± 0.0        2.5±0.0  
Basal cell length (µm)
 
    26 ± 1.0 
c
      24 ± 2.3
 c
 19 ± 1.8
 d
        15.5 ± 4.8 
e 
   22±0.17
 c
       15±0.11
 e  
Nuclei per basal cell
           
4.2 ± 1.1 
c
      3.9 ± 0.7
 c
 3.3 ± 0.3
 cd
      2.5 ± 0.5
 d
      2.5±0.03
 d
      1.8±0.04
 e
 
Branches/apical 100 µm 0.6 ± 0.1 
c
     0.6 ± 0.1
 c
 0.8 ± 0.1
 d 
       5.6 ± 0.4 
e 
     0.7 ± 0.1
 cd
     3.4 ± 0.4
e
 
Spores per colony           100 %     21 %  10 %          0.4 %    12 %           1.3 % 
Germination rate
                   
97 %             97 %  78 %          1 %    60 %           15 % 
Cell wall thickness (nm)
  
56 ± 3
 c
     67 ± 2
 c
 102 ± 3
 d
          107 ± 1
 d 
        100 ± 2
 d          
120 ± 2
 e
  
 
B. Antifungal drug sensitivity index
 b 
Strain:    Wild type                    galD∆         galE∆ 
Growth medium:         Glucose           Galactose          Glucose   Galactose     Glucose    Galactose 
Calcofluor White  1.0  1.5               1.2    2.2           1.1 1.9 
Caspofungin  1.0  1.0  1.1    1.5           1.0 1.4  
Itraconazole  1.0  1.1  1.1     1.5            1.1 1.3 
 
a
  Measurement details are described in Methods. Mean ± SE of two measurements for each 
of four biological replicates were used for statistical analysis (not shown). Values in 
individual rows that are followed by different letters (c-e) are significantly different at 
P < 0.05 (ANOVA). 
b
  Drug sensitivity was measured using a disc diffusion assay (see Fig. 2.7). For Caspofungin, 
sensitivity was the radius (mm) of the clear zone with no visible growth. Mean ± SE of two 
measurements for each of three biological replicates were used for statistical analysis (data are 
presented in supplemental Table S3). Sensitivity index values are for each drug/strain 
combination compared to wild type on that medium. Values > 1.0 are more sensitive than 
wild type. Index values that differed by > 0.2 were based on data that were significantly 
different. 
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Fig. 2.1 Aspergillus nidulans galactose metabolic reactions discussed in this paper. 
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Fig.2.2. Colony phenotype of Aspergillus nidulans wild type (AAE1), galactose-1-phosphate 
uridylyltransferase strains galD∆, galD5 (A212, A213), and galactokinase strains galE∆ and 
galE9 (A214) strains on minimal medium containing galactose with two different nitrogen 
sources and pH levels. Colonies were inoculated from 5 µL droplets containing 5000 conidia, 
and grown for 3 d at 30 °C. The galD∆, A212, A213 strains did not grow beyond the original 
droplet size on MM-Gal containing nitrate (MMN-Gal) or ammonium (MMA-Gal) at pH 4.5, 
but all strains grew and sporulated on these media at pH 7.5.  
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Fig. 2.3. Aspergillus nidulans colony (A) and hyphal (B&C) phenotypes related to galactose 
metabolism. A) Aspergillus nidulans strains grown on MM-Nitrate containing 1 % glucose, 1 
% galactose, or 1 % glycerol at pH 7.5. Wild type (AAE1), deleted (galD∆ and galE∆), 
complemented [galD∆:GAL7 and galE∆:GAL1], and double deletion [ugeA∆, galD∆] strains. 
B) Hyphal branching phenotypes for deleted (galD∆ and galE∆) strains on MM-Gal. 
C) Hyphal branching phenotypes for complemented [galD∆:GAL7 and galE∆:GAL1] and 
wild type strains on MM-Gal Bar in the bottom right-hand image in (C) represents 10 µm for 
B and C.  
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Fig. 2.4. Conidiophore development of Aspergillus nidulans wild type, galD and galE 
strains on medium containing peptides, nitrate and 1 % glucose or 1 % galactose (pH 7.5). 
Well-developed conidiophores of wild type, galD and galE grown on glucose (A, C, G) 
and galactose (B, D, H). Bar in C = 10 m for images A-D, G & H. (E) On glucose, galD 
colonies formed conidiophore vesicles (arrows in E) that frequently failed to form metulae 
and became overgrown by aerial hyphae. (e) Magnified inset shows abnormal conidiophores 
(arrows in E) with detail of naked conidiophore vesicles (v) and conidiphore stalks (s). On 
galactose, galD (D) and galE (H) produced metulae and phialides, but few spores (see 
Table 2.1). Bar in F = 100 m for images E, e & F. 
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Fig. 2.5. Aspergillus nidulans galactose-1-phosphate uridylyl transferase (GalD) and 
galactokinase (GalE) are expressed in the cytoplasm, and their expression is regulated by 
carbohydrate source. (A-D) Fluorescence intensity for both GalD-GFP and GalE-GFP is 
higher for cells grown on minimal medium containing nitrate and 1 % galactose, pH 7.5, 
compared to media containing glucose. These images were collected using identical confocal 
settings. Bar in A = 5 µm, for A-D. (E) Quantitation of GalD-GFP and GalE-GFP intensity, 
using intensity at 30 randomly-selected cellular sites per sample, as measured by system 
software. (F) Relative expression of galD and galE using qRT-PCR, expressed as fold 
changes with respect to actA.  
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Figure 2.6. Galactofuranose immunolocalization in Aspergillus nidulans hyphal walls using 
the L10 monoclonal anti-Galf antibody. A-C) Wild type grown on A) MM-Glu, B) MM-Gal, 
pH 7.5, C) MM-Gal, pH 4.5.  D-F) galD∆ grown on D) MM-Glu, E) MM-Gal, pH 7.5, F) 
MM-Gal, pH 4.5. G-I) galE∆ grown on G) MM-Glu, H) MM-Gal, pH 7.5, I) MM-Gal, pH 
4.5. Lower case letters are corresponding transmission images. The fluorescence intensity in E 
was significantly lower than in A-D; image (e) shows that galD∆ spores germinated poorly on 
MM-Gal. The galD∆ strain had even lower germination on MM-Gal pH 4.5 (f), and the 
spores did not contain galactofuranose (F). Bar in g represents 10 µm for all parts of this 
image.  
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Fig. 2.7. Response of Aspergillus nidulans wild type, galD∆ and galE∆ strains to agents that 
target cell walls (Calcofluor White, CFW), beta-glucan synthesis (Caspofungin, Casp), and 
ergosterol synthesis (Itraconazole, Itra). All strains were grown on minimal medium with 
nitrate at pH 7.5, containing 1 % glucose or 1 % galactose. Quantitative results are provided 
in Table 2.1. Arrows indicates where measurements were taken. 
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Supplemental information 
Supplemental Table S1:  Strains and primers used in this study  
Aspergillus nidulans 
A1149 
a   
pyrG89; pyroA4; nkuA::argB 
A212
 a
    galD5 biA1;wA3 T1(III->VIII) 
A213
 a
    galD5 biA1;wA3 T1(VI;VIII) 
A214
 a
    biA1;wA3;galE9 
AAE1 
b
   pyrG89::Ncpyr4+; pyroA4; nkuA::argB 
AKA1 galD∆c   AN6182::AfpyroA; pyrG89; pyroA4; nkuA::argB 
AKA2 galEΔc   AN4957::AfpyrG; pyrG89; pyroA4; nkuA::argB 
AKA3 GalD-GFP 
c  
AN6182-GA5-GFP-AfpyrG; pyrG89; pyroA4; nkuA::argB 
AKA4 GalE-GFP 
c  
AN4957-GA5-GFP-AfpyrG; pyrG89; pyroA4; nkuA::argB 
AKA6 [ugeA∆, galD∆] c AN4727::AfpyrG; AN6182::AfpyroA; pyrG89; pyroA4; 
nkuA::argB 
Escherichia coli  
BL21-gold (DE3) 
d 
 
Plasmids 
AO18 
a
 S-TAG,  AfpyrG, Kan
R
 
pCR4-TOPO
 e  
Kan
R
, amp
R 
pFNO3
 a  
GA5-GFP, AfpyrG, Kan
R
 
pTN1
 a   
AfpyroA, Amp
R 
Primers   Sequence 5’  3’ 
galD deletion  
PKA1, up galD F
 c
 ACTTATCACTAAGGCATGGCGT 
PKA2, up galD R
 c 
TGGTACCGTTGGAAGCCATATCAAGATACAGTAGGGGAAGAGG 
PKA3, dn galD F
 c 
     TGGCCAAGAGAGGATGGTAAATATCGGAAGAAGTTGGATTCCTA 
PKA4, dn galD R
 c 
GAATGTCTCGAATACAGCGTG 
PKA5, AfPyroA F
 b 
ATGGCTTCCAACGGTACCA  
PKA6, AfPyroA R
b 
TTACCATCCTCTCTTGGCCA 
PKA7, Fusion F
 c 
 AAAATCAGTTTATAGTCGGTCAACTGT 
PKA8, Fusion R
 c 
ATCGATTCAACATTTCTTCAACG 
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galD deletion confirmation 
PKA1, up galD F
 c
 ACTTATCACTAAGGCATGGCGT 
PKA4, dn galD R
 c 
GAATGTCTCGAATACAGCGTG 
Ame16, MidPyroA R
b 
TCAACAACATCTCCGGTACC
  
galE deletion 
PKA21, up galE F  GCAGGGCGCTTTTTGAT 
PKA23, up galE R TGGTACCGTTGGAAGCCATATCAAGATACAGTAGGGGAAGAGG 
PKA24, dn galE F  GAGTATGCGGCAAGTCATGAT GAATATCGCGGCGAGC 
PKA22, dn galE R AGAGGACCACAATGGAATTGAGT 
PKA19, galE Fus-F  GCCGGCGAAGGAATAATG 
PKA20, galE Fus-R GCAACTACTTCAAACAGCTCAGTC 
galE deletion confirmation 
PKA21, up galE F  GCAGGGCGCTTTTTGAT 
Ame8, midPyrG R CACATCCGACTGCACTTCC 
PKA22, dn galE R AGAGGACCACAATGGAATTGAGT 
galD∆::GAL7 complementation   
PKA66, GAL7 F
 c 
TGGCTAGCAAAGATATAAAAGCAG 
PKA67, GAL7 R
 c 
AATTGCGACTTGGACGACATTTACAGTCTTTGTAGATAATG 
PKA68, GAL7 Fus F
 c  
ATGACTGCTGAAGAATTTGA 
PKA69, Up GalD R
 c  
TCAAATTCTTCAGCAGTCATATCAAGATACAGTAGGGGAAGAGG 
PKA70, Dn galD F
 c  
GAGTATGCGGCAAGTCATGAATATCGGAAGAAGTTGGATTCCTA 
galD∆::GAL7 complementation confirmation 
PKA1, up galD F
 c
 ACTTATCACTAAGGCATGGCGT 
PKA4, dn galD R
 c 
GAATGTCTCGAATACAGCGTG 
Ame8, midPyrG R
b 
CACATCCGACTGCACTTCC 
galE∆::GAL1 complementation   
PKA87, GAL1 F
 c 
ATGACTAAATCTCATTCAGAAGAAGTG 
PKA153, GAL1 R
 c 
TGGTACCGTTGGAAGCCATTTATAATTCATATAGACAGCTGCCCA 
PKA85, Up GalE R
 c 
ATGAGATTTAGTCATGGTGGGGTAAACTGAGACTGAC 
PKA86, Dn galE F
 c 
TGGCCAAGAGAGGATGGTAATGAATATCGCGGCGAGC 
galE∆::GAL1 complementation confirmation  
PKA21, Up-galE F
 c 
GCAGGGCGCTTTTTGAT 
PKA22, galE dnR
 c 
AGAGGACCACAATGGAATTGAGT 
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Ame8, midPyrG R
b 
CACATCCGACTGCACTTCC 
galD-gfp tagging 
PKA9, galD F
 c  
ACCACAACCCCAAATACGAA 
PKA10, galD R
 c 
GCCTGCACCAGCTCCGGAATCCAACTTCTTCCGAT 
PKA11, galD dnF
 c 
AGTATGCGGCAAGTCATGAGGACATCCCATGTAGACGTGT 
PKA12, galD dnR
 c 
AAGATTGGCCTCAAATTGCA 
PKA13, GFP-FusF
 c
 GCGGTCAAGGAGGAACAA 
PKA14, GFP-FusR
 c 
CCTATACTTTGAATCTCGAAATCGA 
Ame 27 5GA-GFPF
b 
GGAGCTGGTGCAGGC 
Ame 28 5GA-GFPR
b 
TCATGACTTGCCGCATACT 
galD-gfp tagging confirmation 
PKA9, galD F
 c  
ACCACAACCCCAAATACGAA 
PKA12, galD dnR
 c 
AAGATTGGCCTCAAATTGCA 
Ame8, midPyrG R
b 
CACATCCGACTGCACTTCC 
galE–gfp tagging 
Ame27 5GA-GFP F GGAGCTGGTGCAGGC 
Ame28 5GA-GFP-R  TCATGACTTGCCGCATACT  
PKA25, galE F   TCTGTTCAGCACGTTGCC 
PKA43, galE R  GCCTGCACCAGCTCCAACATCAACCTGAGAAATTGCAG 
PKA44, galE dnF  AGTATGCGGCAAGTCATGAAATATCGCGGCGAGC GGAA 
PKA26, galE dnR CGCAATCTACATCGGCAACTAC  
PKA45, GFP-Fus-F  ATCACTTTCCTCATGGCCC 
PKA46, GFP Fus-R  AGCTGAGTCAGCCCCAA 
galE-gfp tagging confirmation 
PKA25, galEA F  TCTGTTCAGCACGTTGCC 
PKA26, galE dnR CGCAATCTACATCGGCAACTAC 
Ame8, midPyrG R
b 
CACATCCGACTGCACTTCC 
galD∆:: ugeA∆ construction 
ame41, up ugeA-F CTCCTATGGTATGTCTCTTCCAACTT 
ame43, up ugeA-R AATTGCGACTTGGACGACATGGTGAATGTGAATTGAATGCAG 
ame44, dn ugeA-F GAGTATGCGGCAAGTCATGAATGGAAATCTTGAATGGATT 
ame46, dn ugeA-R AACTCGACTTTTCGCAGCTC  
ame42, uge fusion-F  TCCTAACTTTTGTTACTTTAGGCCC 
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ame42, uge fusion-R  GGGTACAAAACCGCTACGC 
cDNA cloning 
PKA15, galD cDNA F
 c 
ATGGTTGAAAGCGTCCTCG 
PKA16, galD cDNA R
 c 
CTAGGAATCCAACTTCTTCCGA 
PKA29, galE F
 c
  ATGGCGACCCCGCAG 
PKA30, galE  R 
c
 TCAAACATCAACCTGAGAAATTGC 
qRT-PCR 
PKA17 GalD qPCR F
 c 
AGCAGGAACGCGTAGTCTTTGAGA 
PKA18 GalD qPCR R
 c 
CACGCTTGTGCGTCTTGCTAATGA 
PKA27 GalE F
 c
 AGCAGTGAGCGTCGACGTGATTAT 
PKA28 GalE R
 c
 TAAGTGCACCAACTAACCCAGCCT 
a Fungal Genetics Stock Center, www.fgsc.net 
b El-Ganiny et al. (2008) 
c This study 
d Novagen (www.emdchemicals.com) 
e Invitrogen (www.invitrogen.com) 
 
Supplemental Table S2:  Raw data that were used to generate qRT-PCR graph 
Gene set Sample Average Ct Ct for Actin DCt 
DDCt (DCtsample-  
DCt control) Fold change 
galE Glu 19.18 23.411 -4.231 
 
1 
 
Gala 16.47 23.41 -6.94 -2.709 6.538 
 
Gly 18.38 23 -4.62 -0.389 1.3 
       galD Glu 19.65 22.21 -2.56 
 
1 
 
Gala 16.24 22.2 -5.96 -3.4 10.55 
 
Gly 19.3 22.5 -3.2 -0.64 1.55 
 
 55 
 
Supplemental Table S3: Antifungal drug sensitivity1 of Aspergillus nidulans wild type, galD∆ 
and galE∆ strains on minimal medium supplemented with nitrate at pH 7.5, containing 
1 % glucose or 1 % galactose.     
Strain:           Wild type                              galD∆                            galE∆ 
Growth medium:         Glucose      Galactose    Glucose         Galactose          Glucose        Galactose 
Calcofluor White 1.0 ± 0.03
a    1.5 ± 0.06b     1.1 ± 0.02a   2.1± 0.03c    1.0 ± 0.02a     1.9 ± 0.06c 
Caspofungin              2.5 ± 0.03
a    2.6 ± 0.03a     2.7 ± 0.03a   3.7 ± 0.02b    2.6 ± 0.03a     3.4 ± 0.06b 
Itraconazole 1.9 ± 0.02
a    2.1 ± 0.03a     2.0 ± 0.03a   2.7 ± 0.02b    2.1 ± 0.03a     2.4 ± 0.06b
  
1
   Drug sensitivity was measured using a disc diffusion assay (see Fig. 2.7). For Caspofungin, 
sensitivity was the radius (mm) of the clear zone with no visible growth. Mean ± SE of two 
measurements for each of three biological replicates were used for statistical analysis. Values 
in individual rows that are followed by different letters (a-d) are significantly different at 
P < 0.05 (ANOVA). These data were presented as drug sensitivity index values in Table 2.1. 
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Supplemental Figure S1. Confirmatory PCR for galD deletion. US: up stream; DS: 
downstream.  gDNA; genomic DNA.  AfpyroA  galD 
 
 
Supplemental Figure S2. Confirmatory PCR for GalD-GFP tagging.  
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Supplemental Figure S3: PCR showing galD and actA amplified from AAE1 cDNA. actA 
is used as a control. 
 
 
Supplemental Figure S4: qPCR Confirmation using primers that span on Exon 1&2. 
 
 
 58 
 
  
 
Supplemental Figure S5: Confirmation PCR for galD::GAL7 strain 
 
Supplemental Figure S6: Confirmation PCR for galE deletion 
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Supplemental Figure S7: Confirmation of GalE-GFP tagging 
 
Supplemental Figure S8: Confirmation PCR for galE::GAL1 strain 
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Supplemental Figure S9. Transmission electron micrographs of cross sections of wild type 
(A, B), galD∆ (C, D) and galE∆ hyphae (E, F). Hyphae were grown on dialysis tubing 
overlying MM-Glu (A, C, E) or MM-Gal (nitrate, pH 7.5) (B, D, F). These images were 
contrast adjusted for comparison of walls; hence the cytoplasm appears relatively dark. 
Arrows indicate the outer surface of the hyphal wall. Bar in A = 100 nm, for A-F.  
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Supplemental Figure 10: ClustalW comparison of amino acid sequences for GalD from 
A1149, A212, and A213. We have sequenced galD from A1149 (WT), galD mutants 
(A212 & A213) and compared with galD sequence at BI (Broad Institute). 
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Supplemental Figure S11: ClustalW comparison of amino acid sequences for GalE from 
A1149 and A214. We have sequenced galE from A1149 (WT), galE mutant (A214) and 
compared with galE sequence at BI (Broad Institute). 
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CHAPTER 3 
Aspergillus nidulans galactofuranose biosynthesis affects antifungal drug sensitivity 
 
This Chapter explored the roles of Galf in hyphal growth, drug sensitivity and the 
relation of Galf with other cell wall carbohydrate pathways. The manuscript has been 
published as Aspergillus nidulans galactofuranose biosynthesis affects antifungal drug 
sensitivity (2012) in Fungal Genetics and Biology 49: 1033-1043 by Md Kausar Alam, 
Amira El-Ganiny, Sharmin Afroz, David A. R. Sanders, Juxin Liu and Susan GW Kaminskyj, 
2012. 
 
This Chapter was based on our hypothesis ``Galf deletion/repressed strains will have a 
wall defect that will make them more sensitive to wall-targeting agents``. The objectives of 
the research in this Chapter were 
1. Roles of Galf biosynthesis pathway enzymes (UgmA, UgeA, UgtA) in fungal 
growth, wall maturation, drug sensitivity 
2. Relationship Galf biosynthesis pathway enzymes with other major carbohydrate 
biosynthesis pathways 
 
My contribution in this Paper: My contribution was to generate conditional strains 
and to confirm drug sensitivity with respect to deletion, repression, and over-expression of 
these Galf biosynthesis genes. I established the immunofluorescence experiment for which we 
got the cover page image. I also showed the relationship of Galf with α-glucan and β-glucan 
using qRT-PCR. I wrote and updated the literature review for the main draft of the submitted 
manuscript, based on an unpublished Chapter in El-Ganiny’s Ph. D. thesis. I completed the 
study, which required generation and analysis of the niiA(p) regulated strains, additional drug 
studies, and integration of several data sets. I generated the first complete draft of the 
submitted manuscript. Professor Susan Kaminskyj and I worked together to revise this draft 
prior to submission. We also worked together on the revision. 
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Running head: Aspergillus Galf influences echinocandin sensitivity 
Key words: Aspergillus nidulans; galactofuranose; UDP-galactopyranose mutase; 
UDP-glucose/galactose-4-epimerase; UDP-galactofuranose transporter; alcA promoter; 
niiA promoter; immunofluorescence; sporulation; hyphal morphometry; drug sensitivity. 
Abbreviations: Af, Aspergillus fumigatus; alcA(p), alcohol dehydrogenase I promoter; CM, 
complete medium; CM3G, complete medium with 3% glucose; CMT, complete medium 
with 100 mM threonine; Galf, galactofuranose; gDNA, genomic DNA; mAb, monoclonal 
antibody; niiA(p), nitrite utilization promoter; MM, minimal medium; MMA, minimal 
medium ammonium; MMN, minimal medium nitrate; qPCR, quantitative real time PCR; 
UDP, uridine diphosphate, UGE; UDP-glucose/galactose-4-epimerase, UGM; UDP-
galactopyranose mutase, UGT; UDP-galactofuranose transporter  
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Abstract 
The cell wall is essential for fungal survival in natural environments. Many fungal 
wall carbohydrates are absent from humans, so they are a promising source of antifungal drug 
targets. Galactofuranose (Galf) is a sugar that decorates certain carbohydrates and lipids. It 
comprises about 5 % of the Aspergillus fumigatus cell wall, and may play a role in systemic 
aspergillosis. We are studying Aspergillus wall formation in the tractable model system, 
A. nidulans. Previously we showed single-gene deletions of three sequential A. nidulans Galf 
biosynthesis proteins each caused similar hyphal morphogenesis defects and 500-fold reduced 
colony growth and sporulation. Here, we generated ugeA, ugmA and ugtA strains controlled 
by the alcA(p) or niiA(p) regulatable promoters. For repression and expression, 
alcA(p)-regulated strains were grown on complete medium with glucose or threonine, 
whereas niiA(p)-regulated strains were grown on minimal medium with ammonium or nitrate. 
Expression was assessed by qPCR and colony phenotype. The alcA(p) and niiA(p) strains 
produced similar effects: colonies resembling wild type for gene expression, and resembling 
deletion strains for gene repression. Galf immunolocalization using the L10 monoclonal 
antibody showed that ugmA deletion and repression phenotypes correlated with loss of hyphal 
wall Galf. None of the gene manipulations affected itraconazole sensitivity, as expected, but 
deletion of any of ugmA, ugeA or ugtA, as well as their repression by alcA(p) or niiA(p), 
increased sensitivity to caspofungin. Strains with alcA(p)-mediated overexpression of ugeA 
and ugtA had lower caspofungin sensitivity. Galf appears to play an important role in A. 
nidulans growth and vigor. 
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3. 1. Introduction 
 Human systemic fungal infections are an increasing threat (Fisher et al., 2012), 
particularly due to improved medical technology leading to larger populations of 
immune-compromised people. Systemic infections from a dozen or more fungi lead to 
morbidity despite aggressive anti-fungal drug treatment (Lass-Florl, 2009). Overall, 
Aspergillus is second only to Candida as a cause of invasive fungal infections (Erjavec et al., 
2009). Humans have few anti-fungal drug options because fungi share many biochemical 
pathways with animals. A major difference between organisms in these kingdoms is that 
fungal cells have a carbohydrate wall. This wall protects the fungal cell from damage, and 
mediates the interaction between the fungus and its environment. If the wall is removed or 
weakened, the fungus cannot survive in natural environments (Bennett et al., 1985). About 90 
% of the fungal wall is composed of polysaccharides that are not found in human hosts 
(Latgé, 2007). Echinocandins are the only antifungal drugs in clinical use that block aspect 
component of fungal wall synthesis, i.e. the formation of β-1,3-glucans that comprise about 
half of fungal cell wall polysaccharides in some species (Espinel-Ingroff, 2009). However, 
echinocandins are clinically effective only against Candida and Aspergillus. They must be 
used intravenously (Denning, 2003); and drug-resistant strains have already been identified 
(Walker et al., 2010). There is a pressing need to develop additional antifungal drugs (Mircus 
et al., 2009) particularly against novel aspects of fungal physiology. Gauwerky et al. (2009) 
suggest that minor wall components as well as virulence factors have the potential to be useful 
anti-fungal drug targets.  
 We are exploring an aspect of wall biosynthesis in Aspergillus nidulans, the 
galactofuranose (Galf) biosynthesis pathway. Galf is the five-membered ring form of 
galactose found in the cell wall of many microorganisms including fungi, but only the six-
member ring form called galactopyranose is found in mammals. In microorganisms, Galf 
residues form the side chains of glycoconjugates including galactomannan. Galf biosynthesis 
genes encode UDP-glucose/galactose-4-epimerase (UgeA) (El-Ganiny et al., 2010), UDP-
galactopyranose mutase (UgmA) (El-Ganiny et al., 2008), and the UDP-galactofuranose 
transporter (UgtA) (Afroz et al., 2011). Although none of these genes was essential for A. 
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nidulans in culture, deletion strains had aberrant wall maturation (Paul et al., 2011) and 500-
fold reduced hyphal growth and sporulation rate.  
 Galf residues in human serum can be used to track a patient’s response to therapy for 
systemic Aspergillus infections (Bennett et al., 1985; Stynen et al., 1992; Shibata et al., 2009). 
Galf has been shown to be essential for the virulence of the pathogenic protozoan, Leishmania 
(Kleckza et al., 2007). Galf could be a virulence determinant in A. fumigatus based on studies 
with a UgmA (also known as GlfA) deletion strain in a murine model (Schmalhorst et al., 
2008). Recent evidence to the contrary (Heesemann et al., 2011) showed that A. fumigatus 
hyphae pretreated with monoclonal antibodies (mAbs) specific to hyphal Galf residues had 
similar virulence to untreated hyphae. Nevertheless, Galf metabolism could still be a useful 
target for anti-fungal drug development (Pederson and Turco, 2003) because it plays 
important although not fully-understood roles in fungal growth.  
 Regulated promoters can be used to explore the role (Waring et al., 1989) and 
requirement (Hu et al., 2007) for Aspergillus genes, typically using the alcA (Waring et al., 
1989; Monteiro and De Lucas, 2010) and niiA (Monteiro and De Lucas, 2010) promoters 
whose expression is controlled by carbon source or nitrogen source, respectively. For 
example, repression of A. nidulans chitin synthase chsB in an alcA(p)-chsB strain caused slow 
growth and highly branched hyphae (Ichinomiya et al., 2002). Repression of 
alcA(p)-regulated A. fumigatus O-mannosyltransferase 2 (Afpmt2) caused growth retardation, 
abnormal cell polarity, defective cell wall integrity, and reduced conidiation (Fang et al., 
2010). Repression of alcA(p)-regulated protein kinase C (pkcA) reduced germination rate, 
hyphal growth and conidiation, as well as increasing hyphal wall thickness and sensitivity to 
wall-selective agents: Caspofungin, Calcofluor White, and Congo Red (Ronen et al., 2007). 
As expected, this strain was also more sensitive to the protein kinase inhibitor staurosporine 
although it responded like wild type to amphotericin B and voriconazole (Ronen et al., 2007). 
Binder et al. (2010) showed that an alcA(p)-pkaA strain grown on repression medium was 
hypersensitive to PAF, an antifungal protein. Taken together, expression-regulated strains 
have been used successfully to study cell wall formation in Aspergillus species. 
 Expression-regulated strains have also been used to identify new cell wall destabilizing 
compounds (Mircus et al., 2009) and to study cell wall integrity in the presence of anti-fungal 
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agents. Fortwendel et al. (2009) used alcA(p)-regulated A. fumigatus strains defective in cell 
wall integrity pathway genes (rasA, cnaA and crzA strains) to show that low cell wall integrity 
correlated with echinocandin sensitivity. Jiang et al. (2008) created A. fumigatus strains 
conditionally expressing alcA(p)-regulated GDP-mannose pyrophosphorylase. These strains 
had defective cell walls, impaired polarity maintenance, reduced conidiation, and increased 
sensitivity to wall targeting chemicals. Regulating gene expression is a powerful adjunct to 
deletion analysis for exploring gene function.  
Here, we describe studies on the function of Galf biosynthesis genes using strains whose 
endogenous promoter was replaced by the alcohol dehydrogenase promoter alcA(p) 
(Ichinomiya  et al., 2002; Waring et al., 1989) which is highly induced by alcohols, especially 
threonine, and is repressed by glucose (Romero et al., 2003, Tribus et al., 2010). As a 
precaution against potential complications from using a sugar-repressed promoter to study the 
carbohydrate-rich wall, we repeated key experiments with these genes regulated by niiA(p), 
which is regulated by nitrogen source (Monteiro et al., 2010). Under gene repression 
conditions with both promoters, the regulated strain colonies phenocopied their respective 
deletion strains. Notably, all the deletion strains were significantly more sensitive to the 
wall-targeting drug Caspofungin, as were the repressed strains. Our results suggest that the 
role of Galf biosynthesis plays multiple roles in fungal growth, wall architecture, and drug 
sensitivity, and as such may be a useful drug target. 
 
3.2. Materials and methods 
3.2.1. Strains, plasmids and culture conditions 
 Strains, primers and plasmids are listed in Suppl Table A. Aspergillus nidulans strains 
were maintained on complete medium (CM) with supplements for nutritional markers as 
described in Kaminskyj (2001). To manipulate alcA(p)-regulated gene expression, CM that 
otherwise contained 1 % glucose was modified as follows: maximum repression used CM 
containing 3 % glucose (CM3G); overexpression used CM lacking glucose but containing 
100 mM threonine (CMT). For niiA(p)-regulated gene expression, minimal medium (MM) 
containing 70 mM NaNO3 (MMN) was used for induction, and MM containing 10 mM 
ammonium tartrate (MMA) was used for repression. Media used for niiA(p)-regulation were 
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supplemented with vitamin solution and pyridoxine. We were not able to find a medium for 
overexpressing niiA(p)-regulated genes. 
 
3.2.2. Construction of regulatable promoter strains 
 A promoter exchange module consisting of AfpyrG and alcA(p) was amplified from the 
plasmid, palcA(p) (a gift of Loretta Jackson-Hayes, Rhodes College). This module was 
inserted immediately upstream of each Galf biosynthesis gene to create alcA(p)-regulated 
strains. A 1.2-kb DNA fragment containing AfniiA(p) was amplified by PCR from genomic 
DNA of wild type A. fumigatus. This was used to create a niiA(p)-regulatable promoter 
module, also with AfpyrG as the selectable marker. This construct was inserted immediately 
upstream of the coding sequence for each Galf biosynthesis gene to create niiA(p)-regulated 
strains (Suppl Fig. A).  
 
3.2.3. Transformation  
 Constructs were transformed into A1149 protoplasts. Protoplasting and transformation 
followed procedures in Osmani et al., (2006) and Szewczyk et al., (2007). Long-term storage 
of competent protoplasts is described in El-Ganiny et al. (2010). Primary transformants were 
grown on selective medium containing 1 M sorbitol or 1 M sucrose as osmostabilizer. Spores 
from these colonies were streaked three times on selective medium prior to gDNA extraction. 
Genomic DNA from transformant spores (see below) was used as template for PCR to 
confirm the each manipulation (Suppl Fig. A). 
 
3.2.4. Isolation of genomic DNA from Aspergillus nidulans spores 
 Approximately 1 X 10
7 
spores from individual 2 d old colonies were harvested in sterile 
distilled water, pelleted in 1.5 mL microfuge tubes, and aspirated to dampness. Tubes 
containing damp spore samples were sealed with lid-locks, floated in 100 mL water, and 
microwaved at full power for 6 min. Then 35 µL of TE buffer (10 mM Tris-Cl, 1 mM EDTA, 
pH 8) was added to each tube. Tubes were vortexed briefly and put on wet ice for 5 min. The 
spore-DNA suspension was centrifuged at 16,000 x g for 5 min to pellet debris. One 
microliter of supernatant was used as PCR template for amplicons up to 4 kb long.  
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3.2.5. RT-PCR and qPCR 
 Gene expression studies compared levels of Galf biosynthesis genes in wild type, 
deleted, and alcA(p)-, and niiA(p)-regulated ugeA, ugmA and ugtA strains. Spores were 
inoculated in CM or induction or repression liquid media, and incubated at 28 °C with 
shaking at 250 rpm for 16 h. Mycelia were collected by centrifugation, frozen in liquid 
nitrogen, and lyophilized. Total RNA was extracted using an RNeasy plant kit (Qiagen) 
following manufacturer’s instructions. RNA concentration was measured using a Nanodrop®, 
then diluted to 400 ng/µL. Genomic DNA elimination and reverse transcription used a 
QuaniTect reverse transcription kit (Qiagen) following the manufacturer instructions (Cuero 
et al., 2003).  
 Quantitative real time PCR (qPCR) was performed in 96-well optical plates in an iQ5 
real-time PCR detection system (Bio-Rad). Gene expression was assayed in triplicate in total 
volume 20 µL reactions containing cDNA at an appropriate dilution and SYBR green 
fluorescein (Qiagen). A no-template control was used for each gene. Actin was used as a 
reference gene (Bohle et al., 2007). Primers actF and actR (Suppl Table A) were designed to 
amplify regions that included an intron in the actA genomic sequence. These primers 
generated a ~200 bp band from cDNA and ~400 bp band from gDNA, to detect genomic 
DNA contamination in the template. The qPCR amplification used the following conditions: 
95 °C/15 min for one cycle, 95 °C/15 s, 55 °C/40 s and 72 °C/30 s for 40 cycles and final 
extension cycle of 72 °C/2 min. Melting curve analysis was done using the following cycle: 
15 s at 65 °C with an increase of 0.5 °C each cycle to 95 °C. For FKS and ags1 gene 
expression analysis, we used wild type (AAE1), ugmA∆, and AfniiA(p)-ugmA strains. The 
relative expression was normalized to actA (Upadhyay and Shaw, 2008) and calculated using 
the ΔΔCt method (Livak and Schmittgen, 2001). Three independent biological replicates were 
performed for each strain/culture condition. 
 
3.2.6. Colony growth and sporulation 
 Colony characters were examined as described in El-Ganiny et al. (2008). Strains were 
grown for two generations on inducing or repressing media to control for possible dowry 
effects, then spores of wild type and regulated strains were streaked on induction or repression 
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media and incubated for 3 d at 28 °C to give isolated colonies. The diameter of ten 
colonies/strain was measured to the nearest millimeter using a dissection microscope. The 
number of spores produced per colony was counted for four colonies/strain. Isolated colonies 
were vortexed in a microfuge tube containing 1 mL water, then samples of spores were 
counted with a hemocytometer.  
3.2.7. Microscopy 
 Samples were prepared for confocal microscopy as described in El-Ganiny et al. (2008). 
Freshly harvested spores were grown on coverslips at 28 ºC for 16 h in induction or 
repression media. Hyphae were fixed and stained with Hoechst 33258 (for nuclei) and 
Calcofluor (for cell walls). Samples were imaged using a Zeiss META510 as described 
previously (El-Ganiny et al., 2008). LSM image browser software was used for measurements 
of hyphal width (at septa) and basal cell length (distance between adjacent septa).   
 Galf content of wild type, ugmA-GFP, ugmAΔ, and niiA(p)-ugmA hyphae was assessed 
using immunolocalization. Monoclonal anti-Galf antibodies L10 and L99 were a generous gift 
of Prof. Frank Ebel (Univ Munich). Primary antibodies were used at full strength; 
TRITC-conjugated goat-anti-mouse was used at 1:10 dilution. Immunofluorescence 
procedures followed El-Ganiny et al. (2008) and samples were examined using confocal 
epifluorescence microscopy.  
 Transmission electron microscopy was used to measure hyphal wall thickness for 
alcA(p)-regulated colonies grown on dialysis tubing overlying CMT or CM3G. Samples were 
prepared as described in Kaminskyj (2000). Hyphal wall thickness was measured where the 
cell membrane bilayer was crisply in focus. Typically three sites were measured for each of 
ten hyphae per strain/medium combination. 
 Scanning electron microscopy was used to examine conidiating wild type and 
alcA(p)-regulated colonies following the procedure in El-Ganiny et al. (2008). Strains were 
grown on dialysis tubing laid on CMT and CM3G for 3 d at 28 ºC. Colonies were fixed by 
immersion in 1 % glutaraldehyde, dehydrated in acetone, critical point dried (Polaron E3000, 
Series II), and gold sputter coated (Edwards model S150B). Samples were imaged with a 
JEOL 840A scanning electron microscope.  
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3.2.8. Drug sensitivity testing.  
 Antifungal agents and solvents were obtained from the following manufacturers: 
amphotericin B, terbinafine, itraconazole, dimethyl sulphoxide (DMSO) (Sigma Chemicals); 
ethanol (VWR); caspofungin (a gift from Schering-Plough, now Merck). Stock solutions were 
prepared as follows: amphotericin B (20 mg/mL in DMSO), itraconazole (1.6 mg/mL in 
DMSO), terbinafine (1.6 mg/mL in 50 % ethanol), and caspofungin (20 mg/mL in sterile 
water). Aliquots of stock solutions were stored at -80 ºC. 
 Wild type and Galf-biosynthesis gene deletion strains were grown on CM; gene-
regulated strains were grown on repression and expression media. Spore suspensions 
collected from 4 d old colonies were filtered through VWR 413 filter paper (average pore size 
5 μm) to remove hyphae and conidiophores. Spores in the filtered suspension were counted 
using a hemocytometer and adjusted to 50,000 spores/μL. 
 Antifungal drug sensitivity testing used a disc-diffusion method modified from 
(Kontoyiannis et al, 2003; Lass-Florl, 2009), as described in Afroz at al. (2011). Strains were 
grown for two rounds on the test media before being used for drug sensitivity studies, to 
compensate for potential spore dowry effects. For the drug sensitivity test, 1 x 10
7
 spores were 
mixed into 20 mL of 50 ºC expression or repression agar and immediately poured in 9 cm 
diameter Petri plates. After the medium had solidified, sterile 6 mm paper discs were placed 
on the agar surface. Anti-fungal drug stock solutions (described above) were micro-pipetted 
onto individual disks: 10 µL of terbinafine and itraconazole, and 20 µL of amphotericin B and 
caspofungin. Solvent control studies with DMSO and 50 % ethanol showed no zone of 
inhibition. The plates were incubated at 28 ºC and assessed after 48 h (Kiraz et al., 2009). 
 The radius of the zone of inhibition was calculated as  
 [diameter (mm) with no visible growth – disk diameter (mm)] / 2  
Two measurements at orthogonal axes were taken for each disk on each plate; four plates 
were assessed for each strain and medium combination, and each experiment was repeated. 
These data were used for statistical analysis. Data are presented as indexed values with 
respect to wild type on CM (for deletion strains) and with respect to wild type on the test 
medium (for regulated strains). 
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3.2.9. Data processing and analysis 
 Confocal images were processed using LSM examiner. Images are presented using 
Adobe Photoshop 7.1. Statistical analysis used Kruskal-Wallis and associated post hoc tests 
with R software:  R 2.13 for kruskal.test, and R 2.9 for kruskalmc.test. 
3.3. Results 
 We examined the roles of Galf-biosynthesis gene products for anti-fungal drug 
sensitivity using conditional strains whose gene expression was under the control of the 
regulatable promoter, alcA(p) (Romero et al., 2003; Tribus et al., 2010). Previously we had 
deleted each of these genes: ugmA (El-Ganiny et al., 2008); ugeA (El-Ganiny et al., 2010); 
ugtA (Afroz et al., 2011), to study the effects on A. nidulans morphogensis, conidiation, and 
wall ultrastructure. We expected that gene repression would have similar effects to gene 
deletion, and that over-expression would have little effect. We used these strains to assess the 
role of Galf biosynthesis in sensitivity to anti-fungal drugs, especially Caspofungin that 
targets cell wall synthesis. For each section, we present ugmA results in detail, followed by 
comparison with results for ugeA and ugtA. The alcA(p) data were confirmed using 
niiA(p)-regulation (Gauwerky et al., 2009; Monteiro and De Lucas, 2010). 
  
3.3.1. Construction and validation of regulated strains.  
 We replaced each endogenous Galf biosynthesis gene promoter with the alcA(p) and 
with the niiA(p) conditional promoters, using AfpyrG as the selectable marker (Szewczyk et 
al., 2007). Primary transformants were grown on CM or MM, respectively, containing 1 M 
sorbitol or 1 M sucrose as an osmotic stabilizer. Strain construction and confirmation is shown 
in Suppl Fig. A.  
 To select media appropriate for regulation of Galf biosynthesis genes in A. nidulans, the 
alcA(p)-ugmA strain was grown on CM containing a variety of carbon sources, and the colony 
morphologies were compared qualitatively. Media included CM with 100 mM threonine 
(CMT), 1 % fructose plus 100 mM threonine, 1 % ethanol, 1 % glycerol, 1 % glucose (CM), 
or 3 % glucose (CM3G), as well as YEPD (1 % yeast extract, 2 % peptone, 2 % dextrose 
[=glucose]) that was previously used in Zarrin et al. (2005). Growth of the alcA(p)-ugmA 
strain on YEPD resembled the ugmAΔ strain, however the sporulation of the wild type strain 
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on YEPD was greatly reduced (not shown) so it was deemed unsuitable for our purposes. In 
comparison, growing the wild type strain on CM vs CM3G vs CMT caused substantially less 
variation in wild type colony characteristics (Table 3.1).  
 Growth of the niiA(p)-regulated ugmA strain was compared on MM containing nitrate 
salts (MMN), nitrite salts, ammonium tartrate (MMA), and ammonium nitrate as nitrogen 
sources. Colony growth of the niiA(p)-ugmA strain resembled wild type on MM containing 
nitrate, nitrite, and ammonium nitrate, but resembled the deletion strain on MMA.  
 The expression level of ugeA, ugmA and ugtA were assessed in wild type and respective 
regulated strains using qRT-PCR, with actA expression as the comparator. Expression of 
ugmA and actA in the wild type transformation parent of the regulated strains was comparable 
on all media used (upper panels in Fig. 3.1A, B). For alcA(p)-ugmA regulation, growth on 
CMT showed roughly comparable ugmA and actA expression levels, whereas growth on 
CM3G caused a dramatic decrease on ugmA but not actA expression (lower panels in Fig. 
3.2A). We found substantially similar results with niiA(p)-ugmA expression levels (with 
respect to actA) when grown on inducting MMN vs repressing MMA media (Fig. 3.1B). We 
also found that regulation of ugeA (upper panel in Fig. 3.1C) and ugtA (lower panel in Fig. 
3.1C) by these promoters was comparable to ugmA. The effect of alc(p)-ugeA, alc(p)-ugmA, 
and alc(p)-ugtA regulation with respect to the wild type strain were also compared using 
qPCR, again with actA as the comparator (Fig. 3.1D). Consistent with our RT-PCR results for 
alcA(p)-regulation, overexpression was associated with 8, 4, and 6-fold increase in ugeA, 
ugmA and ugtA expressions respectively, and repression with 100-150-fold decrease in all the 
alcA(p)-regulated strains (Fig. 3.1D).  
  
3.3.2. Repression of Galf biosynthesis genes causes compact colony growth and reduced 
sporulation 
 Growing the alcA(p)-ugmA strain on CM3G to repress ugmA produced growth and 
sporulation phenotypes similar to the ugmAΔ strain, regarding colony diameter, spores per 
isolated colony, hyphal width, and basal cell length (Table 3.1; Fig. 3.2). Scanning electron 
micrographs showed reduced sporulation was due to a decrease in conidiophore number as 
well as aberrant conidiophore formation (Fig. 3.3). For the alcA(p)-ugeA and alcA(p)-ugtA 
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strains, growth on CM3G resulted in compact colonies with wide, branched hyphae that had 
substantially reduced sporulation. Strains grown on CMT resembled wild type (Table 3.1; 
Figs. 3.2, 3.3).  
 The ugmAΔ and alcA(p)-ugmA repressed strains differed in hyphal wall thickness 
(Table 3.1). The walls of the alcA(p)-ugmA strain on CM3G were twice as thick as wild type 
on the same medium, but only half as thick as the ugmAΔ strain on CM (Table 3.1; El-Ganiny 
et al., 2008). We repeated the alcA(p)-ugmA CM3G fixation on two separate occasions with 
similar results. The alcA(p)-ugeA and alcA(p)-ugtA wall thicknesses when grown on CM3G 
were also thinner than the comparable deletion strains (Table 3.1). Thus, deletion and alcA(p)-
repression phenotypes for Galf biosynthesis genes differed in some quantitative aspects.  
  We expected that over-expression of Galf biosynthesis genes would be benign, since 
their product activity should depend on substrate availability. The alcA(p)-ugmA strain grown 
on CMT produced wild type colonies that sporulated more abundantly than on CM3G (Table 
3.1). In addition, the alcA(p)-ugmA hyphae on CMT were wider than wild type and had 
shorter basal cells (Table 3.1), whereas the alcA(p)-ugeA and alcA(p)-ugtA hyphae more 
closely resembled the wild type strain (Table 3.1).  
  
3.3.3. Deletion and repression of ugmA cause hyphal morphogenesis defects that correlate 
with loss of immunolocalizable wall Galf 
 We expected repression of Galf biosynthesis would reduce wall Galf content, as we had 
previously shown for ugmAΔ (El-Ganiny et al., 2008). Prof. Frank Ebel’s group (Univ. 
Munich) recently generated the L10 and L99 anti-Galf mAbs, (Heesemann et al., 2011) that 
have high affinity for hyphal wall Galf. They generously provided us with samples of each 
mAb. We had strong Galf immunolocalization in wild type phenotype A. nidulans hyphal 
walls using L10 (Fig. 3.4A, B, D), but less intense signal with L99 (not shown). In addition to 
wall staining, the cytoplasm also contained L10-reactive material, consistent with UgmA-GFP 
localization being cytoplasmic (Fig. 3.4B’ and B”) and UDP-Galf being synthesized in the 
cytoplasm prior to Galf incorporation into wall compounds (El-Ganiny et al., 2010). Both 
ugmAΔ (Fig. 3.4C), and niiA(p)-ugmA strains grown on MMA repression medium (Fig. 3.4 
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E), had wide, highly-branched hyphae. As expected, the ugmA deletion and repression strain 
hyphal walls lacked detectable wall Galf (Fig. 3.4C, E), as did their cytoplasm. 
 
3.3.4 Galf biosynthesis affects α-glucan synthase and β-glucan synthase expression 
 Both deletion and repression of Galf biosynthesis in A. nidulans are associated with 
increased hyphal wall thickness (Table 3.1; El-Ganiny et al. 2008), albeit to different levels. 
Damveld et al., (2008) had previously shown that A. niger strains with defective ugmA 
homologues had increased wall α-glucan content. We compared the expression level of 
α-glucan synthase (ags1) in wild type, ugmA∆, and AfniiA(p)-ugmA strains growing on MMN 
and MMA (Fig. 3.5A). As expected, AfniiA(p)-ugmA grown on MMN (induction) had similar 
expression to wild type. Compared to the wild type parental strain, ags1 expression was more 
than 4-fold higher in a ugmA∆ strain, or in the AfniiA(p)-ugmA on MMA (repression). We 
also compared the expression level of β-glucan synthase (FKS) in wild type, ugmA∆, and 
AfniiA(p)-ugmA strains growing on MMN and MMA (Fig. 3.5B). AfniiA(p)-ugmA grown on 
MMN (induction) had almost similar expression to wild type. Compared to the wild type 
parental strain, FKS expression was about 2.5-fold decreased in a ugmA∆ strain, or in the 
AfniiA(p)-ugmA on MMA (repression). 
  
3.3.5 Repression of Galf biosynthesis increases sensitivity to Caspofungin 
 Sensitivity to anti-fungal drugs of wild type and gene deletion strains on CM, 
alcA(p)-regulated strains on CMT and CM3G, and niiA(p)-regulated strains on MMN and 
MMA, was tested using a disc-diffusion drug-sensitivity assay. We compared Caspofungin 
(blocks wall β-1,3-glucan synthesis) with drugs that target ergosterol (Amphotericin B) and 
ergosterol biosynthesis (Itraconazole and Terbinafine). In addition, both 5-fluocytosine and 
Nikkomycin Z were assessed for their effect on wild type and Galf-biosynthesis gene deletion 
strains. Neither of these latter drugs inhibited colony growth, but Nikkomycin Z delayed 
germination by several hours, causing spores to swell considerably before germ tube 
establishment (data not shown).  
 For clarity, Table 3.2 shows drug sensitivity values for Itraconazole and Caspofungin 
only, since in this assay Amphotericin B and Terbinafine results were comparable to 
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Itraconazole. Sensitivities of deletion and regulated expression strains are presented as an 
index compared to wild type on the same medium. Values greater than 1.0 indicate strains and 
conditions associated with drug hypersensitivity. Statistical analysis of the raw data and 
comparison to sensitivity indices showed that an index difference of >0.2 correlated with 
statistical significance. Fig. 3.6 shows representative results related to those in Table 3.2, 
where gene transcription level was controlled by alcA(p).  
 Expression levels of the Galf biosynthesis genes did not significantly affect sensitivity 
to Itraconazole. Caspofungin sensitivity was increased for all three Galf biosynthesis 
gene-deletion strains compared to wild type. Similarly, the alcA(p)- and niiA(p)-regulated 
strains were hypersensitive to Caspofungin when grown on their respective repression media 
(Table 3.2, Fig. 3.6). When these genes were over-expressed on CMT, the alcA(p)-ugmA 
strain was more sensitive to Caspofungin, but the regulated ugeA and ugtA strains were less 
sensitive. Growth of these strains on MMN (expression, but not overexpression) did not affect 
drug sensitivity. Taken together, the hyphal wall Galf content (Fig. 3.4) was consistent with 
our expectations for the Caspofungin sensitivity (Table 3.2) of ugmA deleted and repressed 
strains. 
 
3.4. Discussion 
 Deletion of any of three sequential-acting genes in the Galf biosynthesis pathway causes 
similar defects in A. nidulans hyphal morphogenesis and colony development (El-Ganiny et 
al., 2008; El-Ganiny et al., 2010; Afroz et al., 2011) and in wall surface structure, force 
compliance, and adhesion (Paul et al., 2011). Galf forms the side chains of many 
glycoconjugates (Latgé, 2007; Latgé, 2009) but its role(s) in wall formation and maturation 
are still far from understood. We expected that wild type levels of Galf biosynthesis would be 
important for Caspofungin resistance because we had previously found that the walls Galf 
deletion strains were structurally compromised (Paul et al., 2011). To test this we compared 
the drug sensitivity of gene deletion and wild type with regulated Galf-biosynthesis strains. 
This is the first study to explore the roles of Galf biosynthesis proteins on drug sensitivity of 
A. nidulans strains using the alcA and niiA promoters, and the first to examine the effect of 
regulating genes in the Galf biosynthesis pathway. We expected that the products of these 
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genes would have similar effects on sensitivity to antifungal compounds that targeted cell 
walls but not to those that targeted other aspects of fungal physiology. Consistent with this, 
we found increased echinocandin sensitivity for the deletion strains and repressed strains, but 
no significant change for compounds affecting ergosterol or its biosynthesis.  
  
3.4.1. Altering Galf biosynthesis gene expression level affects wall formation, colony growth, 
and development 
 The phenotypes of strains deleted or repressed for Galf biosynthesis pathway genes 
were generally comparable. Repression of alcA(p)-ugmA with 3 % glucose (CM3G) and of 
niiA(p)-ugmA with ammonium (MMA) both caused colony and hyphal defects comparable to 
the ugmAΔ strain (El-Ganiny et al., 2008). Consistent with our RT-PCR and qPCR results, 
this is strong evidence that our regulatable promoter strains were functioning as expected. 
Similar results have been found for regulated histone deacetylase (rpdA) controlled by alcA(p) 
and xylP(p) (Tribus et al., 2010), and repression of protein kinase C (pkcA) on hyphal growth, 
wall thickness, and antifungal compound sensitivity (Ronen et al., 2007).  
 Gene-deletion and gene-repression phenotypes were qualitatively similar in most 
respects. However, for each of the Galf biosynthesis genes considered in this study, 
alcA(p)-repressed strains sporulated better than the comparable deletion strains, and their 
hyphal walls were half the thickness of the respective deletion strains. These anomalies 
prompted us to repeat our studies on all three genes using niiA(p)-regulation which is 
repressed by ammonium. Results for colony growth and development regulated by the niiA(p) 
were comparable to those for alcA(p), consistent with the phenotypes were caused by changes 
in gene expression level. Overexpression of alcA(p)-ugmA on CMT also caused a hyper-
branching phenotype that slightly reduced colony growth rate. Taken together, repression vs 
deletion morphology, and (over)expression vs wild type phenotypes were generally similar. 
 In A. niger, mutation of ugm1 is associated with an increase in wall alpha-glucan 
content (Damveld et al. 2008). We tested whether there was a comparable relationship 
between Galf and alpha-glucan in A. nidulans using qPCR to compare alpha-glucan synthase 
(ags1) levels. Both the ugmAΔ and alcA(p)-ugmA strain grown on repression medium had 
about four-fold increases in ags1 expression. The MOPC104E mAb has previously been used 
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for an α-glucan dot blot assay, however to date we have been unable to replicate these results 
at least with immunofluorescence. The function of Aspergillus wall α-glucan is not yet well 
understood (He and Kaminskyj, in preparation). Notably, a triple AGS mutant in A. fumigatus 
was found to lack α-1,3-glucans (Henry et al., 2011). This triple deletion strain had a wild 
type phenotype on solid medium, suggesting that α-1,3-glucans may be dispensable for A. 
fumigatus vegetative growth (Henry et al., 2011) at least under these conditions.  
  
3.4.2. Altering Galf biosynthesis-gene expression level affects Caspofungin sensitivity 
 We compared sensitivity of wild type, Galf biosynthesis-gene deletion strains, and Galf 
biosynthesis-regulated strains for their sensitivity to Caspofungin compared to drugs that 
target fungal membranes via ergosterol or ergosterol-biosynthesis. In this study, sensitivity to 
Itraconazole was typical of other membrane-targeting drugs, and was not related to Galf 
biosynthesis gene presence or function. Therapeutically, Aspergillus species are reported to be 
resistant to Itraconazole (Erjavec et al., 2009), making it a useful control treatment. Statistical 
analysis compared average radii of growth inhibition, presented as an index of sensitivity with 
respect to wild type.  
 All of the gene deletion strains were significantly more sensitive than wild type to 
Caspofungin, consistent with our previous AFM studies on the deletion strains that showed 
defects in wall architecture and strength (Paul et al., 2011). For ugmA strains regulated by 
alcA(p) and niiA(p), colonies grown in repression conditions were at least as Caspofungin-
sensitive as the knockout strains. Since we showed that deletion or repression of ugmA 
decreased fksA expression, this might contribute to Caspofugin sensitivity. Unexpectedly, 
colonies with over-expressed alcA(p)-ugmA were also significantly more sensitive to 
Caspofungin than wild type. This is consistent with the abnormal width and branching of 
overexpressed alcA(p)-ugmA hyphae, but the cause is not known. 
 Unlike ugmA, although both ugeA and ugtA, alcA(p)- and niiA(p)-repression caused 
Caspofungin hypersensitivity, the alcA(p)-overexpressed ugeA and ugtA strains were 
significantly less sensitive to Caspofungin. Consistent wit this, increasing Mycobacterium 
ugmA expression was reported to increase resistance to isoniazid (Richards et al., 2009). Galf 
biosynthesis genes have both shared and divergent functions in cell wall metabolism. 
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3.4.3 Effect of gene deletion versus gene repression 
 We had expected that gene deletion and repression phenotypes would be similar for 
most aspects of colony and cell morphometry, since net UgmA and UgtA activity should be 
substrate-limited and to our current knowledge the only role of Galf is in the cell wall. 
Contrast enhancement of the RT-PCR results in Fig. 3.1 showed that transcription was not 
abolished on gene repression media. Similarly gene over-expression was expected to have 
little effect due to substrate limitations, but found that Caspofungin sensitivity decreased for 
alcA(p)-overexpression of ugeA and ugtA. Transcript stability and translation of ugmA mRNA 
has not been explored in this study.  
 Galactose metabolism genes are clustered in Saccharomyces cerevisiae (Slot and Rokas, 
2010). In A. nidulans the ugmA and ugtA coding sequences are AN3112 and AN3113, 
respectively, but the other genes in its Leloir pathway are not clustered. Gene product 
interaction is important for many pathways, e.g. signal transduction, reviewed in Keshet and 
Seger (2010). Surface topography and charge mediate protein-protein interactions. The 
surface of a selectable marker product will be unlike the gene product it replaces, so it cannot 
participate in wild type pathway interactions. In contrast, suppression of gene expression, 
even to 1 % of wild type level as estimated for alcA(p)- and niiA(p)-ugmA repression in this 
study, could lead to a small amount of wild type protein. Consistent with this, some aspects of 
the repression morphometry phenotypes were less severe than the deletion strains. The 
alcA(p)-overexpression drug sensitivity phenotypes also suggest that modulating wild type 
gene product abundance might have subtle effects. 
 In sum we have shown that the alcA(p)- and niiA(p)-regulated control of Galf 
biosynthesis provides novel information about the role of this pathway in A. nidulans. In 
general, the gene repression and gene deletion phenotypes were comparable for colony 
growth and morphology, and overexpressed strains resembled wild type. That this was not 
always so, suggests possible interactions with other aspects of cell wall synthesis or 
maintenance. Notably, deletion and repression phenotypes were significantly more sensitive 
to Caspofungin, suggesting that as proposed in Paul et al. (2011), their walls are significantly 
less robust. We remain hopeful that an inhibitor of this pathway may be therapeutically 
beneficial. 
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Table 3.1: Colony and hyphal characteristics 
a
 of wild type and deletion strains grown 
on CM, and wild type and alcA(p)-regulated Aspergillus nidulans galactofuranose 
biosynthesis strains grown on over-expression (CMT) and repression (CM3G) media. 
  
 
Character Expression (medium) Wild type ugmA ugeA ugtA 
Colony Neutral (CM; wild type, Δ)  17±0.4f   4±0.2g  5±0.2g  4±0.2g 
diameter  Overexpression (CMT) 22±0.5
f
 17±0.6
g
 21±0.5
f
 16±0.2
g
 
(mm)
b
 Repression (CM3G) 16±0.4
f
   4±0.2
g
  5±0.2
 g
  4±0.1
g
 
Spores Neutral (CM; wild type, Δ)  107±15f 0.2±0.1g   0.4±0.1 g  1.3±0.2g 
/colony  Overexpression (CMT)  12.4±1
f
 8.2±1
g
 10.8±1
fg
 13.8±4
f
 
(x 10
6
)
c
 Repression (CM3G)   38±11
f
 0.6±0.1
g
   3.0±0.6
g
  3.8±0.1
g
 
Hyphal Neutral (CM; wild type, Δ)  2.7±0.4f 3.6±0.6g 3.6±0.1 g 3.5±0.1g 
width  Overexpression (CMT) 2.1±0.03
f
 3.0±0.0
g
 2.2±0.04
f
 1.9±0.05
h
 
(µm)
d
 Repression (CM3G) 3.1±0.05
f
 3.7±0.1
g 
 3.6±0.1
g
      3.4±0.0
g
 
Basal cell Neutral (CM; wild type, Δ)  26±1f   15±1g 14±1g 16±1g  
length Overexpression (CMT) 27±1.2
f
   14±0.6
g
 22±1.2
h
 25±0.5
h
 
(µm)
d
 Repression (CM3G) 30±1.7
f
   17±1.0
g
 24±1.1
f
 16±0.5
g
 
Cell wall  Neutral (CM; wild type, Δ)  54±2f 204±10g 123±4h 183±1i 
thickness Overexpression (CMT) 36±2
f
   42±1
g
   30±1
h
   40±1
g
 
(nm) 
e
 Repression (CM3G) 50±2
f
   82±3
g
   59±2
g
   83±5
g 
 
a  Values are presented as mean ± standard error. For colonies grown on CM, values for 
wild type and ugmAΔ hyphae were taken from El-Ganiny et al. (2008); for ugeAΔ 
hyphae from El-Ganiny et al. (2010); for ugtAΔ hyphae from Afroz et al. (2011). 
Cellular characteristics were compared using a Kruskal-Wallis test, and shown for 
each characteristic to be significantly different at P<0.05. Differences for strains 
grown on CMT or CM3G were compared using a Kruskal-Wallis multiple comparison 
test. For each row, values followed by different letters (f-i) are significantly different 
at P<0.05.  
b 10 colonies per strain/medium combination 
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c
 
At least 3 colonies per strain/medium combination. 
d  50 measurements per strain/medium combination. Hyphal width was measured at 
septa. Basal cell length was between adjacent septa. 
e  Measured from transmission electron micrographs for at least seven cross-sectioned 
hyphae per strain/medium combination, typically at three places per hypha where the 
cell membrane bilayer was crisply in focus.  
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Table 3.2: Antifungal drug sensitivity
a
 index
b
 comparing wild type, deletion, and 
alcA(p)-regulated Galf biosynthesis strains.      
Itraconazole
c
   
Expression (medium) Wild type      ugmA       ugeA      ugtA 
Neutral (CM); wild type and Δ strains 1.0 1.1 1.1 1.1 
 alcA(p) Overexpression (CMT) 0.8 1.1 0.9 1.1 
             Repression (CM3G) 0.8 1.1 1.0 1.1 
 niiA(p) Expression (MMN) 1.0 1.0 1.1 1.0 
             Repression (MMA) 1.0 1.2 1.2 1.2 
 
Caspofungin
c
   
Expression (medium) Wild type      ugmA       ugeA      ugtA 
Neutral (CM); wild type and Δ strains 1.0 1.8 1.3 1.7 
alcA(p) Overexpression (CMT) 1.0 1.3 0.5 0.7 
            Repression (CM3G) 1.0 1.9 1.5 1.8 
niiA(p) Expression (MMN) 1.0 1.0 0.9 1.0 
            Repression (MMA) 1.0 1.9 1.6 1.7 
      
a  Drug sensitivity was measured using a disc diffusion assay (see Fig. 3.6). For Caspofungin, 
sensitivity was the radius (mm) of the clear zone with no visible growth (see arrows on 
Fig. 3.6B). Mean ± SE of two measurements for each of four biological replicates were 
used for statistical analysis (Kruskal-Wallis multiple comparison test). Data that used for 
statistical analysis were presented in supplemental Table B. 
b Index sensitivity values are for each drug/strain combination compared to wild type on that 
medium. Wild type values are compared to CM with 1 % glucose. Gene deletion strains 
are compared to wild type on CM. Regulated strains are compared to wild type on the 
same medium. Index values > 1.0 are more sensitive than wild type. Index values that 
differed by > 0.2 were based on data that were significantly different. 
c  See Materials and Methods for details regarding drug dosage and medium formulation.  
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Fig. 3.1. Expression of ugmA, ugeA, and ugtA in wild type and regulated strains. A, B) RT-
PCR showing actA and ugmA expression in wild type and ugmA-regulated strains. 
A) alcA(p)-ugmA grown on overexpression medium CMT, and repression medium 
CM3G. B) niiA(p)-ugmA grown on expression medium MMN, and repression medium 
MMA. C) RT-PCR showing the ugeA (upper panel) and ugtA (lower panel) expression 
in regulated strains grown on overexpression medium CMT, and repression medium 
CM3G. D) Relative expression using qPCR of ugeA, ugmA, and ugtA with respect to 
actA for wild type grown on CM, and alcA(p)-regulated strains grown on CM3G 
(repression) and CMT (over-expression).  
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Fig. 3.2. Colony morphology of wild type and conditional promoter-regulated strains of 
ugmA, ugeA, ugtA. In each of A and B, the colonies are the same age. A) Wild type and 
alcA(p)-regulated strains grown on complete medium containing 100 mM threonine 
(CMT) or 3 % glucose (CM3G) as sole carbon sources, for gene over-expression or 
repression, respectively. B) Wild type and niiA(p)-regulated strains grown on minimal 
medium containing nitrate (MMN) or ammonium (MMA) for gene expression or 
repression, respectively.   
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Fig. 3.3. Scanning electron micrographs showing: colony (A), and conidiophore (B) 
phenotype for wild type and alcA(p)-regulated ugmA, ugeA, and ugtA strains grown on 
CMT for overexpression and CM3G for repression.  C) Colony and conidiophores of 
ugmA∆ on CM. On CMT media, the alcA(p) strains have abundant conidiophores with 
long chains of spores similar to wild type strain. On CM3G media, alcA(p)-ugmA, 
alcA(p)-ugeA, alcA(p)-ugtA produced many fewer conidiophores similar to ugmA∆ 
strain. Scale bar is 100µm for A & C (upper panel) and 10 µm for B & C (lower panel).   
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Fig. 3.4. Galactofuranose immunolocalization in Aspergillus nidulans hyphae using the L10 
monoclonal antibody. (A) wild type, B) UgmA-GFP, C) ugmAΔ, D) niiA(p)-ugmA 
grown on induction medium, E) niiA(p)-ugmA grown on repression medium. Lower 
case letters are corresponding brightfield images. B’ shows UgmA-GFP distribution, 
which is cytoplasmic, as expected. B” shows a merge of B and B’. Bars = 10 m.  
 
 
 
Fig. 3.5. The expression of α-glucan synthase (ags1) and β-glucan synthase (fksA) is affected 
by galactofuranose biosynthesis. Quantitative PCR results for ags1 (A) and fksA (B) 
expression (as fold changes with respect to actA ± SE) for wild type, ugmA deletion, 
and ugmA-regulated strains.  
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Fig. 3.6. Response of wild type and alcA(p)-regulated ugmA, ugeA, and ugtA strains to A) 
Itraconazole and B) Caspofungin. The alcA(p)-regulated genes were overexpressed by 
growth complete medium containing 100 mM threonine (CMT), and repressed by 
growth on complete medium containing 3% glucose (CM3G). Arrows indicate the edge 
of the zone with no visible growth, from where diameter was measured. On 
Caspofungin, sensitivity is measured at the innermost clear zone.  
 
 90 
 
Supplemental Table A: Strains, primers and plasmids used in this study 
Strains 
Name     Description   Genotype 
A1100
a
     Wild type    A. fumigatus AF293 
A1149
a
     A. nidulans    pyrG89; pyroA4; nkuA::argB 
AAE1
b
     A. nidulans    pyrG89:N. crassa pyr4+; pyroA4; nkuA::argB 
AAE2
b
     A. nidulans ugmAΔ   AN3112::AfpyrG; pyrG89; pyroA4; nkuA::argB 
AAE5
c
      A. nidulans ugeAΔ   AN4727::AfpyrG; pyrG89; pyroA4, nkuA::argB 
ASA1
d
      A. nidulans ugtAΔ   AN3113::AfpyrG; pyrG89; pyroA4; nkuA :: argB 
AAE12
e
   A.nidulans alcA(p)-ugmA  ugmAp::pyrG:alcAp:ugmA; pyrG89; pyroA4; nkuA::argB 
AAE13
e
   A. nidulans alcA(p)-ugeA  ugeAp::pyrG:alcAp:ugeA; pyrG89; pyroA4; nkuA::argB 
ASA4
e
     A. nidulans alcA(p)-ugtA  ugtAp::pyrG:alcAp:ugeA; pyrG89; pyroA4; nkuA::argB 
AKA10
e
     A. nidulans niiA(p)-ugmA  ugmAp::pyrG:niiAp:ugmA; pyrG89; pyroA4; nkuA::argB 
AKA11
e
     A. nidulans niiA(p)-ugeA  ugeAp::pyrG:niiAp:ugeA; pyrG89; pyroA4; nkuA::argB 
AKA12
e
    A. nidulans niiA(p)-ugtA  ugtAp::pyrG:niiAp:ugeA; pyrG89; pyroA4; nkuA::argB 
Primers Sequence 5`→3` 
Promoter exchange alcA(p) 
Ame115
e 
 ugmAF  TCCTATCACCTCGCCTCAAAATGCTTAGTCTAGCTCGCAAGAC 
Ame 23
b
   ugmA  R  GCCTGCACCAGCTCCCTGCGCCTTATTCTTAGCAAA 
Ame 1
b
     UpugmAF  GACTCTTGAGATTTGCTTGGGTCTC 
Ame114
e
  UpugmAR  TCAGTGCCTCCTCTCAGACAGAGAAGAGAGCGAAGCTGCAG 
Ame118
e
  Promoter F  CTGTCTGAGAGGAGGCACTGA 
Ame119
e
  PromoterR  TTTGAGGCGAGGTGATAGGA 
Ame116
e
  ugmAFusF  GTAGTTGACAAGCATACGGAGTACTC 
Ame117
e
  ugmAFusR  GGACCAGTAGGGACCTTCCT 
Ame120
e
   ugeAF  TCCTATCACCTCGCCTCAAAATGCCTTCTGGATCTGTCCT 
Ame 48
c
  ugeA R   TTATTTCTTGAGCTGTTCCAGC 
Ame 41
c
 UpugeA F   CTCCTATGGTATGTCTCTTCCAACTT 
Ame121
e
 UpugeA R  TCAGTGCCTCCTCTCAGACAGGGTGAATGTGAATTGAATGCAG 
Ame122
e
 ugeAFus F  TGTTACTTTAGGCCCGCAAG 
Ame123
e
 ugeAFus R  GTCCACAGCCACAGATCCTC 
SA1
d
 Up ugtA F   AAATAATATCTGCTTCGACCCACA 
SA67
e
 UpugtA R  TCAGTGCCTCCTCTCAGACAGTTTGAGAGCGCGAGCTTG 
SA71 
e
 ugtAF   TCCTATCACCTCGCCTCAAAATGAGCAGCTCCGAAGAGAA 
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SA31 
d
 ugtA R   TTAAGCATTGCCAGTACTGGC 
SA5 
d
 ugtA Fus F  ATAGTGACAATAATTTTCTCCAGAGAA 
SA69 
e 
ugtA Fus R  GGAATCGGGAGCGTAGCT 
Ame134 
e
 Midpromoter F  GTGTTTGGTGTTGCCAAAGAC 
Promoter exchange niiA(p) 
KA114
e   
niiAF(PyrGTail) GAGTATGCGGCAAGTCATGAGTCGGTATCGATTGAAGGAAAC 
KA115
e
  niiA R   CCAGTATGGTACCACAGCTCAT 
KA117
e
 UgmAF(NiiATail) ATGAGCTGTGGTACCATACTGGATGCTTAGTCTAGCTCGCAAGA 
KA118
e
 UgeA F(NiiATail) ATGAGCTGTGGTACCATACTGGATGCCTTCTGGATCTGTCCT 
KA116
e
 UgtA F(NiiATail) ATGAGCTGTGGTACCATACTGGATGAGCAGCTCCGAAGAGAA 
 
qRT-PCR 
Ame 84
e 
 ugm F   CGTTCCCAGCTTTCAGGATA 
Ame 85
e
  ugm R   CTTTGCAGCACCCAATCC 
Ame100
e
 act F   TTCGGGTATGTGCAAGGC 
Ame101
e
 act R   TCGTGACAACACCGTGCT 
SE11
e
  FKS F   GTGTGGTCCGTTTCGCTATT 
SE12
e
  FKS R   GCTCAAGAAGGATGCCACTC 
SE15
e 
 ags1F   ACGCTCTTCCTCGCACTG 
SE16
e
  ags1R   GAGGTTATGGCATAGGTTGTG 
Plasmids 
palcA(p)
f
   pGEM, alcA(p), AfpyrG ampR 
a
 Fungal Genetics Stock Center www.fgsc.net. 
b
 El-Ganiny et al. (2008) 
c
 El-Ganiny et al. (2010) 
d
 Afroz et al. (2011) 
e
 This study. 
f
 Dr. Loretta Jackson-Hayes, Rhodes College, Memphis TN. 
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Supplemental Table B: Antifungal drug sensitivity
1
 comparing wild type, deletion, and 
alcA(p)-regulated Galf biosynthesis strains.      
Itraconazole   
Expression (medium)                                Wild type       ugmA           ugeA  ugtA 
Neutral (CM); wild type and Δ strains        7.0 ± 0.3 a       7.8 ± 0.2 a     7.5 ± 0.2 a      7.4 ± 0.1a 
alcA(p) Overexpression (CMT)                   8.3 ± 0.3 a    8 ± 0.2 a        6.6 ± 0.2 b      7.6 ± 0.1a 
             Repression (CM3G)                       7.0 ± 0.1a        7.6 ± 0.2 a      7.3 ± 0.2 a      7.8 ± 0.3a 
 niiA(p) Expression (MMN)                        7.0 ± 0.2a     7.1 ± 0.1 a      7.0 ± 0.2 a      7.0 ± 0.1a 
             Repression (MMA)                        6.8 ± 0.2a     8.0 ± 0.1 a      7.8 ± 0.2 a      8.0 ± 0.1a 
 
Caspofungin   
Expression (medium)                               Wild type        ugmA         ugeA          ugtA 
Neutral (CM); wild type and Δ strains       3.5 ± 0.05a      6.3 ± 0.2b     4.5 ± 0.6c        6 ± 0.2b 
alcA(p) Overexpression (CMT)                  4.3  ± 0.2a      4.5 ± 0.1a    1.7 ± 0.1c        3.4 ± 0.2d 
            Repression (CM3G)                      3.4 ± 0.1a      6.8 ± 0.2b    2.8 ± 0.2c        6.2 ± 0.2bb 
niiA(p) Expression (MMN)                       3.4±0.1a        3.34±0.1 a    3.1±0.2 a        3.47±0.1 a 
           Repression (MMA)                           3.1±0.1a        5.56±0.1b     5.21±0.1c        5.9±0.1bc 
      
1  Drug sensitivity was measured using a disc diffusion assay (see Fig. 3.6). For Caspofungin, 
sensitivity was the radius (mm) of the clear zone with no visible growth (see arrows on 
Fig. 3.6B). Mean ± SE of two measurements for each of four biological replicates were 
used for statistical analysis (Kruskal-Wallis multiple comparison test). For each row, 
values followed by different letters (a-c) are significantly different at P<0.05. 
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Supplemental information: 
 
Supplemental Figure A. 
Promoter exchange for ugmA. 
A) Cartoon showing gDNA for a) wild type, b) alcA(p), c) niiA(p), including position of 
primers used for confirmation PCR. d) Expected sizes for amplicons using the primer 
pairs in a-c. 
B-D) Confirmatory PCR using gDNA template from B) wild type A1149, C) alcA(p)-ugmA, 
and D) niiA(p)-ugmA. 
 
 
Supplemental Figure B. Growth and conidiation of Wild type and alcA(p)--‐ugmA strains on 
CM and YEPD    
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CHAPTER 4 
Aspergillus nidulans cell wall composition and function change in response to hosting 
several Aspergillus fumigatus UDP-galactopyranose mutase activity mutants. 
 
This Chapter demonstrates how modification of A. nidulans UDP-galactopyranose 
mutase leads to changes in cell wall α-glucan and β-glucan content, hyphal surface adhesion 
and response to antifungal drugs. The manuscript has been accepted for publication on 2, 
December, 2013 as Aspergillus nidulans cell wall composition and function respond to 
hosting several Aspergillus fumigatus UDP-galactopyranose mutase activity mutants in 
PLoS One by Md Kausar Alam*, Karin E. van Straaten, David A. R. Sanders and Susan 
GW Kaminskyj, 2013. 
*Correcsponding author 
 
This Chapter was based on our hypothesis ``Strains lacking UgmA or hosting mutated 
UgmA will have significantly altered carbohydrate content in their cell wall compared to the 
wild type strain. These UgmA defective strains will also have less or no Galf in their cell wall. 
The objectives of the research in this Chapter were 
1. Characterization of structurally important amino acid residues of AfUgmA using A. 
nidulans as a host. 
2. To explore the role of Galf in A. nidulans hyphal surface adhesion and response to 
antifungal drugs 
3. To determine how modification of A. nidulans UDP-galactopyranose mutase leads 
to changes in cell wall α-glucan and β-glucan content 
4. To determine the cell wall Galf content in UgmA defective strains. 
 
My contribution in this Paper: I designed and performed all the experiments mentioned in 
this manuscript except the enzyme kinetic study, which was performed by Dr. Karin van 
Straaten. I generated all the final figures and wrote the manuscript, which was edited by Dr. 
Kaminskyj, Dr. David Sanders and Dr. Karin van Straaten prior to submission. I am the 
corresponding author of this paper.  
 95 
 
Aspergillus nidulans cell wall composition and function change in response to hosting 
several Aspergillus fumigatus UDP-galactopyranose mutase activity mutants. 
 
Md Kausar Alam
*
, Karin E. van Straaten, David A. R. Sanders, and Susan G.W. Kaminskyj 
Department of Biology, University of Saskatchewan, 112 Science Place, Saskatoon, 
SK S7N 5E2, Canada. 
*author for correspondence. Email:  kausar.alam@usask.ca 
 
Abstract 
Deletion or repression of Aspergillus nidulans ugmA (AnugmA), involved in 
galactofuranose (Galf) biosynthesis, impairs growth and increases sensitivity to Caspofungin, 
a β-1,3-glucan synthesis antagonist. The A. fumigatus UgmA (AfUgmA) crystal structure has 
been determined. From that study, AfUgmA mutants with altered enzyme activity were 
transformed into AnugmA∆ to assess their effect on growth and wall composition in A. 
nidulans. The complemented (AnugmA::wild type AfugmA) strain had wild type phenotype, 
indicating these genes had functional homology. Consistent with in vitro studies, AfUgmA 
residues R182 and R327 were important for its function in vivo, with even conservative 
amino (RK) substitutions producing AnugmA∆ phenotype strains. Similarly, the conserved 
AfUgmA loop III histidine (H63) was important for Galf generation: the H63N strain had a 
partially rescued phenotype compared to AnugmA∆. Collectively, A. nidulans strains that 
hosted mutated AfUgmA constructs with low enzyme activity showed increased hyphal 
surface adhesion as assessed by binding fluorescent latex beads. Consistent with previous 
qPCR results, immunofluorescence and ELISA indicated that AnugmA∆ and AfugmA-
mutated A. nidulans strains had increased α-glucan and decreased β-glucan in their cell walls 
compared to wild type and AfugmA-complemented strains. Like the AnugmA∆ strain, 
A. nidulans strains containing mutated AfugmA showed increased sensitivity to antifungal 
drugs, particularly Caspofungin. Reduced β-glucan content was correlated with increased 
Caspofungin sensitivity. Aspergillus nidulans wall Galf, α-glucan, and β-glucan content was 
correlated in A. nidulans hyphal walls, suggesting dynamic coordination between cell wall 
synthesis and cell wall integrity. 
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4.1 Introduction 
The cell wall is essential for the survival of fungi in natural environments. In fungi, the 
cell wall is about one quarter of the average fungal biomass (Gastebois et al., 2009), and about 
a third of the fungal genome (~4000 genes) is involved in cell wall biosynthesis and 
maintenance (de Groot  et al., 2009). Polysaccharides and glycoconjugates contribute to 
proper functioning of the cell wall and cell membranes that collectively form the interface 
between the fungal cell and its environment (Tefsen et al., 2012). Due to the importance of 
cell walls for fungal growth and host invasion, and the relative lack of conservation with 
animal cell components, the cell wall is expected to be a good source of potential antifungal 
targets (Bowman and Free, 2006; Aimanianda and Latgé, 2010) 
Aspergillus fumigatus is considered to be the most important airborne, human 
pathogenic fungus (Latgé, 2001). Aspergillus nidulans is a closely related model species with 
easy molecular genetic manipulation (Todd et al., 2007a). Carbohydrate analysis of A. 
fumigatus and A. nidulans walls shows that both species have similar composition (Guest and 
Momany, 2000), ~40% each of α-glucan and β-glucan (Gastebois et al., 2009; Free, 2013). 
Despite decades of research characterizing fungal cell wall composition and structure 
(Bowman and Free, 2006; de Groot  et al., 2009), many details remain poorly understood. 
Notably, recent evidence shows that fungal walls can be rapidly remodeled in response to 
environmental change (Kovács, 2013), adds another layer of complexity.  
 Galactofuranose (Galf) has an important role in fungal wall maturation (El-Ganiny et 
al., 2008 & 2010, Afroz et al., 2011; Alam et al., 2012). Galf is found in glycoconjugates that 
are important for survival or virulence of microorganisms including some bacteria, protozoa 
and fungi (; Pan et al., 2001; Beverley et al., 2005; Kleczka et al., 2007; Schmalhorst et al., 
2008; Lamarre  et al., 2009), but it is lacking in vertebrates. Since Galf is absent from higher 
eukaryotes and is involved in growth or virulence of some bacteria and fungi, the enzymes 
involved in its biosynthesis are potential drug targets (Pan et al., 2001; Pedersen and Turco, 
2003). Notably, loss of or reduction in wall Galf following gene deletion or repression in A. 
nidulans correlated with increased caspofungin sensitivity in vitro (Afroz et al., 2011; Alam et 
al., 2012). In vivo pathogenicity studies related to wall Galf are few, and to date are equivocal 
(Lamarre  et al., 2009; Schmalhorst et al., 2008). We have characterized the Galf biosynthesis 
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pathway in A. nidulans as a model system (El-Ganiny et al., 2008 & 2010, Afroz et al., 2011; 
Paul et al., 2011; Alam et al., 2012) and are extending this to A. fumigatus in preparation for 
future testing of antifungals.  
 UDP-galactopyranose mutase is the first committed enzyme in the Galf biosynthesis 
pathway in both A. fumigatus (AfGlfA [Schmalhorst et al., 2008] also called AfUgmA 
[Lamarre et al., 2009]) and A. nidulans (AnUgmA [El-Ganiny et al., 2008]). 
Aspergillus nidulans strains deleted for AnugmA have 500-fold reduced hyphal growth and 
spore production (El-Ganiny et al., 2008). UgmA is unique in A. nidulans and A. fumigatus, 
but is not essential in either species.  
 The crystal structure of AfUgmA has been determined (van Straaten et al., 2012). 
AfUgmA has conserved arginine residues, R182 and R327 that are important for function in 
vitro. In addition, H63 and F66 are expected to contribute to AfUgmA activity because the 
loop containing them changes position depending on the redox state of the FAD cofactor (van 
Straaten et al., 2012). Assessing the roles of these amino acids for the in vivo Aspergillus 
phenotype is expected to refine the in vitro characterization of UGM (van Straaten et al., 
2012), since in vitro enzymatic studies might not be precisely comparable to their in vivo 
function (Garcia-Contreras et al., 2012), and because H63N mutant did not express 
sufficiently for in vitro characterization. Here we examined the in vivo effects of structurally 
and functionally important amino acid residues of AfUgmA using A. nidulans as a host 
system, comparing cell wall composition, hyphal surface adhesion and response to antifungal 
drugs.  
 
4.2. Results 
 We used A. nidulans as a host for wild type (WT), wild type complemented (WC), and 
single amino acid mutants of AfUgmA to assess their effect on colony growth, wall 
composition, wall surface adhesiveness, and drug sensitivity. We hypothesized there would be 
concordance between AfUgmA function in vitro, and the in vivo phenotype; in vivo 
characterization provided additional information. 
 
4.2.1 Fungal phenotype for mutations affecting AfUgmA activity  
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 We generated an [AnugmA::wild type AfugmA] complemented (WC) strain in A. 
nidulans to confirm functional homology, and for quantitative characterization that had not 
been done previously (El-Ganiny et al., 2008). The WC strain phenocopied wild type 
A. nidulans hyphal morphometry and colony development (Figure 4.1, Table 4.1, and Figure 
S7). Table 2 presents the relative enzyme activity of wild type and mutated UgmA strains, 
derived from data in Table 3 of (van Straaten et al., 2012). As expected, the R327K and 
R327A strains phenocopied the AnugmAΔ strain for spore formation, colony growth, and 
hyphal morphometry (Figure 4.1, Table 4.1). Reduced sporulation was due to fewer 
conidiophores and aberrant conidiophore formation (Figure S2), comparable to the AnugmAΔ 
strain. The R182K in vivo phenotype had improved sporulation compared to AnugmAΔ but 
not colony growth. There were no significant differences between the R182A and AnugmAΔ 
phenotypes (Fig. 4.1, Table 4.1). Sporulation in A. nidulans appears to have a less stringent 
requirement for Galf content than does hyphal growth (Table 4.2).  
 H63 is expected to contribute to AfUgmA activity because it is part of the flexible loop 
(loop III) above the si-face of the isoalloxazine ring that changes position due to the redox 
state of the FAD cofactor (van Straaten et al., 2012). Structural analysis suggests H63N might 
keep UgmA loop III in the conformation similar to that seen in prokaryotic UGMs (Beis et al., 
2005; Partha et al., 2009; Sanders et al., 2011) and the reduced AfUgmA structure (van 
Straaten et al., 2012) by forming an H-bond with Q458. The in vitro H63N enzyme activity 
was not tested because of low protein expression for this construct. Notably, the in vivo H63N 
phenotype was comparable to that of R182K (Table 1, Figures 4.1 and S2), implying that the 
H63N strain likely would show a similar enzyme activity to R182K. This suggests that the 
flexibility of loop III plays a role in the catalytic activity of AnUGM. As with R182K, the 
major improvement compared to AnugmAΔ was in sporulation. This is consistent with Galf 
having multiple roles in the Aspergillus phenotype, with sporulation being more responsive to 
low levels of UgmA activity than hyphal morphology.   
 F66 is at the end of AfUgmA loop III and may control loop III flipping and 
consequently opening of the mobile loops depending on the redox state of the cofactor (van 
Straaten et al., 2012). The AfUgmA-F66A enzyme activity was almost double that of R182K 
(Table 2). In vivo, the F66A phenotype was relatively comparable to wild type (Table 4.1, 
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Figure 4.1) regarding sporulation (Figure S2) and hyphal morphometry, but restricted for 
colony diameter.  
 Together, these data show that AfUgmA R327 is critical for function in vitro and in 
vivo. H63, F66, and R182 each contribute to catalytic efficiency but to a much lesser extent. 
For all mutants, sporulation was less dependent on UgmA activity than hyphal or colony 
morphometry, consistent with the fact that ugmA∆ and R327A strains had limited sporulation. 
In sum, the in vivo AfUgmA mutant phenotypes correlated well with in vitro UgmA activity, 
and for H63N the in vivo data extended otherwise unobtainable characterization. 
 
4.2.2 Loss of wall Galf is associated with increased hyphal surface adhesion 
We used modified fluorescent polysterne beads visualized with confocal microscopy 
to assess hyphal surface adhesiveness, as adapted from (Alam et al., 2012). The WT and WC 
hyphae had relatively fewer fluorescent beads attached compared to AnugmA∆. Bead 
attachment for the strains with R182K, R182A, R327K, or R327A was similar to AnugmA∆ 
(Figure 4.2). Figure 4.2 used bead adhesion by the R327A strain to represent all of these latter 
mutant strains. For the F66A and H63N strains, bead attachment was slightly higher than wild 
type or WC strains but much lower than AnugmA∆ or the other mutant strains (Figure 4.2). 
The bead adhesion assay showed major changes in adhesion, but did not discriminate between 
subtle differences. It might be due change in surface hydrophobicity or charge. Atomic force 
microscope (AFM) force mapping might reveal these changes, but this is currently beyond 
our scope. However, our previous published paper showed using AFM force mapping that 
ugmAΔ strain hyphal wall surfaces had higher adhesion and reduced resilience compared to 
wild type A. nidulans walls (Paul et al., 2011).  
 
4.2.3 AfUgmA active site mutations do not affect UgmA-GFP cytoplasmic distribution   
El-Ganiny et al. showed that AnUgmA-GFP was cytoplasmic and evenly distributed 
along hyphae, consistent with UgmA lacking a signal peptide (also suggested in Lamarre et 
al., 2009). To confirm that expression of wild type and mutated AfUgmA did not affect 
cytoplasmic distribution in A. nidulans, strains were C-terminal GFP-tagged under the control 
of the ugmA endogenous promoter (Figure S1). Previously, we had found that N-terminal 
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AnUgmA-GFP abolished wild type UgmA function, since an RFP-UgmA strain had a 
AnugmA∆ phenotype (El-Ganiny and Kaminskyj, unpublished). The WC-GFP strain had WT 
hyphal and colony morphology, and abundant conidiation (data not shown), indicating that 
AfUgmA-GFP did not interfere with A. nidulans growth. The A. nidulans strains containing 
GFP-tagged R182A, R327A or H63N had compact colony growth, phenotypically similar to 
the respective untagged strains. GFP distribution in each strain was cytosolic, excluded from 
membrane-bounded organelles, and lacked a pronounced longitudinal gradient (Figure 4.3), 
consistent with wild type distribution of AnUgmA in A. nidulans (El-Ganiny et al., 2010).  
To confirm that the even GFP distribution was not due to cleavage of the GFP tag, we 
extracted total proteins from the wild-type and mutated GFP-tagged strains (WT, R182A-
GFP, R327A-GFP, H63N-GFP and AfUgmA-GFP) strains, followed by separation of proteins 
using 10 % SDS-PAGE and western blotting with anti-GFP (Figure 4.3B). Notably, the great 
preponderance of signal was at 87 kDa, consistent with GFP-tagged UgmA, and essentially 
none was at 27 kDa, which would be consistent with cleaved GFP. The anti-GFP western 
blotted protein preparations from GFP-tagged mutant strains were consistent with wild type 
AnUgmA-GFP distribution (El-Ganiny 2010) and with AfUgmA-GFP distribution (Figure 
S6). This suggested that the phenotype effects of mutated AfUgmA constructs did not relate to 
alterations in sub-cellular distribution. We do not have an anti-UgmA, so we were unable to 
perform the complementary experiments to directly measure the intracellular UgmA levels in 
vivo in order to confirm the stability of AfUgmA.  
  
4.2.4 Alteration in Galf affects wall glucan composition in A. nidulans  
Alam et al. 2012 showed using qPCR that gene expression of α-glucan synthase, agsB 
and β-glucan synthase, fksA were influenced by the level of AnugmA activity. However, 
synthase gene expression is not necessarily directly related to wall glucan content. We 
quantified cell wall α-glucan, β-glucan, and Galf using ELISA (Table 4.2) and 
immunofluorescence (Figures 4.4-4.6) in WT, WC, mutated and AnugmA∆ strains.   
Aspergillus nidulans WT and WC strains had strong Galf immunolocalization in 
hyphal walls (Figure 4.4). The F66A strain had the highest level of hyphal wall Galf 
immunofluorescence of any of the mutants, consistent with ELISA quantification (Table 4.2) 
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and with its relatively high in vitro UgmA activity (Table 4.2). The R182K and H63N strain 
hyphal wall Galf immunofluorescence quantitation was half that of F66A (Figure 4.4), 
comparable to ELISA results (Table 4.2) showing Galf content in these strains is 35-45 % of 
F66A. Low hyphal wall Galf was consistent with phenotypic differences, showing 
concordance between wall composition and hyphal morphology (Figure 4.1, Tables 4.1, 4.2). 
WT, WC and F66A cell wall Galf content in (Table 2) was correlated with sporulation (Table 
4.1, Figs. 4.1, S2). The R327K, R327A, R182A strains lacked immunolocalizable Galf and all 
aspects of their phenotype resembled the AnugmAΔ strain. Taken together, wall Galf content 
was consistent with in vitro AfUgmA activity and with other aspects of hyphal and colony 
development phenotype. 
Aspergilllus nidulans wild type and WC hyphal walls had relatively low α-glucan 
content (Table 4.2, Figure 4.5) compared to mutant and AnugmAΔ strains. This is consistent 
with our previous qPCR studies on gene expression (Alam et al., 2012), but was more 
nuanced regarding cellular distribution. Alpha-glucan staining was most pronounced in the 
older hyphal regions, and was undetectable at wild type and WC hyphal tips. The α-glucan 
immunofluorescence intensities were stronger in the R327K, R327A, R182K, R182A and 
AnugmA∆ strains (Figure 4.5), but again were substantially lower at hyphal tips (not shown). 
ELISA results for α-glucan (Table 4.2) were comparable to immunofluorescence 
quantification in older regions of the hyphae. In sum, wall α-glucan content of all the mutants 
and AnugmA∆ strains was influenced by alteration in Galf and it was inversely correlated with 
UgmA enzyme activity levels (Table 4.2). 
Aspergillus nidulans wild type and WC hyphal walls had relatively higher β-glucan 
levels than the mutants and AnugmAΔ strains (Figure 4.6, Table 4.2). The quantitative 
difference in β-glucan level between WT, WC, F66A and all other strains was more 
pronounced than for α-glucan or Galf. ELISA results for β-glucan were consistent with 
immunofluorescence quantification, showing a decline in wall β-glucan content with decrease 
in UgmA enzyme activity levels (Table 4.2). 
These data show the relative importance of AfUgm amino acid residues in and near the 
active site is R327 > R182 ~ H63 >> F66. Clearly, in vitro enzyme and in vivo phenotype 
 102 
 
analysis have strong complementarity. We plan to use phenotype analysis as part of our 
strategy to assess the efficacy of potential UgmA-inhibitor compounds. 
 
4.2.5 Loss of AfUgmA activity leads to increased sensitivity to some antifungal compounds 
If Galf biosynthesis is to achieve its promise as an antifungal drug development target, 
most likely as a part of a combination therapy, strains with reduced AfUgmA should be 
expected to be more sensitive to antifungal compounds. We compared Caspofungin (β-glucan 
synthesis), Itraconazole (ergosterol synthesis), and Calcofluor White (chitin crystallization) 
sensitivity on all the strains (Table 4.2). Analysis of the raw drug sensitivity data showed that 
index values that differed by 0.2 were significantly different, as it had been seen in our 
previous studies (Alam et al., 2012). None of the mutations notably affected sensitivity to 
Calcofluor White. Strains with substantially reduced Galf (R182 and R327 mutants) were 
significantly more sensitive to Itraconazole. Furthermore, Caspofungin sensitivity was 
significantly increased for all of the mutant strains compared to wild type, almost 2-fold for 
R327K and AnugmAΔ. Even F66A, which still had a substantially wild type hyphal and 
colony phenotype, and wall composition was significantly more sensitive to Caspofungin 
(Table 4.2).  
 
4.3. Discussion 
 We used quantitative methods to correlate in vitro UgmA enzymatic function and in 
vivo fungal cell and developmental phenotype related to site-directed changes to conserved 
amino acid residues in the AfUgmA catalytic site. We were able to assess residues for which 
there was structural and in vitro enzymatic function information (van Straaten et al., 2012), as 
well as residues where enzymatic activity had not yet been assessed. These analyses provide a 
coherent picture of changes in A. nidulans related to the efficacy of an enzyme involved in an 
early step in Galf biosynthesis in Aspergillus that affects wall composition-structure-function.  
 Previously we showed qualitatively that A. fumigatus AfugmA restored wild type hyphal 
morphology in the A. nidulans ugmAΔ strain (El-Ganiny et al., 2008). We have extended that 
preliminary observation with quantitative assessment of colony phenotype and wall 
composition for A. nidulans whose native AnUgmA had been replaced with wild type 
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AfUgmA or with AfUgmA constructs mutated in or near the enzyme active site. This approach 
provided a way to correlate structure and function of AfUgmA, regardless of whether gene 
products could be analyzed in vitro. According to van Straaten et al. (van Straaten et al., 
2012), for in vitro enzymatic studies all the mutants (except H63N) were over-expressed, 
purified and studied, with no apparent changes in protein stability. There was no evidence of 
changes to the overall protein structure as the mutants crystallized under similar conditions 
and resulted in similar crystallographic structures (van Straaten et al., 2012). In addition, none 
of the mutations affected the cellular AfUgmA distribution assessed with GFP-tagging and 
anti-GFP immuno-blotting. These results are consistent with the effects we observed being 
due to changes in AfUgmA activity or other aspects of cellular interaction. Since all the 
mutants were expressed under endogenous AnugmA promoter to assess phenotype in vivo, it 
is also possible that these effects might be due to the instability of mutant protein.  Although 
western blot showed the same level of fluorescence intensity for GFP tagged mutants and 
wild type AfUgmA against anti-GFP antibody, direct intracellular evaluation of these mutants 
and wild type AfUgmA stability in vivo is beyond our scope at this moment because of 
lacking an antibody directed against AfUgmA. 
 
 Comparing protein structure analysis and in vitro enzymatic activity of wild type 
AfUgmA with conservative (RK) and non-conservative (RA) mutants showed that R327 
was essential to UgmA function (van Straaten et al., 2012). Structural data in (van Straaten et 
al., 2012) shows that R327 stabilizes the position of the diphosphates of the nucleotide sugar 
and facilitates positioning of the galactose for catalysis. The R327K mutation impaired 
enzyme function whereas the R327A mutation produced a strain with no UgmA activity 
detectable in vitro (Table 4.2, and van Straaten et al., 2012). Consistent with this, A. nidulans 
strains whose wild type AnUgmA had been replaced with AfUgmA-R327A qualitatively and 
quantitatively resembled the AnugmAΔ strain. The role of R182 was slightly less critical than 
that of R327 (Table 4.2). R182 is important for sugar orientation related to catalysis, as well 
as for catalytic efficiency (van Straaten et al., 2012). When AfUgmA-R182K replaced the 
native AnUgmA, the R182K strain showed significantly better growth and sporulation than 
AnugmAΔ, whereas the R182A strain resembled the AnugmAΔ deletion strain.  
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This is the first time that we have been able to partially rescue the AnugmAΔ 
phenotype by genetic means. Previously we had shown that low levels of Calcofluor White, 
or 1 M sucrose, partially remediated the AnugmAΔ defects, however this was only for 
morphogenesis of submerged hyphae, and not for sporulation (El-Ganiny et al., 2008). 
Similarly, the R182K strain showed that sporulation was more effectively remediated by low 
levels of Galf than was hyphal morphogenesis. Galf immunolocalization using EBA2 (El-
Ganiny et al., 2008) vs L10 (Alam et al., 2012) shows substantially different localization 
patterns. EBA2 preferentially stained conidia, metulae and phialides, whereas L10 stained 
hyphae. Together these suggest that there are at least two different types of Galf-containing 
compound in Aspergillus walls.  
We also examined the roles of two amino acids that could be functionally important 
because they are part of loop III, which moves upon redox state of the cofactor (van Straaten 
et al., 2012). H63 is a highly conserved residue for prokaryotic and eukaryotic UGMs. The 
H63N construct expressed poorly in vitro so it had not been studied for in vitro enzyme 
activity. Histidine is positively charged at physiological pH whereas asparagine is polar but 
not charged. Correlating strain phenotype characteristics with estimates of UgmA activity 
suggested that the H63N strain UgmA activity would be comparable with the R182K strain. 
F66 is a highly conserved residue amongst eukaryotic UGMs. The AfUgmA F66A strain 
showed a 6.3-fold decrease in UgmA activity compared to wild type AfUgmA in vitro (Table 
4.2). The in vivo F66A phenotype was similar to wild type indicates that in vivo function of 
UgmA does not impair at this level of decrease in in vitro activity.  Our results further 
indicate that changes in AfUgmA loop III affect catalytic activity and that H63 is important 
but not critical for UGM activity. 
 Our previous work showed that deletion or down-regulation of any of three sequential 
genes in A. nidulans Galf biosynthesis was associated with comparable reductions in hyphal 
growth rate and sporulation (El-Ganiny et al., 2008 & 2010, Afroz et al., 2011; Alam et al., 
2012), with increased sensitivity to fungal wall-targeting compounds (Afroz et al., 2011; 
Alam et al., 2012), with changes in α-glucan and β-glucan synthase gene expression (Alam et 
al., 2012), and with changes in wall surface adhesion (Paul et al., 2011). Here we have 
correlated the effect of mutations in AfUgmA (transformed into A. nidulans) with 
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morphometry, with quantitative immunofluorescence, with ELISA quantification of wall 
carbohydrates, with changes in wall adhesiveness, and with sensitivity to anti-fungal 
compounds.   
Notably, reductions in wall Galf content correlated with increased wall α-glucan 
content (r
2
=0.972, P<0.0001) and in decreased wall β-glucan content (r2= 0.980, P=0.0001) 
shown in this study were consistent with increased agsB and decreased fksA expression (Alam 
et al., 2012).  Not surprisingly, A. nidulans cell wall α-glucan and β-glucan content were also 
strongly correlated (r
2
=0.993, P<0.0001). Given that in wild type cells α-glucan and β-glucan 
are each thought to comprise about 40 % of the A. nidulans wall (Gastebois et al., 2009; Free, 
2013), this strongly suggests that the cell is metabolically constrained as to where it 
apportions metabolites for wall synthesis, so that increases in abundance of one major 
polymer must limit the resources available for synthesis of the others. However, this does not 
directly explain why engineered changes in Galf content (perhaps 5 % of total [Lamarre et al., 
2009]) are so strongly related to changes in α-glucan and β-glucan content. We suspect these 
will be coordinated through the cell wall integrity pathway, which is a focus of current 
research. 
Decreased fksA expression and β-glucan content correlated with increased sensitivity 
to Caspofungin (r
2
=0.855, P<0.0005), which is mechanistically satisfying. Notably, an ugmA 
overexpressed strain also showed Caspofungin hypersensitivity (Alam et al., 2012) suggesting 
that balanced expression of wall components is important for wild type phenotype and drug 
resistance.  
The mutant (except F66A) and deletion strains also showed a smaller but still 
significant increase in sensitivity to Itraconazole. Previously using AFM force mapping (Paul 
et al., 2011) we had found that ugmAΔ strain wall surfaces were more force-compliant than 
wild type walls, suggesting that they had reduced resilience. Itraconazole targets ergosterol 
biosynthesis, and so is expected to affect membrane fluidity. It appears likely that a 
combination of wall and membrane defects is particularly difficult for a fungal cell to resist. 
Once UGM inhibitors have been developed, we expect that they will show enhanced efficacy 
if given in combination with amphotericin B as well as Itraconazole.  
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Compared to wild type, AnugmA∆ A. nidulans had higher adhesion to AFM Si3N4 
probe tips (Paul et al., 2011). In addition, AfugmA∆ strains have been shown to be highly 
adherent to pulmonary epithelial cells, to glass or plastic surfaces compared to wild type 
(Lamarre et al., 2009). Consistent with these previous results, AnumgA∆ and mutant strains 
have increased hyphal adherence to latex beads compare to wild type strain (Figure 4.2). 
Higher adhesion (Lamarre et al., 2009) has been correlated with both higher and lower 
pathogenicity (Schmalhorst et al., 2008; Lamarre et al., 2009) but there are few studies of this 
type and further research is needed. This disparity could be due to lower growth rates in 
AfUgmA mutants, thus potentially also to lower tissue penetration.  
Taken together, we have shown that fungal phenotype can provide useful estimates of 
functional information on the role of some amino acid residues, even though their mutant 
gene products were poorly expressed in vitro (i.e. H63N). Our results in this study suggest 
that UgmA activity correlated with hyphal phenotype: a < 7-fold decrease produced a wild 
type phenotype (wild type AfUgmA, F66A), ~20-fold decrease resulted in partial function 
(H63N and R182K), and a ≥ 70-fold decrease (R182A, R327K, R327A, AnUgmAΔ) was 
insufficient to synthesize a functional level of wall Galf. 
In conclusion, we have shown that reduced AfUgmA activity due to mutation did 
impair A. nidulans growth in a manner substantially similar to gene deletion and gene down-
regulation. UgmA distribution was not affected by these manipulations. Loss or absence of 
Galf increased wall α-glucan but reduced wall β-glucan (which were strongly correlated), and 
with increased hyphal surface adhesion and Caspofungin sensitivity. Thus, it seems that A. 
nidulans needs a balanced expression of UgmA (not high, not low [Alam et al., 2012]) to 
generate a resilient wall for normal growth and wall surface integrity. In the future, we 
anticipate that our approach will also be useful for assessing the effects of UgmA-targeting 
drugs (under development by the Sanders group). 
 
4.4 Materials and methods  
4.4.1 Strains, plasmids, and culture conditions 
 Strains, primers and plasmids are listed in Table S1. The A. nidulans strains were 
maintained on complete medium (CM) supplemented for nutritional markers as described in 
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(Kaminskyj, 2001). Bacterial strains were grown on LB with antibiotics as required (Table 
S1). All water was freshly prepared by 18 MegOhm ultrapure (Barnstead NanoDiamond). 
 
4.4.2 Site-directed mutagenesis and overexpression of F66A-AfUGM 
Site-directed mutagenesis of the F66A AfUGM mutant was
 
performed using the 
QuikChange
TM
 site-directed mutagenesis kit (Stratagene, Inc.) according to the manufacturer's 
protocol. Comparable methods were used for creating the other SDM strains (van Straaten et 
al., 2012). Over-expression vector pET22b harboring the AfUGM gene was used
 
as the 
template DNA. The PCR mixture contained 50 ng of
 
template DNA and 15 pmole of each 
primer. PCR amplification was carried out in a GeneAmp PCR PTC100 System. The original 
methylated plasmid
 
was digested with DpnI, then 2 µL of the reaction
 
was used to transform 
competent E. coli Dh5α cells (Novagen). Ampicillin-resistant colonies were selected from the 
LB plates, and the specific mutation
 
was verified by DNA sequencing. The mutant enzyme 
was overexpressed
 
and purified as previously described (van Straaten et al., 2012). 
4.4.3 Enzyme kinetics 
Kinetic constants for F66A AfUGM mutant were determined as previously described (van 
Straaten et al., 2012a). A fixed concentration of AfUGM mutant protein (500 nM) was chosen 
so as to have less than 40% conversion to the product UDP-Galp. Reactions were carried out 
with 0 – 300 µM of UDP-Galf in a final volume of 100 µL 50 mM phosphate buffer pH 7.0 
and 20 mM freshly prepared sodium dithionite. The incubations were carried out for 1 min at 
37 °C then quenched with 100 µL n-butanol. The conversion of UDP-Galp to UDP-Galf was 
monitored at 262 nm using HPLC (Waters). The amount of conversion was determined by 
integration of the UDP-Galp and UDP-Galf peaks. The initial velocity was calculated from 
the substrate concentration and percentage UDP-Galp conversion. Kinetic parameters were 
determined with GraphPad Prism software (GraphPad Software, San Diego, CA) using 
nonlinear regression analysis. 
 
4.4.4 Mutagenesis and transformation 
 Strains used in this study are shown in Supplemental Table S1. The wild type (WT) and 
wild type complemented (WC) strains were compared with AfUgmA mutants R327K, R327A, 
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R182K, R182A, F66A and H63N, and with the AnugmA strain. AfugmA constructs for 
mutations in the AfUgmA active site and in AfUgmA loop III that had been used for structural 
studies (van Straaten et al., 2012) were used to generate AnugmA replacement constructs 
using fusion PCR (Figure S1) according to (Szewczyk et al., 2007). We used an AfpyrG 
selectable marker controlled by the α-tubulin promoter [tubA(p)-pyrG] to ensure a constitutive 
level of marker expression, whereas the wild type or mutated version of AfugmA
 
was 
controlled by their endogenous promoters (Figure S1). Constructs were transformed into wild 
type protoplasts (Szewczyk et al., 2007; Osmani and Oakley, 2006). Confirmation of the 
correct gene manipulations used genomic DNA (isolated as described in [Yang Y et al., 
2008]) from putative transformant strains as a template for PCR (Figure S4) with 
combinations of primers as shown Suppl Table S1. Prior to phenotype analysis, genomic 
DNA from each A. nidulans strain was extracted. ugmA was amplified from these genomic 
DNA samples using PCR. Primers that we used to amplify ugmA target 100 bp upstream and 
100 bp downstream (inside of tubA promoter) (Figure S1) of ugmA. PCR products were 
sequenced in order to confirm the expected construct generation and replacement. Fusion 
construction for replacement cassettes used primers that were ~50 bp inside of upstream and 
downstream primers from both sides. To confirm the correct insertion site, we used the 
outside pair of primers.  
 
4.4.5 Colony growth, sporulation and surface adhesion 
 Colony characters were examined as in (El-Ganiny et al., 2008). Strains were streaked 
on CM and incubated for 3 d at 28 °C to give isolated colonies. The diameter of ten 
colonies/strain was measured to the nearest millimeter using a dissection microscope. The 
number of spores produced per colony was counted for four colonies/strain.  
 The hyphal surface adhesion assay was modified from (Lamarre et al., 2009). 
Fluorescent (excitation maximum 520 nm; emission maximum 540 nm) 0.5 μm diameter 
polystyrene beads (Sigma: aqueous suspension, 2.5 % solids content) were diluted 1:10 in 
sterile phosphate buffered saline (PBS). One hundred microliters of bead solution was added 
to CM liquid containing 20,000 spores and incubated for 8 h at 37 °C with 150 r.p.m. Images 
of germlings were collected using a Zeiss META510 confocal microscope with a 63x, 1.2 
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N.A. multi-immersion objective, a 514 nm excitation from Ar ion laser at 20 % power, and a 
530–600 nm emission filter. 
 
4.4.6 Cell wall preparation  
 Cell wall extraction was performed according to (Momany et al., 2004). Colonies were 
grown in shaken liquid at 37 
o
C for 48 h, filtered through Whatman #1 filter paper, washed 
with ultrapure water, and then with 0.5 M NaCl. Fungal hyphae were broken using 1 mm 
glass beads in buffer [20 mM Tris, 50 mM EDTA, pH 8.0]. Cell walls were separated from 
cytoplasmic debris by centrifugation at 3000 x g for 10 min. The pellet containing the cell 
wall fraction was washed with same buffer with stirring for 4 h at 4 
o
C, followed by a wash 
with ultrapure water. The pellet was frozen at -80 
o
C, then lyophilized overnight.  
 
4.4.7 ELISA  
 Our ELISA protocol was adapted from (Momany et al., 2004). Isolated A. nidulans cell 
walls [0.5 mg/mL in PBS] were incubated in 96-well Immulon 2HB plates (Sigma) overnight 
at 4 
o
C. Subsequent steps were performed at room temperature using monoclonal antibodies 
to Galf (L10; provided Prof. Frank Ebel, Univ Munich), α-1,3-glucan (MOPC-104E; Sigma), 
and β-glucan [(1-3)-β-glucan directed monoclonal antibody, Cat. No. 400-2, Biosupplies, 
Australia]. Primary antibodies were diluted 1:10 (Galf), 1:30 (α-glucan), or 1:50 (β-glucan). 
Secondary antibodies (1:500) were alkaline phosphatase-conjugated goat anti-mouse IgM 
(Sigma) (for Galf and α-glucan) and alkaline phosphatase-conjugated goat anti-mouse IgG 
(for β-glucan). At the final step, wells were incubated with alkaline phosphatase substrate 
(Sigma) (1 mg/mL) dissolved in substrate buffer (0.5 mM MgCl2.6H2O, 9.6 % 
diethanolamine, pH 9.6) for 30 min. Absorbance at 405 nm was recorded using ELISA reader. 
All ELISA experiments were performed at least twice with three replicates. We used PBS and 
cell wall extracts of wild type and deleted strains without primary antibody as a control. 
 
4.4.8 Protein extraction and western blot 
 To extract total protein, A. nidulans conidia were grown in complex media (CM) for 20 
h. Mycelia were then collected from liquid cultures by filtration through Miracloth paper, 
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washed with distilled water, dried on paper towels, and ground to a powder with mortar and 
pestle in liquid nitrogen (Efimov, 2003). The ground mycelium was resuspended and boiled in 
the urea/SDS buffer (Osherov, 1998): 1% SDS, 9 M urea, 25 mM Tris-HCl (pH 6.8), 1 mM 
EDTA, and 0.7 M 2 mercaptoethanol). The debris was removed by centrifugation at 13000 x 
g. Total protein concentration was determined by the Bio-Rad protein assay. UgmA-GFP 
fusions were detected on Western blots using purified mouse anti-GFP polyclonal antibody 
(eBioscience).  IRDye 800-conjugated anti-mouse IgG was used as a secondary antibody. 
Bands were detected using the Odyssey Infrared Imaging System (LI-COR Biosciences). 
Images were processed by Odyssey 3.0.16 application software (LI-COR Bioscience).  
 
4.4.9 Microscopy   
 Samples were prepared for confocal microscopy as described in (El-Ganiny et al., 
2008). Galf, α-glucan and β-glucan were immunolocalized using the same primary antibodies 
as described for ELISA. Primary antibodies were used at full strength for L10, at 1:50 
dilutions for α-glucan and β-glucan. GFP was immunolocalized using anti-GFP primary 
antibody (eBioscience) at a dilution of 1:100. TRITC-conjugated goat-anti-mouse was used as 
secondary antibody at 1:100 dilutions. Immunofluorescence procedures followed (Alam et al., 
2012). Samples were examined using confocal epifluorescence microscopy. The relative 
immunofluorescence intensity was quantified using Zeiss image browser software at 25 
isolated cellular sites at hyphal wall where we had near-median confocal slices of subapical 
cells.  
 Scanning electron microscopy was used to examine conidiation following preparation as 
in (Alam et al., 2012). Strains were grown on dialysis tubing laid on CM for 3 d at 28 ºC. 
Colonies were fixed by immersion in 1 % glutaraldehyde, dehydrated in acetone, 
critical-point dried (Polaron E3000, Series II), and gold sputter coated (Edwards model 
S150B). Samples were imaged with a JEOL 840A scanning electron microscope.  
 
4.4.10 Drug sensitivity testing 
 Sensitivity to Caspofungin, Itraconazole and Calcofluor White of wild type and 
engineered UgmA strains was measured using a disc-diffusion assay as described in (Afroz et 
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al., 2011, Alam et al., 2012). Stock solutions: itraconazole (1.6 mg/mL in DMSO), Calcofluor 
White (10 mg/mL in 25 mM KOH), and Caspofungin (20 mg/mL in sterile water) were stored 
at -80 
o
C. For this test, 1 x 10
7
 spores were mixed into 20 mL of 50 ºC CM agar and 
immediately poured in 9 cm Petri plates. Stock solutions were pipetted onto sterile 6 mm 
paper discs placed on the agar surface: 20 µL of CFW, 10 µL of itraconazole, and 20 µL of 
caspofungin. Solvent controls, DMSO and 50 % ethanol, showed no zone of inhibition. The 
plates were incubated at 30 ºC for 48 h, before measuring the zone of inhibition (Alam et al., 
2012).  
 Drug sensitivity is presented as an index compared to wild type on the same medium, so 
that values greater than 1.0 indicate hypersensitivity. Statistical analysis of the raw data and 
comparison to sensitivity indices showed that a difference of >0.2 in index value correlated 
with statistical significance. Representative plates from the Caspofungin study are shown in 
Figure S3. Quantitative results are shown in Table 4.2. 
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Table 4.1: Colony and hyphal characteristics
a 
of wild type, and AnugmA strains 
complemented with wild type AfUgmA, single residue AfUgmA mutants and deletion 
strains grown on CM.  
Strains Spores/colony 
(×10
6
)
b
 
Colony diameter 
(mm)
c
 
Hyphal 
width (μm)d 
Basal cell 
length (μm)d 
Wild type (A1149) 109 ± 3.0
e
 18 ± 0.5
e
 2.5 ± 0.1
e
 29 ± 1.7
e
 
AnugmA∆:AfugmA 99 ± 2.3f 17 ± 0.6e 2.5 ± 0.1e 27 ± 1.7e 
F66A 90 ± 2.8
g
 13 ± 0.3
f
 2.6 ± 0.1
e
 24 ± 0.9
e
 
H63N 6.4 ± 0.4
h
 7.3 ± 0.4
g
 3.3 ± 0.1
f
 18 ± 0.8
f
 
R182K 3.2 ± 0.2
i
 6.2 ± 0.3
h
 3.4 ± 0.1
fg
 17 ± 1.8
f
 
R182A 1.3 ± 0.1
j
 5.0 ± 0.3
i
 3.5 ± 0.1
gh
 16 ± 0.7
fg
 
R327K 1.2 ± 0.1
j
 5.1 ± 0.3
i
 3.5 ± 0.1
ghi
 15 ± 0.8
g
 
R327A 0.6 ± 0.1
k
 4.6 ± 0.4
i
 3.6 ± 0.2
hi
 14 ± 0.8
g
 
AnugmA∆ 0.5 ± 0.4k 5.2 ± 0.4i 3.7 ± 0.1hi 14 ± 0.8g 
 
a  Values are presented as mean ± standard error. Statistical significance of the mean values 
was compared using a Kruskal–Wallis test, and shown for each characteristic to be 
significantly different at P < 0.05. For each column, values followed by different letters (e–
k) are significantly different at P < 0.05. 
b At least 4 colonies per strain were counted. Spores of wild type and mutated strains were 
streaked on CM and incubated for 3 d at 28 °C to give isolated colonies. 
c The diameter of ten colonies/strain was measured using a dissection microscope. 
d  Hyphal width was measured at septa. Basal cell length was between adjacent septa for 
n=25 measurements per strain. 
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Table 4.2: Aspergillus nidulans wild type and chimaera cell wall carbohydrates
a
, 
antifungal drug sensitivity
ac, and relative UGM activityb. 
Strains Relative 
UgmA  
Galf 
a
 
 
α-glucan a 
 
β-glucan a 
 
Antifungal drug 
sensitivity
a
  
 activity
b
    Casp
c
 Itra
c
 CFW
c
 
Wild type 1 1 1 1 1 1 1 
AnugmA :: 
AfugmA 
nd 0.96 1.05 0.96 1 1 1 
F66A 0.16 0.78 1.18 0.87 1.2 1 1.1 
H63N na 0.52 1.46 0.74 1.5 1.1 1.1 
R182K 0.10 0.43 1.58 0.69 1.7 1.2 1.2 
R182A 6.0 x 10
-6
 0.13 1.68 0.60 1.5 1.2 1.1 
R327K 0.015 0.09 1.70 0.60 1.9 1.2 0.9 
R327A bd 0.04 1.79 0.58 1.7 1.2 1.1 
AnugmA∆ nd 0.00 1.84 0.57 1.9 1.2 1 
 
a
 Absorbance at 405 nm was recorded using ELISA reader, Results are presented as an index 
of OD values with respect to wild type. Cell walls were isolated from A. nidulans strains 
after 48 h growth. Index sensitivity values are for each drug/strain combination compared 
to wild type. Index values > 1.0 were more sensitive than wild type. Index values that 
differed by > 0.2 were based on data that were significantly different: see Table S2 
b
 Relative UGM activity in vitro with respect to wild type, derived from data in (33) and this 
study for F66A. nd, not determined; na, not available (low protein expression); bd, below 
detection. 
c
 Caspofungin, Casp; Itraconazole, Itra; Calcofluor White, CFW. See Materials and Methods 
for drug dosage and medium formulation. Drug sensitivity was measured using a disc 
diffusion assay as described in methods (Figure S3). For Caspofungin, sensitivity was the 
radius (mm) of the clear zone with no visible growth. Mean ± SE of two measurements for 
each of four biological replicates were used for statistical analysis (Table S2).   
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Figure 4.1. Colony morphology of Aspergillus nidulans wild type (WT) strain complemented 
with wild type AfUgmA (WC), single residue AfUgmA mutants (F66A, H63N, R182K, 
R182A, R327K, R327A) and AnugmAΔ strains, grown on complete medium at 30 °C for 3 d. 
The colour difference between WT and WC strains was due to slightly different ages of 
culture. See Figure S7 for a direct comparison of the spore colours of these two strains. 
 
 
Figure 4.2. Surface adhesion of Aspergillus nidulans strains to fluorescent polysterene beads. 
Wild type (WT), strain complemented with wild type AfUgmA (WC), single residue AfUgmA 
mutants (F66A, H63N and R327A) and AnugmAΔ strains. Bar = 20 µm is for all images. 
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Figure 4.3. In vivo distribution of GFP-tagged AfUgmA in Aspergillus nidulans. A. Wild type 
complemented (WC) and single residue mutants (H63N, R182A and R327A) have 
comparable AfUgmA-GFP distribution. The single residue mutants have the ugmAΔ hyphal 
morphology. Bar = 20 µm for all images. B. Confirmation of AfUgmA-GFP fusion protein 
distribution by Western blot. Total protein was extracted from A. nidulans wild type (WT; 
AAE1) and GFP-tagged AfUgmA strains (R182A-GFP, R327A-GFP, H63N-GFP, 
AnUgmA::AfUgm-GFP). Total Proteins (15 µg/lane) were separated on 10% SDS-PAGE and 
immunoblotted with an anti-GFP antibody. 
 
Figure 4.4. Galactofuranose immunolocalization (A) and immunofluorescence quantification 
(B) using confocal system software (see Methods).  Error bar shows standard error. 
Aspergillus nidulans wild type (WT), wild type AfUgmA-complemented (WC), mutated 
AfUgmA (as listed), and AnugmAΔ. Bar = 10 m for all images.  
 116 
 
 
Figure 4.5. Alpha-glucan immunolocalization (A) and immunofluorescence quantification 
(B) using confocal system software (see Methods). Error bar shows standard error. 
Aspergillus nidulans wild type (WT), wild type AfUgmA-complemented (WC), mutated 
AfUgmA (as listed), and AnugmAΔ. Bar = 10 m for all images. 
 
 
Figure 4.6.  Beta-glucan immunolocalization (A) and immunofluorescence quantification (B) 
using confocal system software (see Methods). Error bar shows standard error. Aspergillus 
nidulans wild type (WT), wild type AfUgmA-complemented (WC), mutated AfUgmA (as 
listed), and AnugmAΔ. Bar = 10 m for all images. 
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Supporting Information 
Table S1:  Strains and primers used in this study  
Aspergillus  
A1100 
a
  Aspergillus fumigatus wild type, AF293 
A1149 
a 
  Aspergillus nidulans pyrG89; pyroA4; nkuA::argB  
AAE1 
  
Aspergillus nidulans pyrG89:: Ncpyr4+; pyroA4; nkuA::argB 
A. nidulans ugmAΔ b  AN3112::AfpyrG; pyrG89; pyroA4; nkuA::argB 
AnugmA::AfugmA
c
  AN3112::AfugmA:tubAp:AfpyrG; pyrG89; pyroA4; nkuA::argB 
F66A
c
  AN3112::AfugmA-F66A:tubAp:AfpyrG;pyrG89;pyroA4;nkuA::argB 
H63N
c
                         AN3112::AfugmA-H63N:tubAp:AfpyrG;pyrG89;pyroA4;nkuA::argB 
R182K
c
                        AN3112::AfugmA-R182K:tubAp:AfpyrG;pyrG89;pyroA4;nkuA::argB 
R182A
c
                       AN3112::AfugmA-R182A:tubAp:AfpyrG;pyrG89;pyroA4;nkuA::argB 
R327K
c
                       AN3112::AfugmA-R327K:tubAp:AfpyrG;pyrG89;pyroA4;nkuA::argB 
R327A
c
                       AN3112::AfugmA-R327A:tubAp:AfpyrG;pyrG89;pyroA4;nkuA::argB 
AfugmA-GFP
c    
AN3112::AfugmA-GA5-GFP-tubAp-AfpyrG;pyrG89;pyroA4; nkuA::argB 
H63N-GFP
c   
AN3112::AfugmA-H63N-GA5-GFP-tubAp-AfpyrG;pyrG89;pyroA4; 
nkuA::argB 
R182A-GFP
c
    AN3112::AfugmA-R182A-GA5-GFP-tubAp-AfpyrG;pyrG89;pyroA4; 
nkuA::argB 
R327A-GFP
c   
AN3112::AfugmA-R327A-GA5-GFP-tubAp-AfpyrG;pyrG89;pyroA4; 
nkuA::argB 
 
Escherichia coli  
BL21-gold (DE3) 
d  
 
Plasmids 
pAfugmA
 e 
pET22b, AfugmA, amp
R 
pAfugmA-F66A 
e 
pET22b, AfugmA-F66A, amp
R
 
pAfugmA-H63N 
e 
pET22b, AfugmA-H63N, amp
R
 
pAfugmA-R182K 
e 
pET22b, AfugmA-R182K, amp
R
 
pAfugmA-R182A 
e 
pET22b, AfugmA-R182A, amp
R
 
pAfugmA-R327K 
e 
pET22b, AfugmA-R327K, amp
R
 
pAfugmA-R327A 
e 
pET22b, AfugmA-R327A, amp
R
 
pFNO3
 a 
GA5-GFP, AfpyrG, Kan
R
 
 
Primers   Sequence 5’  3’ 
Replacement of AnugmA   
P1, Up AnugmA F
c 
GACTCTTGAGATTTGCTTGGGT 
P2, Up AnugmA R
c 
ACATATCGGGGTGGGTCATGAAGAGAGCGAAGCTGCAG 
P3, AfugmA F
 c
 ATGACCCACCCCGATATGT 
P4, AfugmA(tupAp-tail)  R
c 
AGTCACGTGCTGCATTTACTGGGCCTTGCTCTTG
 
P5, tupAp F
 c 
ATGCAGCACGTGACTATT 
P6, tupAp (pyrG-tail) R
 c 
AATTGCGACTTGGACGACATCTTGTCTAGGTGGGTGGT
 
P7, AfpyrG F
c 
ATGTCGTCCAAGTCGCAATT  
P8, AfpyrG R
c
 TCATGACTTGCCGCATACTC  
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P9, dn AnugmA(pyrG-T) F
c 
GAGTATGCGGCAAGTCATGAAACTCTTCTGCGTGGATGG 
P10, dn AnugmA R
c
 GGACTGCAGGTTGAAGCAG 
 
 
Fusion construct generation for replacement   
P11, Fusion Up AnugmA F
c
 CCGTCCTTCGTAGAGTACTTGAG 
P12, Fusion dnAnugmA R
c 
GGTTGAACGATGTCAGCGTA 
 
Replacement confirmation of AnugmA 
P1, Up AnugmA F
c  
GACTCTTGAGATTTGCTTGGGT 
P10, dn AnugmA R
c   
GGACTGCAGGTTGAAGCAG 
Ame8, midPyrG R
b 
CACATCCGACTGCACTTCC
 
 
 
AfugmA-gfp tagging 
P13, AfugmA(GFP-tail) R
 c  
CTCCAGCGCCTGCACCAGCTCCCTGGGCCTTGCTCTTGG 
P14, Dn AnugmA R
 c  
ATCAGTGCCTCCTCTCAGACAGAACTCTTCTGCGTGGATGG 
Ame 27 5GA-GFPF
b 
GGAGCTGGTGCAGGC 
Ame 28 5GA-GFPR
b 
TCATGACTTGCCGCATACT 
 
AfugmA-gfp tagging confirmation 
P1, Up AnugmA F
c 
GACTCTTGAGATTTGCTTGGGT 
P10, dn AnugmA R
c   
GGACTGCAGGTTGAAGCAG 
Ame8, midPyrG R
b 
CACATCCGACTGCACTTCC
 
 
 
Fusion constructs generation using fusion PCR for GFP tagging strains (same as replacement)   
P11, Fusion Up AnugmA F
c 
CCGTCCTTCGTAGAGTACTTGAG 
P12, Fusion dnAnugmA R
c 
GGTTGAACGATGTCAGCGTA 
 
H63N SDM 
H63N forward GTCGGTGGTCACGTCATCGCCTCCCACTACAAGTATTTC  
H63N reverse GAAATACTTGTAGTGGGAGGCGATGACGTGACCACCGAC 
 
a Fungal Genetics Stock Center, www.fgsc.net 
b El-Ganiny et al. (2008) 
c This study 
d Novagen (www.emdchemicals.com) 
e van Straaten et al. (2012) 
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Table S2: Antifungal drug sensitivity
1
 of wild type, deletion, and mutated Galf biosynthesis 
strains.  
Strains Antifungal drug sensitivity
a
  
 Casp
c
 Itra
c
 CFW
c
 
Wild type 4.25±0.3
 a
        5.25±0.2
 a
        2.0±0.1
 a
        
AnugmA :: 
AfugmA 
4.38±0.2
 a
        5.25±0.1
 a
        2.0±0.2
 a
        
F66A 4.75±0.1
 a
        5.5±0.1
 a
        2.25±0.3
 
a
        
H63N 6.13±0.1
 b
        6.0±0.1
 a
        2.5±0.3
 a
        
R182K 7.13±0.1
 bc
        6.13±0.2
 a
        2.13±0.1
 
a
        
R182A 6.38±0.3
 bc
        6.25±0.3
 a
        2.13±0.1
 
a
        
R327K 7.38±0.2
 c
        6.25±0.1
 a
        1.89±0.
a
        
R327A 8.00±0.2
 c
        6.5±0.2
 a
        2.25±0.2
a
        
AnugmA∆ 8.25±0.3 c        6.5±0.1 a        2.0±0.2 a        
 
1
 Caspofungin, Casp; Itraconazole, Itra; Calcofluor White, CFW. See Materials and Methods 
for drug dosage and medium formulation. Drug sensitivity was measured using a disc 
diffusion assay as described in methods (Figure S3). For Caspofungin, sensitivity was the 
radius (mm) of the clear zone with no visible growth. Mean ± SE of two measurements for 
each of four biological replicates were used for statistical analysis (not shown). Statistical 
significance of the mean values was compared using a Kruskal–Wallis test, and shown for 
each characteristic to be significantly different at P < 0.05. For each column, values 
followed by different letters (a–c) are significantly different at P < 0.05. Data are presented 
as sensitivity index in Table 4.2.  
 
 120 
 
 
 
 
 
 
 
 
Figure S1. Strategy for generation of complemented, mutated and GFP tagged mutated 
strains in A. nidulans. A. Replacement of A. nidulans ugmA with wild type and mutated A. 
fumigatus ugmA. B. GFP-Tagging of A. nidulans UgmA with wild type and mutated A. 
fumigatus UgmA. 
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Figure S2. Scanning electron micrographs of Aspergillus nidulans showing: colony (A-H), 
and conidiophore (a-h) phenotype for wild type and mutated strains on complex media. Scale 
bar is 100 μm for A -H and 10 μm for a-h. A) wild type (AAE1), B) AnugmA::AfugmA, C) 
AnugmA::AfugmA-F66A, D) AnugmA::AfugmA-H63N, E) AnugmA::AfugmA-R182K, F) 
AnugmA::AfugmA-R182A, G) AnugmA::AfugmA-R327K, H) AnugmA::AfugmA-R327A, I) 
AnugmAΔ. 
 
 
Figure S3: Response of wild type (WT), complemented, mutated and deleted strains to 
Caspofungin. Sensitivity is measured at the innermost clear zone (arrows). WT; wild type, 
AnugmA::AfugmA, AnugmA::AfugmA-F66A, AnugmA::AfugmA-H63N, AnugmA::AfugmA-
R182K, AnugmA::AfugmA-R182A, AnugmA::AfugmA-R327K, AnugmA::AfugmA-R327A, 
AnugmAΔ.  
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Figure S4. Confirmatory PCR for site directed mutated (SDM) replacement strain. This 
figure is for replacement of AnugmA by AfugmA-R327A in A. nidulans. In addition to 
Confirmatory PCR, confirmation of all SDM strains was also done by DNA sequencing. 
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Figure S5. Confirmatory PCR for SDM-GFP tagging strains. This figure is for tagging 
AfugmA-R327A with GFP and expressing in A. nidulans. In addition to Confirmatory PCR, 
confirmation of all GFP tagged strains was also done by DNA sequencing. 
 
 
Figure S6. GFP immunolocalization in Aspergillus nidulans using anti-GFP antibody. Wild 
type complemented (WC) and single residue mutants (H63N, R182A and R327A) have GFP 
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localization comparable to AfUgmA-GFP distribution. Green channel: GFP distribution; Red 
channel: anti-GFP straining. Bar = 20 µm for all images.   
 
 
Figure S7: Colony morphology and spore colour of Aspergillus nidulans wild type (WT), 
complemented (WC) strains grown on complete medium at 30 °C for 3 d. Both WT and WC 
strains were grown on same plate. No difference in colony morphology was observed. Arrow 
indicates respective strains.  
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CHAPTER 5 
Revealing the interacting partners of Aspergillus nidulans UDP-galactopyranose mutase 
using tandem affinity purification (TAP) and mass spectrometry.  
 
This Chapter is based on the hypothesis that UgmA is part of a protein complex that 
likely includes UgeA, UgtA, and members of α-glucan and beta-glucan metabolism. This 
Chapter will be submitted in future with further study for publication as “Revealing the 
interacting partners of Aspergillus nidulans UDP-galactopyranose mutase using tandem 
affinity purification (TAP) and mass-spectrometry analysis”. 
 
The objectives for this research are  
1. To adopt the TAP tag strategy in our lab for studying protein interaction networks 
2. To identify the interacting partners of UgmA 
 
My contribution in this Chapter: I have generated C-terminal and N-terminal TAP 
tagged UgmA strains and confirmed the right insertions using DNA sequencing. I have 
purified UgmA from total proteins extract and pulled down UgmA with its interacting 
partners on polyacrylamide gel. I have sent the bands for Mass-spec analysis to NRC 
Mass-Spec facilities. Mass-Spec results will be confirmed by a future student using yeast 
two-hybrid system. I generated all the final figures and wrote the first draft, which was edited 
by Dr. Kaminskyj. 
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Revealing the interacting partners of Aspergillus nidulans UDP-galactopyranose mutase 
using tandem affinity purification (TAP) and mass-spectrometry analysis 
Md. Kausar Alam and Susan GW Kaminskyj 
Abstract 
Galactofuranose (Galf) is a nonessential component of the fungal cell wall, but its 
presence is important for Aspergillus growth, wall maturation and integrity. Previously, we 
showed that deletion or repression of any of three sequential-acting Galf biosynthesis genes 
caused increased cell wall thickness in A. nidulans. In addition, we have recently shown that 
Galf-repressed strains had increased alpha-glucan and decreased beta-glucan content in their 
cell walls. This suggested that the Galf biosynthesis pathway might relate to other major cell 
wall synthesis pathways, particularly alpha-glucan and beta-glucan synthesis. Currently, how 
modification of Galf biosynthesis leads to changes in cell wall composition is unknown. In 
addition, how Galf is deposited in the cell wall is elusive. The cytosolic enzyme 
UDP-galactopyranose mutase (Ugm) is the first committed enzyme in the Galf biosynthesis 
pathway. Revealing the interacting partners of UgmA using a proteomic approach might help 
us to elucidate the molecular mechanism behind wall Galf deposition and its effect on the 
proportion of wall alpha-glucan and beta-glucan composition. Advanced biochemical 
methods combined with molecular biology and mass spectrometry are required to identify 
protein–protein interaction to understand the function of a given protein in its protein context. 
We used Tandem Affinity Purification (TAP) tagging combined with LC-MS/MS to study the 
interacting partners of UgmA. Tandem affinity purification and mass-spectrometry analysis 
we showed that UgmA has three major predicted interaction partners: AN6688, AN6010 and 
AN5327. These three proteins are involved in cytoskeleton generation, osmotic adaptation, 
and cell signalling pathway respectively. Unexpectedly, none are involved in galactose 
metabolism or Galf transport. Further study is necessary to confirm these interactions using 
yeast two-hybrid screening and/or immunoprecipitation. Further study will help us to 
understand Galf biosynthesis and dynamic coordination of Galf biosynthesis pathway with 
other wall carbohydrate polymers for Aspergillus wall formation. 
 
 127 
 
5.1. Introduction 
The fungal cell wall is essential for the survival and growth of fungi and to establish 
fungus-environment and host-pathogen interactions (Latgé, 2007; Cummings and Doering, 
2009). Fungal cell walls are mainly composed of glucans, chitin, galactomannan and 
mannoproteins (Free 2013). Polysaccharides and glycoconjugates have significant 
contributions to biological events including cell wall generation. In filamentous fungi, wall 
formation is also an integral part of hyphal extension (Read, 2011). Despite decades of effort 
to characterize the composition and architecture of fungal cell walls (Bartnicki-Garcia, 1968; 
Bowman et al 2006; de Groot et al 2009), many details still remain poorly understood. In 
particular, recent evidence shows that cell wall composition can be remodeled following 
environmental change (Levin, 2005; Fujioka et al 2007; Levin 2011), and altering certain 
minor wall components can cause major phenotype effects (Levin, 2005; Fujioka et al 2007; 
Levin 2011; Chapter 3 and references therein).  
Galactofuranose (Galf) is a minor but important cell wall component (Chapter 3&4) 
(Lamarre et al., 2009). Interestingly, the presence of Galf is restricted to bacteria (Leone et al 
2010), protozoa (Oppenheimer et al 2011), fungi (El-Ganiny et al., 2008; Latgé, 2009; Tefsen 
et al., 2012) as well as certain algae (Cordeiro et al 2008), archaea (Eichler and Adams, 2005), 
and lower invertebrates (Novelli et al 2009). Galf is essential in Mycobacterium tuberculosis, 
making Galf biosynthesis a drug target against mycobacteria (Scherman et al., 2003). In A. 
fumigatus walls, Galf is said to account for about 5 % of the total wall dry weight (Lamarre et 
al., 2009; Free, 2013) and is reported to be part of galactomannans, glycoproteins, 
sphingolipids and lipophosphogalactomannans (Latgé, 2009). Although Galf is not essential 
for fungal survival, its presence is important for cell wall growth, maturation and integrity 
(El-Ganiny et al 2008; Lamarre et al 2009; El-Ganiny et al, 2010; Afroz et al 2011; Paul et al, 
2011).  
The cytosolic enzyme UDP-galactopyranose mutase (Ugm) is the key enzyme in the Galf 
biosynthesis pathway. Ugm is responsible for interconversion of UDP-galactopyranose 
(6-membered ring) and UDP-Galf (5-membered ring). Deletion of ugm from Mycobacterium 
tuberculosis showed that it was essential for growth and survival (Pan et al., 2001). Targeted 
replacement of the orthologue glf in L. major (the causative agent of leishmaniasis) caused 
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attenuation of virulence (Kleczka et al., 2007). Deletion of ugmA in A. fumigatus, A. nidulans, 
and A. niger revealed that the corresponding knock-out strains were all completely lacking in 
Galf and exhibited marked alterations to their cell wall and growth (Damveld et al. 2008; 
El-Ganiny et al 2008; Lamarre et al 2009; El-Ganiny et al 2010). Damveld et al. (2008) had 
shown that A. niger strains with defective ugmA homologues had impaired colony growth and 
increased wall α-glucan content. In our previous study, we showed that deletion or repression 
of ugmA caused increased cell wall thickness in A. nidulans. In addition, we have shown that 
ugmA-deleted strains had increased alpha-glucan and decreased beta-glucan in their cell walls. 
Therefore, our previous studies suggested that Galf biosynthesis pathway might have 
relationships with other major cell wall synthesis pathway such as alpha-glucan and 
beta-glucan. Recent studies on Galf biosynthesis indicated it is important for Aspergillus 
growth and cell maturation (El-Ganiny et al 2008 and 2010, Afroz et al 2011; Alam et al 
2012). However, how Galf is generated and deposited to the cell wall still remains elusive. In 
addition, how modification of UgmA expression leads to a change in cell wall composition 
(Chapter 4) is still unknown. Revealing the interacting partners of UgmA using a proteomic 
approach might help us to elucidate the molecular mechanism behind wall Galf deposition and 
alteration of wall alpha-glucan and beta-glucan content. 
Biochemical methods combined with molecular biology and mass spectrometry are 
required to efficiently identify protein–protein interaction in the absence of a specific 
antiserum. These methods can clarify the role of a given protein through understanding its 
interacting protein context. The tandem affinity purification (TAP) method represents an 
biochemical application that was first described for Saccharomyces cerevisiae (Rigaut et al., 
1999; Puig et al., 2001) and was further applied to prokaryotes, plants, and mammalian cells, 
including humans, for in vivo studies (Rohila et al., 2004; Butland et al., 2006; Rohila et al., 
2006; Gregan et al., 2007). TAP-tagging is based on a recombinant fusion tag containing two 
tags; two tandemly-repeated Staphylococcus aureus protein A epitopes that bind to IgG 
sepharose during the first purification step, and a calmodulin-binding peptide (CBP) that 
binds to calmodulin affinity resin in the second purification step. The protein A domain is 
connected to CBP by a tobacco etch virus (TEV) protease cleavage site. Purified and eluted 
protein is then separated by SDS-PAGE. Individual protein bands are sent for mass 
 129 
 
spectrometry (MS) identification. The identification of putative interacting partners of the 
protein of interest should be confirmed by other methods, including the yeast two-hybrid, 
immunoprecipitation or bimolecular fluorescence complementation methods.  
In this study, we describe the adaptation of the TAP purification protocol including all 
required steps (protein extract preparation, purification procedure, visualization of proteins in 
the SDS gels, and final mass spectrometry identification) to study the interaction network of 
Aspergillus nidulans UgmA. Using tandem affinity purification and mass-spectrometry 
analysis, we showed that UgmA interacted with proteins that are involved in cytoskeleton 
generation, osmotic adaptation, and cell signalling pathways. Further study will help us to 
understand Galf biosynthesis and dynamic coordination of Galf biosynthesis pathway with 
other wall carbohydrate polymers for Aspergillus wall formation. 
5.2. Materials and methods 
5.2.1 Strains, Plasmids and Cultures conditions 
Strains, primers and plasmids are listed in Table S1. The A. nidulans strains were 
maintained on complete medium (0.5 % yeast extract, 1 % bacto-peptone, 0.1 % casamino 
acids, 1 % glucose, vitamins, and micronutrients) supplemented for nutritional markers as 
described in Kaminskyj (2001). Bacterial strains were grown on Luria Bertani (LB) medium 
with antibiotics as required (Table S1).  
 
5.2.2 Construction of linear recombinant DNA for transformation and for generation of 
C-terminal and N-terminal TAP-tagged UgmA strains. 
A codon optimized C-terminal TAP tag was amplified using primers cTAP1 and 
cTAP2 from plasmid pME3156 (a gift from Dr. Özgür Bayram, Germany). This was then 
fused with C-terminal of UgmA to generate UgmA::cTAP construct using fusion PCR as 
described in Szewczyk et al. (2007). The final module was generated using fusion PCR as 
US-UgmA::UgmA::cTAP::AfPyrG::DS-UgmA. This module was then transformed into 
A1149 protoplasts. Protoplasting and transformation followed procedures in Osmani et al. 
(2006) and Szewczyk et al. (2007). Primary transformants were grown on selective medium 
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containing 1 M sorbitol or 1 M sucrose as osmostabilizer. Confirmation of gene manipulation 
used genomic DNA from putative transformant strains as a template for PCR with 
combinations of primers, as shown in Supplementary Table S1. Primer binding sites used for 
confirmation were 50 bp outside the sites used for construction or were in the selectable 
marker. We used an A. fumigatus pyrimidine (AfpyrG) selectable marker controlled by the 
α-tubulin promoter [tubA(p)-pyrG] to ensure a constitutive level of marker expression, 
whereas the ugmA::cTAP was controlled by endogenous promoters (Figure 5.1). Prior to 
protein extraction, a genomic DNA sample from each A. nidulans strain was extracted. A 
ugmA::cTAP sequence was amplified from these genomic DNA samples using PCR. PCR 
products were sequenced in order to confirm the expected construct generation.  
 
5.2.3 Culturing of the fungal strains and crude extract preparation 
We inoculated 5× 800 mL liquid media with A. nidulans ugmA::cTAP, nTAP::ugmA, 
and wild-type control strains on CM (1 × 10
6 
per 1 mL medium) and grew these cultures for 
20 h at 37°C and 250 rpm. The TAP tag protocol was adopted from Bayram et al., 2012. 
Briefly, mycelia were filtered through a Miracloth filter using a vacuum flask connected to the 
air pump, then washed with harvest solution (0.96 % NaCl, 1 % dimethyl sulphoxide 
(DMSO), 1 mM phenylmethyl sulphonyl fluoride (PMSF)). Mycelia were ground in liquid 
nitrogen with a chilled mortar/pestle, and then transferred into 15 mL Falcon tubes and stored 
at −80°C. Approximately 40 g mycelia for each strain were transferred to three 50 mL Sorval 
centrifuge tubes. Five millilitres of collection buffer (100 mM Tris–HCl pH 7.5, 0.1 % NP-40, 
1 mL PMSF, and 100 mL dithiothreitol) supplemented with EDTA-free protease inhibitor 
tablets (Roche), and phosphatase inhibitors (Merck) were added to the bottom of each Sorval 
tube containing frozen mycelia. Another 5 mL of collection buffer was l layered on the top of 
the tube and mixed until buffer was absorbed by the mycelium. Tubes were kept on ice for 
5-10 min. Tubes were then centrifuged at 20,000 x g for 30 min at 4 °C. Supernatant was 
transferred to bovine serum albumin-treated 50 mL Falcon tubes containing washed (using 
collection buffer) IgG sepharose.  
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5.2.4 TAP purification and SDS PAGE  
Crude extract/IgG sepharose mixture was incubated on a rotating platform at 4 °C for 
2 h. This mixture was then passed through chromatography columns with gravity. IgG 
sepharose was accumulated at the bottom of the columns. Sepharose was then washed with 
2 × 10 mL wash buffer 1 (250 mM NaCl, 40 mM Tris–HCl pH 8.0, 0.1 % NP-40, 1 mL 
PMSF, 100 mL DTT) supplemented with ethylene diamine tetra-acetate (EDTA)-free 
protease inhibitor tablets and phosphatase inhibitors, once with 10 mL wash buffer 2 
(150 mM NaCl, 40 mM Tris–HCl pH 8.0, 0.1 % NP-40, 1 mM PMSF, 1 mM DTT) and once 
with TEV cleavage buffer (TCB) (150 mM NaCl, 40 mM Tris–HCl pH 8.0, 0.1 % NP-40, 0.5 
mM EDTA, 1 mM PMSF, 1 mM DTT) supplemented with E-64. TEV protease cleavage was 
executed by adding 1 mL TCB and 20 µL of AcTEV™ enzyme (Invitrogen) and rotating the 
suspension overnight at 4 °C. TEV protease treated suspensions was then transferred to new 
column which had 300 µL of washed calmodulin affinity resin (Stratagene) and 6 mL of 
calmodulin-binding buffer (CBB).  CBB columns were closed and rotated at 4 °C for 1 h. 
CBB columns were washed with 3 × 1 mL CBB. At the end, 2 X 500 µL elution buffer (EB) 
was added to the column and proteins were collected in 1.5 mL vials. Trichloroacetic acid 
(TCA)-precipitation was performed and then TCA-precipitated eluate was loaded onto a 10 % 
polyacrylamide gel, and then stained with Coomassie Brilliant Blue G (Sigma). Protein bands 
were cut out and sent to the NRC mass spectrometry facility for analysis.  
5.2.5 In-gel digestion procedures  
In-gel digestion was carried out at NRC mass spectrometry facility using the 
MassPrep II Proteomics Workstation (Micromass, UK). Briefly, Coomassie-stained protein 
gel bands were cut into pieces of ~1 mm
3
 and placed into 96-well plates. Gel bands were 
de-stained twice (10 min incubations) with 100 μL of 1:1 (v/v) ammonium bicarbonate: 
acetonitrile. Protein reduction was performed with the addition of 10 mM DTT prepared in 
0.1 M ammonium bicarbonate, for 30 min at 37 ºC. This step was followed by alkylation, 
achieved by adding 50 μL of 55 mM iodoacetamide (IAA) prepared in 0.1 M ammonium 
bicarbonate. The alkylation reaction was carried out for 20 minutes also at 37 ºC. Gels are 
washed and dehydrated before being saturated with 25 μL of 6 ng/μL trypsin prepared in 
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50 mM ammonium bicarbonate; digestion was carried out at 37 ºC for 5 h. Peptides were 
extracted with 30 μL 0.1% trifluoroacetic acid/3% acetonitrile for 30 min, and then twice with 
24 μL, 0.1% trifluoroacetic acid/50% acetonitrile for 30 min. The combined extracts were 
dried in a speed vac (Labconco, Fishier Scientific). Samples were reconstituted in 40 μL of 
0.1 % trifluoroacetic acid/3 % acetonitrile for LC-MS analysis. 
5.2.6 LC-MS Spectra collection and Data analysis   
For MS analysis we used commercial service of NRC MS facility. Briefly, tryptic 
peptides extracted from each gel slice were injected onto a liquid chromatographic column, 
then sample mass was analysed with a Quadrupole Time-Of-Flight (Q-TOF) Global Ultima 
mass spectrometer (Micromass, Manchester, UK) is equipped with a nano-electrospray (ESI) 
source and interfaced with a nanoACQUITY UPLC solvent delivery system (Waters, Milford, 
MA, USA). 
Samples were analyzed using Data Dependant Acquisition (DDA), which consists of 
the detection of multiply charged positive ions (z = 2, 3, and 4 were used herein) from an MS 
survey scan. The mass scan range was set from m/z 400 to 1900 with a scan time of 1 s. Up to 
three MS/MS scans were triggered from each MS scan event (signal intensity threshold was 
16 counts/second), with collision energy ranged from 20 to 80 eV depending on the charge 
state and precursor m/z. In MS/MS experiments, data was acquired in continuum mode with a 
scan time of 1.9 s, and dynamic exclusion of previously detected precursors was set at 2 min; 
peptides from trypsin and keratin were also excluded from MS/MS data collection.   
The RAW mass spectra data files collected from each sample were processed with 
ProteinLynx Global Server 2.4 (PLGS 2.4, Waters), a PKL file was generated and 
subsequently submitted to Mascot (Matrix Science Ltd., London, UK) for peptide search 
against the NCBInr protein database hosted by National Research Council of Canada (NRC, 
Ottawa). In the database searching parameters, a maximum of one tryptin miscleavage was 
allowed. The mass tolerance for precursor peptide ions was ± 50 ppm and for fragment ions it 
was ± 0.2 Da. Peptides of identified proteins were individually blasted against a public 
A. nidulans genome-wide protein sequence database of the Broad Institute 
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(http://www.broad.mit.edu/annotation/genome/aspergillus_nidulans/Home.html) to ensure 
their unambiguous assignment to the Mascot-specified protein. 
5.3. Results and discussion 
 
To explore the coordination of the Galf biosynthesis protein UgmA with that of other wall 
carbohydrate biosynthesis proteins, tandem affinity purification (TAP) and LC-MS were used.  
 
5.3.1 Construction and validation of tagging strains 
A linear fusion construct containing 1 kb upstream of ugmA, the whole ugmA expression 
sequence (genomic ugmA has 5 introns) except the stop codon, codon optimized TAP tag, 
nutritional marker AfpyrG, and 1 kb downstream of ugmA (Up-UgmA::UgmA::cTAP:: 
tubA(p)-::AfpyrG::DS-UgmA) was integrated into A. nidulans genomic DNA by homologous 
recombination (Fig. 5.1). Primary transformants were grown on CM containing 1 M sorbitol 
or 1 M sucrose as an osmotic stabilizer. Strain construction and confirmation is shown in Fig. 
5.1. The nTAP::ugmA or ugmA::cTAP construct was controlled by the endogenous ugmA 
promoter, whereas the nutritional marker, AfpyrG was controlled by the α-tubulin promoter 
[tubA(p)-pyrG] to ensure a constitutive level of marker expression. The correct strain 
generation was confirmed by both PCR and sequencing analysis. Growth of ugmA::cTAP, 
nTAP::ugmA and wild-type were compared on CM. Growth of ugmA::cTAP was comparable 
to wild type strain (Fig. 5.2). However, nTAP::ugmA had substantially reduced sporulation, 
thereby resembling the ugmA∆ strain (Fig. 5.2).  
 
5.3.2 Identification of interacting partners of UgmA using TAP tagging 
We used tandem affinity purification (TAP) to identify UgmA-interacting proteins (a 
generalized TAP protocol is summarized in Fig. 5.3). Purified recombinant UgmA of A. 
nidulans carrying the functional UgmA tagged at its C-terminus by TAP tag (ugmA::ctap) 
were analyzed by mass spectrometry (Fig. 5.4). Analysis of the purified UgmA complex by 
SDS-PAGE showed several bands, which were absent from a control purification using 
extract from wild-type cells (Fig. 5.4). As judged from percent sequence coverage and 
number of peptides per protein, we identified AN6688 (Septin B; AspB), AN6010 (SgdE) and 
AN5327 (uncharacterized) as interacting partners of UgmA (Fig. 5.4 and Table1).  
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Septins are evolutionarily conserved GTP-binding proteins that form complexes and 
act as organizational cues, recruiting critical proteins to areas of new growth and cell division 
(Longtine et al., 1996; Field and Kellogg, 1999; Gladfelter et al., 2001; Hernandez-Rodriguez 
and Momany 2013). Septins are found in all eukaryotes except higher plants (Pan et al., 2007; 
Estey et al., 2011) and are involved in a variety of cellular processes including cytokinesis, 
vesicle trafficking, cytoskeleton organization, polarity (Lindsay and Momany, 2006; 
Hernández-Rodríguez et al. 2012). The filamentous fungus Aspergillus nidulans has five 
septins: AspA, AspB, AspC, AspD, and AspE (Hernández-Rodríguez et al. 2012). AspB is an 
essential gene (Momany and Hamer, 1997). However, other evidence showed that deletion of 
AspB caused aberrant morphology in several developmental stages and reduced conidiation 
(Momany and Hamer, 1997; Westfall and Momany, 2002). AspB localizes to sites of 
septation and branching and to emerging conidiophore layers, bars and filaments throughout 
vegetative growth and asexual reproduction (Westfall and Momany, 2002; 
Hernández-Rodríguez et al. 2012). 
SgdE is an Hsp70-family protein required for conidial germination in A. nidulans. The 
sgdE gene is expressed at increased levels during osmoadaptation (Osherov and May, 2000).  
Single deletion of sgdE has not been performed in A. nidulans. In Candida albicans, SgdE is 
localized at yeast-form cell surface, but not the hyphal cell surface. It is also present in 
cytoplasmic extracts of C. albicans hyphae (Urban et al. 2003).  
AN5327 is an uncharacterized protein in A. nidulans. It has high amino acid sequence 
identity with S. cerevisiae and C. albicans VPS1. VPS1 is a small GTPase that is important 
for biofilm formation and filamentous growth. In C. albicans VPS1 is induced upon 
adherence to polystyrene (Marchais et al. 2005). Saccharomyces cerevisiae VPS1 is involved 
in actin cytoskeleton organization and associates with Golgi membranes (Ekena and Stevens, 
1995).  
 
5.4. Conclusion and future work for this Chapter: 
 
Using TAP tag and mass-spec analysis we showed that UmgA has at least three 
interacting partners. These are AN6688 (Septin B; AspB), AN6010 (SgdE) and AN5327 
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(uncharacterized) (Fig. 5.4). Without further investigation, it is too early to say whether 
UgmA really interacts with these proteins. It might be possible that these proteins bound 
nonspecifically to UgmA during purification. In order to confirm these interactions, we will 
have to study one-to-one interactions of UgmA with each of these proteins separately. 
One-to-one protein interaction can be confirmed by using different in vivo and in vitro 
techniques. These are bimolecular fluorescent complementation (split YFP), yeast two-hybrid 
system, and immunoprecipitation (IP). We will aso use reverse TAP to look for UgmA. 
Future work for this project might involve confirming these interactions of UgmA with 
AN6688, AN6010 and AN5327. Our future studies on these interactions will help to elucidate 
the molecular mechanisms underlying Galf generation and deposition in cell wall. We expect 
that these will eventually lead to better understanding Aspergillus cell wall formation. In 
addition, AN6010 and AN5327 are not fully characterized in A. nidulans. Single deletion of 
each of these proteins will help us to understand their phenotypic roles in A. nidulans growth. 
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Figure 5.1. Strategy for generation of UgmA-cTAP tagged strain in A. nidulans. 
cTAP: C-terminus Tandem affinity purification, DS: downstream, WT: wild type,  
gDNA: genomic DNA.   
 
 
 
 
Figure 5.2: Colony morphology and spore colour of Aspergillus nidulans wild 
type (WT), ugmA-cTAP and ugmA-nTAP strains grown on complete medium at 
30 °C for 3 d. ugmA-nTAP has lower spore production. However, no phenotypic 
difference in colony morphology was observed for wild type (WT) and 
ugmA-cTAP strains.  
 
 
 137 
 
 
 
Figure 5.3: Work-flow of the tandem affinity protocol. UgmA is fused to C-
TAP in the following order: (UgmA)-CBP-(TCS)-Protein A domain. 
Application steps of the protocol.  
1
st
 step: Binding of UgmA-TAP to the IgG sepharose.  
2
nd
 Step: TEV cleavage of the CBP domain and fusion protein from the IgG.  
3
rd
 Step: Binding of CBP to the calmodulin affinity resin.  
4
th
 Step: EGTA elution of the calmodulin affinity resin bound fusion protein and 
interaction partners.  
5
th
 Step: Elution of UgmA using EGTA.  
TAP: tandem affinity purification, CBP: calmodulin-binding peptide, X-Y-Z: 
putative interacting partners, TCS: TEV cleavage buffer, TEV: tobacco etch 
virus. 
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Figure 5.4: Identification of the interaction partners of the UgmA-TAP protein 
in A. nidulans. Strains were grown 20 h, total proteins were isolated and purified 
using TAP protocol. Purified UgmA was then run on 10% SDS-polyacrylamide 
gel and stained with Coomassie-blue. Individual bands were then sent for mass-
spec analysis. Peptides of identified proteins were individually blasted against a 
public A. nidulans genome-wide protein sequence database of the Broad Institute 
(http://www.broadinstitute.org/scientific-community/science/projects/fungal-
genome-initiative/fungal-genome-initiative) to ensure their unambiguous 
assignment to the Mascot-specified protein. 
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Table 5.1: Peptides identified from the bands using mass-spec belong to AN3112, 
AN6688, AN5327, and AN6010. 
Protein Hits Peptides Identified  Protein sequence 
coverage 
Mass 
AN3112.2 (UgmA) R.VPSFQDILQGR.M 
K.YFDDCINEALPK.E 
K.EDDWYEHQR.I 
K.GQWVPYPFQNNISMLPK.E   
K.CIDGMIDAAIEHR.V 
K.DFDEWIVR.M 
R.MMGTGVADLFMRPYNYK.V 
K.VWAVPTTK.M 
K.MQCAWLGER.V 
K.AVTTNVILNK.T 
K.TAGNWGPNATFR.F 
R.DGTGGIWIAVANTLPK.E 
K.TVTLGDGTTVGYQK.L 
R.ATIFSNYSPYNQPDASK.K 
R.ATIFSNYSPYNQPDASKK.L 
K.KLPTLQLADGSKPK.N 
K.LPTLQLADGSKPK.N 
R.RFDHGYPTPSLER.E 
K.LQSMDIWSR.G 
R.RLVDGAQAFAK.N 
41% 59764 
AN6688                              
(Septin B;AspB) 
R.YDAYLEAEN.V 
K.ADTLTDDEISMFK.K 
K.VPFAVVGANSEVATSDGR.K 
10% 46826 
AN5327 
(uncharacterized) 
 
 K.TAGNWGPNATFR.F 
 R.DGTGGIWIAVANTIPK.E 
 K.QLFYSSTHVIGVGIR.G 
8% 90000 
AN6010 (SgdE) R.AQLESLVEPLISR.T 
K.YSPAQIGGFVLGK.M 
4% 72328 
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Supplemental Information 
Table S1:  Strains and primers used in this study  
Aspergillus  
AAE1
a      
   Aspergillus nidulans pyrG89::Ncpyr4+; pyroA4; nkuA::argB     
A. nidulans ugmA-cTAP
b
 AN3112::ugmA-cTAP:tubAp:AfpyrG;pyrG89;pyroA4;nkuA::argB 
A. nidulans ugmA-cTAP
b
 AN3112::ugmA-cTAP:tubAp:AfpyrG;pyrG89;pyroA4;nkuA::argB 
 
Escherichia coli  
BL21-gold (DE3)
d  
 
Plasmids 
pME3156
c 
pME3156, TAP, amp
R 
 
Primers   Sequence 5’  3’ 
cTAP tagging of ugmA   
P1 ugmA F  ATGCTTAGTCTAGCTCGCAAGACT 
P2 ugmA (TAP-tail) R  CTTTTTCCATCTTCTCTTCTGCGCCTTATTCTTAGCA 
P3 cTAP F  AAGAGAAGATGGAAAAAGAATTTCAT 
P4 cTAP (tubA(p)-tail) R AGTCACGTGCTGCATTCAGGTTGACTTCCCCGC 
P5 tupAp F
  
ATGCAGCACGTGACTATT 
P6 tupAp (pyrG-tail) R
  
AATTGCGACTTGGACGACATCTTGTCTAGGTGGGTGGT
 
P7 AfpyrG F
 
ATGTCGTCCAAGTCGCAATT  
P8 AfpyrG R TCATGACTTGCCGCATACTC  
P9 dn AnugmA(pyrG-T) F
 
GAGTATGCGGCAAGTCATGAAACTCTTCTGCGTGGATGG 
P10 dn AnugmA R GGACTGCAGGTTGAAGCAG 
 
 
Fusion construct generation  
P11 Fusion ugmA F CCGTCCTTCGTAGAGTACTTGAG 
P12 Fusion dn ugmA R
 
GGTTGAACGATGTCAGCGTA 
 
Confirmation of ugmA-cTAP 
P1 ugmA F
 
ATGCTTAGTCTAGCTCGCAAGACT 
P10 dn ugmA R
   
GGACTGCAGGTTGAAGCAG 
Ame8 midPyrG R
 
CACATCCGACTGCACTTCC
  
 
Sequence primers for Confirmation of ugmA-cTAP 
P13 mid ugmA F
  
ACATTGTCAACGGCGCTG 
P14 mid tupA(p) R
  
CCATCCTTTCTGGGTCGC 
 
a El-Ganiny et al. (2008) 
b This study 
c This study 
d Novagen (www.emdchemicals.com) 
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  CHAPTER 6  
                                                        General Discussion 
Galactose metabolism is conserved from prokaryotes to metazoans, consistent with its 
importance in catabolism for generation of ATP from sugars and its importance in anabolism 
for generation of extracellular carbohydrates and carbohydrate-conjugated proteins and lipids. 
Previous research by El-Ganiny and colleagues (2008, 2010) and Afroz et al. (2011) focussed 
on characterizing the function of three sequentially acting genes in the Aspergillus nidulans 
Leloir pathway: UgeA, UgmA, and UgtA. The research presented in this thesis focussed on 
placing the Leloir pathway genes, particularly ugmA, in their larger metabolic context. This 
included characterization of upstream genes GalD and GalE (Chapter 2), an analysis of the 
consequences of repression or overexpression of the Leloir genes including effects on alpha- 
and beta-glucan synthesis (Chapter 3), further characterization of the phenotypic 
consequences of particular amino acid residues in the UgmA active site (Chapter 4), and 
preliminary identification of protein interactors of UgmA (Chapter 5). 
6.1. Galactose metabolism is more complex in Aspergillus nidulans than in 
Saccharomyces cerevisiae 
The highly conserved Leloir pathway enzymes GalD and GalE are involved in 
galactose metabolism (Ross et al. 2004). In my first project (Chapter 2) characterization of 
phenotypes related to the roles of GalD
 
and GalE
 
revealed the complexity of galactose 
metabolism in A. nidulans. Previously Roberts (1963, 1970) described some roles of mutant 
alleles of these enzymes in galactose metabolism, and Fekete et al. (2004) explored the 
enzymatic role of galactokinase in Aspergillus nidulans. However, the biological function of 
galactokinase (GalE) and galactose-1-phosphate uridylyltransferase (GalD) had not 
previously been well characterized in Aspergillus. 
Although GalD and GalE are essential for growth on D-galactose in many systems 
including S. cerevisiae (Dickson & Riley, 1989; Slepak et al. 2005, Seiboth et al 2007), my 
study showed that A. nidulans GalD and GalE
 
play multiple but not essential roles in growth 
on galactose. Only GalD was essential for A. nidulans growth on galactose at pH 4.5, 
indicating that an alternative pathway of galactose metabolism might be available in 
A. nidulans at higher pH. By complementing respective S. cerevisiae genes, I showed that 
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A. nidulans GalD and GalE are functionally homologous to S. cerevisiae GAL7 and GAL1, 
respectively (Chapter 2). Thus, functional homology does not always ensure homologous 
function in different systems. As in S. cerevisiae, GalD and GalE gene expression was 
up-regulated when growing on galactose as a sole carbon source (Chapter 2). However, 
GAL7-GFP localization shows a clumped distribution in S. cerevisiae (Christacos et al. 2000), 
whereas GalD-GFP fluorescence distribution was even (Chapter 2). Together, this evidence 
strongly suggested that galactose metabolism is more complex and flexible in A. nidulans 
than in S. cerevisiae. 
There are few existing hypotheses that might describe the disparity of galactose 
metabolism between yeast and filamentous fungi. First of all, the S. cerevisiae Leloir pathway 
enzymes have been proposed to form multi-enzyme complexes (Abadjieva et al. 2001; 
Kindzelskii et al. 2004). Unlike in Saccharomyces, pronounced galactose toxicity has not 
been reported in Aspergillus and their Leloir pathways genes are not clustered. Slot and Rokas 
(2010) suggested that gene clustering may correlate with Leloir pathway defects that produce 
toxic intermediates. GAL7 deficient cells had high accumulation of galactose-1-phosphate as 
an intermediate product, which has been shown to be toxic to both yeasts and mammals 
(Tsakiris et al., 2002; Slepak et al, 2005). Secondly, although the Leloir pathway appears to 
be the main D-galactose degrading route in Aspergillus, alternative or additional galactose 
metabolism pathways via galactitol, sorbitol and fructose (Elorza and Arst, 1971) and 
fructose-6-phosphate and sorbose-6-phosphate have been proposed in A. nidulans (Fekete et 
al. 2004). Flipphi et al. (2009) hypothesized that galactitol can also be epimerized to 
D-tagatose via L-sorbose, which might be catabolized via D-sorbitol and D-fructose to 
D-fructose-6-phosphate. Although an alternative pathway of galactose metabolism has not 
been reported in yeast, a non-phosphorolytic pathway for D-galactose utilization has been 
reported for A. niger (Elshafei & Abdel-Fatah 2001) but neither the genes nor the proteins 
have been identified. Similarly, a Hypocrea jecorina strain with deleted galE was able to 
grow on D-galactose (Seiboth et al. 2004). Aspergillus species, including A. nidulans, have 
approximately twice as many genes as S. cerevisiae and genomes approximately three times 
larger than that of S. cerevisiae (Goffeau et al 1996), indicating the difference in genomic 
organization between Aspergillus and Saccharomyces. Finally, although galactose metabolism 
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is conserved between yeast and filamentous fungi to the extent that many S. cerevisiae genes 
can fully complement A. nidulans gene deletion strains, the regulatory circuits achieving the 
cellular process appear to be distinct. Galactose metabolism genes in S. cerevisiae are 
regulated by the interplay of three proteins: a transcriptional activator, Gal4, a repressor, 
Gal80, and an inducer, Gal3 (Sellick et al 2008). However, the orthologues of GAL3 and 
GAL4 are absent in the genomes of H. jecorina and A. nidulans (Sellick et al 2008). 
Moreover, the genomic organization of the Leloir pathway genes in filamentous fungi reveals 
a major difference to yeasts, as they are not clustered (Slot and Rokas, 2010), indicating that 
galactose metabolism differs in filamentous fungi compared to yeast.  
 
6.2. Galf is nonessential, but is an important cell wall component 
During my Ph.D. research, I studied the roles of Galf in fungal growth, sporulation, 
wall maturation and hyphal surface adhesion in A. nidulans using two different approaches. In 
Chapter 3, I explored the roles of Galf biosynthesis genes using strains whose endogenous 
promoter was replaced by the alcohol dehydrogenase promoter alcA(p) or the nitrogen 
regulated niiA(p) promoter. In Chapter 4, I showed how modification of AfUgmA leads to 
changes in cell wall α-glucan and β-glucan content, hyphal surface adhesion and response to 
antifungal drugs in A. nidulans. Previously, it was showed that deletion of any of three 
sequential-acting genes in the Galf biosynthesis pathway causes similar defects in A. nidulans 
hyphal morphogenesis and colony development (El-Ganiny et al., 2008; El-Ganiny et al., 
2010; Afroz et al., 2011) and in wall surface structure and force compliance (Paul et al., 
2011). My work also showed that down-regulation of any of these genes, or AfUgmA site-
directed mutagenesis in the enzyme active site, caused roughly comparably deficits in fungal 
growth, cell wall architecture, asexual sporulation, hyphal surface adhesion and response to 
antifungal drugs (Chapters 3 & 4).  
Previous work by El-Ganiny et al (2008 & 2010) and Afroz et al (2011) showed that 
none of the Galf biosynthesis enzymes is essential for viability of A. nidulans. Using a new 
anti-Galf antibody called L10, I also showed that Galf was absent in the cell wall of ugeA∆, 
ugmA∆, and ugtA∆ strains (Chapter 3). Although Galf is nonessential for Aspergillus wall 
deposition, its presence is important for normal cell wall maturation, morphogenesis, hyphal 
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growth and surface integrity (Chapters 3 & 4). Schmalhorst et al. (2008) showed that an 
A. fumigatus strain deleted for its UgmA homologue had a similar phenotype to ugeA∆, 
ugmA∆, ugtA∆ strains. In addition, I showed that cell wall surface properties are severely 
compromised in A. nidulans strains that lacked Galf. Previously Paul et al. (2011) showed that 
ugmA∆ A. nidulans had higher adhesion to AFM Si3N4 probe tips. AfugmA∆ strains have 
been shown to be highly adherent to pulmonary epithelial cells, to glass or plastic surfaces 
compared to wild type (Lamarre et al., 2009). This change in adhesion properties was shown 
to be due to the unmasking of the cell wall mannan by removal of Galf in A. fumigatus 
(Lamarre et al., 2009).  
Galf is also found as glycoconjugates on the cell surface of Leishmania and 
Trypanosoma and as such is important in parasite-cell interactions (Kleczka et al., 2007; 
MacRae et al., 2006). Galf is essential in Mycobacterium tuberculosis, making Galf 
biosynthesis as a drug target against mycobacteria (Scherman et al 2003). Unlike some 
bacteria and protozoa, Galf contribution to Aspergillus pathogenicity has not been well 
established yet. Although Galf lacking strains are highly adhesive, higher adhesion (Lamarre 
et al., 2009) has been correlated with both higher and lower pathogenicity (Schmalhorst et al., 
2008; Lamarre et al., 2009) but there are few studies of this type and further research is 
needed. This disparity could be due to lower growth rates in AfUgmA mutants, thus 
potentially also to lower tissue penetration.  
 
All together, these result and previous studies clearly show that Galf is non essential 
but important Aspergillus wall component which contributes many aspects of fungal growth, 
sporulation, wall maturation and surface integrity. My study also indicated that Galf lacking 
strains have severely compromised wall surfaces, which requires future study to explore its 
role in host-pathogen interaction or pathogenicity. 
 
6.3. Loss or absence of Galf contributes to increased sensitivity to antifungal drugs 
In addition to having multiple roles in Aspergillus growth, sporulation and wall 
architecture (Chapters 3 and 4), the loss of Galf is correlated with increased antifungal drug 
sensitivity. As Galf deletion strains were structurally compromised (Paul et al., 2011), we 
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expected that wild type levels of Galf biosynthesis would be important for Caspofungin 
(beta-glucan synthase inhibitor) resistance. To test this, we compared the drug sensitivity of 
gene deletion and wild type with regulated Galf-biosynthesis strains and explore the role of 
Galf biosynthesis proteins on drug sensitivity (Chapter 3). This study was initiated in 2010 by 
Dr. El-Ganiny, but required substantial additional work before publication. I also tested this 
hypothesis on A. nidulans strains that hosted mutated and wild type versions of the A. 
fumigatus homologue AfUgmA (Chapter 4).  
As expected, we found increased echinocandin sensitivity for the deletion strains and 
repressed strains, but no significant change for compounds affecting ergosterol or its 
biosynthesis (Chapter 3). All the AfumgA mutants in A. nidulans (Chapter 4) also showed 
significantly increased sensitivity towards Caspofungin. Consistent with this, Afroz et al 
(2011) showed that the ugtA∆ strain was hypersensitive to Caspofungin. None of the deletion, 
repression or AfUgmA mutations notably affected sensitivity to Calcofluor White that targets 
chitin microfibril crystallization or to Itraconazole that targets fungal membrane ergosterol 
biosynthesis. As a result, sensitivity to Itraconazole was typical of other membrane-targeting 
drugs, and was not related to Galf biosynthesis gene presence or function. Calcofluor White 
(CFW) is a wall-targeting agent, which inhibits fungal growth, but is not clinically useful. 
Although my studies did not indicate a significant increase in CFW sensitivity, previously 
El-Ganiny et al. (2008) showed that the A. nidulans ugmAΔ strain was more sensitive to high 
concentrations of CFW (30 μg/mL or more) than the wild type strain. Consistently, the 
A. niger ugmAΔ strain was also more sensitive to high concentrations of CFW (30 μg/mL or 
more) than the wild type strains (Damveld et al., 2008). Interestingly, low levels of CFW 
(10 μg/mL) or growth on high osmolarity medium partially remediated the ugmAΔ strain 
phenotype defects (El-Ganiny et al. 2008), consistent with Galf being important in cell wall 
structure and/or function. 
 Increased drug sensitivity of ugmA-deleted, -repressed, and -mutated strains to 
Caspofungin was consistent with our studies on the deletion and mutated strains that showed 
defects in wall architecture, wall surface integrity. An addition, previous AFM studies on the 
deletion strains showed defects in wall architecture and strength (Paul et al., 2011). 
Unexpectedly, colonies with over-expressed alcA(p)-ugmA were also significantly more 
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sensitive to Caspofungin than wild type. This is consistent with the abnormal width and 
branching of overexpressed alcA(p)-ugmA hyphae (Chapter 3), but the cause is not known. 
Consistent with this, increasing Mycobacterium ugmA expression was reported to increase 
resistance to isoniazid (a cytochrome P450 system inhibitor) (Richards and Lowary, 2009).   
 Galf biosynthesis genes have both shared and divergent functions in cell wall 
metabolism. In sum we have shown that the alcA(p)- and niiA(p)-regulated control and site 
directed mutation of Galf biosynthesis genes provide novel information about the role of this 
pathway in A. nidulans. Notably, deletion, mutation and repression phenotypes were 
significantly more sensitive to Caspofungin, suggesting that their walls are significantly less 
robust. We remain hopeful that an inhibitor of this pathway may be therapeutically beneficial. 
My results clearly indicated that Galf lacking strains are hypersensitive to cell wall targeting 
drug, suggesting that Galf biosynthesis could be a target for combination therapy.  
 
6.4. Coordination of Galf biosynthesis with other cell wall carbohydrate pathways 
During my PhD. research I have shown that the deletion or repression or mutation of Galf 
biosynthesis genes decreases fksA expression (Chapter 3) and wall beta-glucan content 
(Chapter 4). However, deletion or repression or mutation of Galf biosynthesis genes increased 
agsB expression (Chapter 3) and wall alpha-glucan content (Chapter 4). The co-ordination of 
the Galf pathway with beta-glucan and alpha-glucan pathways had never been reported 
previously in A. nidulans and A. fumigatus. Previously Damveld et al. 2008 showed that 
mutation of ugm1 is associated with an increase in wall alpha-glucan content in A. niger.  
Decreased fksA expression and β-glucan content correlated with increased sensitivity to 
Caspofungin, which is mechanistically satisfying. This relationship has not been previously 
reported in fungi.  
Not surprisingly, A. nidulans cell wall α-glucan and β-glucan content were found to be 
strongly correlated. This suggests that the cell is metabolically constrained as to where it 
apportions metabolites for wall synthesis, so that increases in abundance of one major 
polymer must limit the resources available for synthesis of the others. However, this does not 
directly explain why engineered changes in Galf content are so strongly related to changes in 
α-glucan and β-glucan content. In an attempt to find how this relationship is maintained, I 
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used a tandem affinity purification (TAP) method combined with LC-MS/MS to study the 
interacting partners of UgmA (Chapter 5). My preliminary results suggested that UgmA has 
three predicted interaction partners (Chapter 5). Interestingly, none of them belong to 
alpha-glucan or beta-glucan biosynthesis pathways. This strongly suggested that there are no 
direct interactions among Galf, alpha-glucan and beta-glucan biosynthesis proteins. The 
question how this dynamic co-ordination is maintained still remains open.  
It is highly possible that Galf co-ordinates with alpha-glucan and beta-glucan pathway 
via cell wall integrity pathway (CWI).  CWI signaling pathway controls the remodeling of cell 
wall during growth and morphogenesis, and response to environmental challenges (Levin, 
2005; Fujioka et al 2007; Fuchs and Mylonakis, 2009; Levin, 2011; Dichtl et al 2012). In 
fungi, the CWI signalling pathway regulates shape and biosynthesis of the cell wall (Smits et 
al 1999; Fujioka et al 2007; Dichtl et al 2012). CWI pathway transmits wall stress signals 
from the cell surface to the Rho1 GTPase, which proceeds via Pkc1p and a downstream 
mitogen-activated protein kinase (MAPK) cascade (Levin, 2005 & 2011; Dichtl et al 2012). 
CWI pathway is induced in response to several environmental stimuli such as osmotic stress, 
pH, and high temperature (Levin, 2005; Fujioka et al 2007; Levin, 2011), resulting in 
increased levels of expression of numerous genes, many of which encode integral cell wall 
proteins or enzymes involved in cell wall biogenesis. These include beta-1,3-glucan synthases 
(Fks1p and Fks2p) (Fujioka et al 2007; Levin, 2011), alpha-1-3 glucan (agsA and agsB) 
(Fujioka et al 2007) and chitin synthase (Chs3p) (Chant et al 1991; Birkaya et al 2009). In 
fungi, preventing the synthesis of one component of the cell wall is known to lead to a 
compensatory increase in another. For example, inhibition of beta-(1,3)-glucan synthesis by 
caspofungin resulted in a compensatory increase in chitin synthesis in C. albicans which was 
achieved through CWI signalling pathway (Walker et al., 2008). We did not look at the 
relationship Galf with chitin synthesis pathway because of the involvement of many genes in 
chitin synthesis in A. nidulans. However, Nikkomycin Z (a chitin synthase inhibitor) caused 
morphological defects in wildtype A. nidulans hyphae, but was not able to inhibit the growth 
of either the wild type or the Galf-defective strains, when assessed using disc diffusion 
method (Chapter 3). Taken all together, it might be possible that when Galf is removed due to 
deletion or mutation of Galf biosynthesis genes, CWI pathway becomes activated. This 
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activation might lead to changes in beta-glucan and alpha-glucan synthesis for A. nidulans 
survival. 
My study clearly showed that there is a dynamic coordination between cell wall Galf, 
with α-glucan, and β-glucan. This aspect of co-ordinations had never been reported previously 
in Aspergillus. This also suggests the possibility to use the Galf biosynthesis pathway as 
model to study essential wall components, particularly beta-glucan. 
 
6.5. Possibility for anti-Galf as a part of a cocktail of anti-fungal treatments 
Galf appears to be both a structural and an antigenic component of important cell 
surface molecules in a variety of microbes, ranging from bacteria to parasites and fungi (Tsuji 
et al 2001; Latgé, 2009). Inability to synthesize Galf compromises cell integrity in 
Mycobacterium tuberculosis, resulting in severely decreased viability and attenuated survival 
in the host (Pan et al 2001). Genetic deletion or chemical inhibition of UGM prevents 
mycobacterial growth (Pan et al 2001; Dykhuizen et al 2008). In Leishmania, loss of Galf 
synthesis results in severe defects in the early stages of mammalian infection (Kleczka et al 
2007; Madeira et al 2009). Galf synthesis by Ugm is essential in C. elegans (Novelli et al 
2009). As a consequence, a recent study suggested that Galf biosynthesis pathway can also be 
a potential drug target in pathogenic nematodes (Wesener et al 2013).  
Galf is not essential for any fungi studied to date. However, its presence is important 
for cell wall growth, maturation and integrity. In addition, Galf residues appear to form part of 
the secreted antigens in invasive aspergillosis infections (Leitao, 2003).  Although the effects 
of Galf observed vary with organism, generally Galf deficient strains are hypersensitive to 
wall-targeting drugs and exhibit a constitutive osmotic stress phenotype (Afroz et al., 2011; 
El-Ganiny et al, 2008). Gauwerky et al. (2009) and Aimanianda & Latgé (2010) suggest that 
non-essential wall components as well as virulence factors have the potential to be useful 
anti-fungal drug targets.  
Since none of the Galf biosynthesis genes are essential for survival in fungi, inhibition 
of the Galf biosynthesis pathway would not be fungicidal. However, substantial growth 
reduction might reduce the Aspergillus capacity to infect an immunocompromised host. 
Consistently, recent reviews of antifungal therapeutic strategies are no longer suggesting that 
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therapies need to be limited to killing fungi but rather to reduce their ability to cause disease 
(Gauwerky et al., 2009). For example, echinocandins including caspofungin do not kill 
Aspergillus (Denning, 2003) but in experimental animal studies these drugs induce 
morphological changes that decrease fungal pulmonary injury (Petraitiene et al., 2002) and so 
they are clinically effective. In addition, every step of the Aspergillus Galf biosynthesis 
pathway is synthesised by single gene. Therefore, their enzymatic functions are less likely 
compensated by genetic redundancy, and thus have higher likelihood of being drug targets. 
For example, synthesis of Aspergillus β-1,3-glucan is catalyzed by only one enzyme that is 
encoded by single gene, fksA (Kelly et al., 1996). In contrast, at least eight genes with 
overlapping functions are involved in chitin synthesis (Mellado et al., 1995). Therefore, the 
echinocandins (β-1,3-glucan synthesis inhibitors) are clinically useful, whereas chitin 
synthase inhibitors (Nikkomycin Z) have not proven to be effective drugs in clinical use 
(Latgé, 2007).  
All together, the pathogenic contribution of Galf is not fully clarified. Galf 
biosynthesis is not essential in Aspergillus species, unlike Trypanosoma (Roper et al., 2002) 
and several pathogenic bacteria (Pan et al., 2001), so selection pressure to overcome a future 
potential therapeutic compound might be reduced. However, considering Galf-lacking strains 
had substantially reduced growth and hypersensitivity to caspofungin, anti-Galf drugs (once 
created) may be useful in combination with existing antifungal drugs. Combination therapy is 
already in use to combat fungal infection (Baddley and Pappas, 2005; Mihu et al., 2010). For 
example, it has been shown that toxicity of amphotericin B can be reduced in combination 
with echinocandins (Mihu et al., 2010). Use of flucytosine in combination with many other 
drugs helps in preventing the rapid development of resistance (Johnson et al., 2004). 
Altogether, considering the emergence of resistance against antifungal drugs and the high rate 
of mortality from fungal infections, there is a pressing need for new therapeutic options. Use 
of combination therapy, especially anti-Galf drugs (once created) in combination with 
echinocandins may overcome both emergence resistance and infection problems.  
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6.6. Future directions 
The potential for Galf to be a part of combination therapy, and its relationship with 
other major wall carbohydrate pathways, has not been previously explored.  My Ph. D. 
research explored these two aspects of Galf-biosynthesis pathway in Aspergillus, which may 
receive widespread research attention for future drug development and cell wall formation 
studies. Based on my Ph. D. research, the following experimental directions are possible. 
1. From my first project (Chapter 2) we have shown that characterization of 
phenotypes related to the roles of GalD
 
and GalE
 
reveals the complexity of 
galactose metabolism in A. nidulans. Based on literature we also suggested that the 
complexity of galactose metabolism in Aspergillus might be due to availability of 
alternative pathway of galactose metabolism and the genomic organization of the 
Leloir pathway genes in filamentous fungi. Alternative pathways of galactose 
metabolism (Fekete et al. 2004; Flipphi et al. 2009) are not well characterized in 
filamentous fungi. Exploring these putative alternative pathways might help us to 
better understand the growing environment of medically and industrially important 
Aspergillus species.  
2. My study showed that Galf is important for Aspergillus growth, sporulation, cell 
wall maturation and integrity. However, the pathogenic contribution of Galf is still 
debatable, and this needs to be resolved. The pathogenicity of different 
Galf-defective strains can be tested in tissue culture or animal model systems. 
Preliminary results, through collaboration with our group, showed that ugmAΔ 
strains cannot grow in tissue culture plates although the wild type can, suggesting 
that ugmAΔ strains will be less able to cause disease. I also attempted to use Zebra 
fish larvae as an alternative model to study Aspergillus infection. My preliminary 
results indicated that Aspergillus spores were unable to form colonies on zebra fish 
larvae if we exposed them through water. To further continue this study we needed 
a microinjection facility. Unfortunately, we did not find any microinjection 
facilities at level-2 lab. This is why I could not continue this experiment. Future 
developments in this area will include development of zebra fish larvae as a new 
animal pathogenicity model system for Aspergillus infection study. 
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3. Crystal structure of AfUgm is solved (van Straaten et al 2012) and our study 
showed that R327 is essential for AfUgm function (Chapter 4). Based on structural 
and functional information, it might be possible to develop an inhibitor against 
UgmA in collaboration with Dr. David Sanders who has expertise on drug 
development. Once an anti-Galf drug is developed, disc diffusion assay can be 
adapted to screen and compare the effect of candidate compounds in combination 
with Caspofungin for their effect against Aspergillus strains. An inhibitor against 
prokaryotic UGM was developed to prevent mycobacterial growth (Dykhuizen et 
al 2008). Although inhibitor against eukaryotic UGM has not been developed yet, 
a prokaryotic inhibitor can partially inhibit UGM function (Wesener et al 2013).  
Prokaryotic UGM inhibitors have not been tested against Aspergillus, likely 
because there is insufficient material available for this study, but possibly also due 
to the relatively low sequence conservation outside the enzyme active site. 
However, we remain hopeful that the use of combination therapy, especially anti-
Galf drugs in combination with echinocandins may overcome both emergence 
resistance and infection problems.  
4. Using TAP tag and mass-spec analysis we showed that UmgA appears to have at 
least three interacting partners including AN6688 (Septin B; AspB), AN6010 
(SgdE) and AN5327 (uncharacterized) (Fig. 5.4). However, it is too early to say 
whether UgmA actually interacts with these proteins. In order to confirm these 
potential interactions, we have to study one-to-one interactions between UgmA 
with each of these proteins separately. One-to-one protein interaction can be 
assessed by using in vivo as well as in vitro techniques. These include bimolecular 
fluorescent complementation (split YFP), yeast two hybrid system, 
co-immunoprecipitation (Co-IP; using an epitope tagged strain plus available 
antibody), and TAP tagging the genes of interest to determine if they interact with 
UgmA. Our future studies on these interactions are expected to help elucidate the 
molecular mechanisms underlying Galf generation and deposition in cell wall, 
which eventually should lead to better understanding Aspergillus cell wall 
formation. In addition, AN6010 and AN5327 are not fully characterized in A. 
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nidulans. Single deletion analysis of each of these proteins should help us to 
understand their phenotypic roles in A. nidulans growth. 
5. My study also showed that cell wall Galf, α-glucan, and β-glucan content are 
correlated in A. nidulans hyphal walls, suggesting a dynamic coordination between 
cell wall synthesis and cell wall integrity. However, how modification of Galf 
biosynthesis leads to change in cell wall compositions is still unknown. 
Interestingly, tandem affinity purification combined with LC-MS/MS suggested 
that there are no direct interactions among Galf, alpha-glucan and beta-glucan 
biosynthesis proteins. The question how is this dynamic co-ordination maintained 
remains open. In fungi, preventing the synthesis of one component of the cell wall 
is known to lead to a compensatory increase in another, which is achieved via the 
cell wall integrity pathway (CWI). Future studies might include study the co-
ordination of Galf pathway with α-glucan, and β-glucan pathway via targeting 
CWI pathway members.  
In summary, my thesis has presented a comprehensive study on the roles of Galf 
biosynthesis in the model experimental fungal system Aspergillus nidulans. My results clearly 
show that Galf plays important roles in Aspergillus growth, sporulation, hyphal wall 
architecture, wall maturation, wall surface integrity and also in responses to currently 
available antifungal drugs.  The co-ordination of the Galf pathway with alpha-glucan and 
beta-glucan synthesis is also presented in this thesis. To begin to explore how coordination 
might occur, my research studied interacting partners of UgmA. Although compounds that 
could inhibit Galf biosynthesis have yet to be generated, there are considerable reasons for 
continuing to work in this area.  In particular, pathogenic contribution of Galf in Aspergillus 
needs to be resolved. Future study also needs to explore the co-ordination of the Galf pathway 
with α-glucan, and β-glucan pathways. Besides potentially being part of combination therapy, 
Galf can also serve a model sugar to study essential wall components, particularly 
beta-glucan. Future study on UgmA interactions may also elucidate the molecular 
mechanisms underlying Galf generation and deposition in cell wall which eventually lead to 
better understand the Aspergillus cell wall formation. Finally, the details of fungal cell wall 
composition and structure are still a very complicated puzzle; each element plays a role on its 
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own as well as in concert with the others in the functioning of this structure. Therefore, the 
more we study the fungal wall, the better we will understand its formation, host interaction, 
and pathogenic contribution which will eventually allow us to find a better therapeutic 
approach. 
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Appendix A: Zebra fish larvae as an experimental model system for vertebrate 
pathogenesis  
Aspergillosis is the second most common human systemic fungal disease. Zebrafish 
are vertebrates and their larvae are transparent, so they have the potential to be a superior 
model for Aspergillus infection in a vertebrate system. The only alternative non-vertebrate 
model that is occasionally utilized is the silkworm larva. However, this model does not allow 
for proper determination of pathogenicity since Aspergillus spores are injected into the larvae 
directly.  
The hypothesis to be tested was that zebrafish larvae could serve as an effective model 
for studying Aspergillus infection. Specific research objectives were aimed at assessing 
colonization of zebrafish larvae by fungal spores, assessing the potential impact of 
colonization on larvae, and examining changes in pathogenicity following colonization by 
Aspergillus wild type and mutants. For assessing pathogenicity and infection, newly hatched 
larvae were exposed to Aspergillus spores that express green fluorescent protein through 
water. It was expected that this would allow us to monitor the progress of Aspergillus growth 
in the transparent zebrafish larvae at real time using fluorescence microscopy. The experiment 
was conducted at 9 CM Petri dish where 25 larvae (newly hatched to 2 d old) were put into 
sea water. Then larvae were exposed to Aspergillus spores at different concentration (10
5 
-10
9
 
spores/dish) through water. Several trials were carried out until 7 d post-fertilization using 
standard protocol. Unfortunately, we did not see any growth of Aspergillus on larvae. We did 
not even observe any mortality or abnormalities in larval development. Therefore, this 
experiment clearly indicates that Aspergillus spores are unable to form colonies on zebra fish 
larvae if we exposed them through water. For this study we included A. fumigatus, A. flavus, 
A. nidulans strains. A. flavus is one of the major causes of farm fish disease (Olufemi & 
Roberts, 1986, Hashem, 2011). Therefore, we included A. flavus for our infection study. But 
in all cases our results turned out to be negative.  
For studying Candida infection in Zebrafish larvae, microinjection was used to inject 
spores directly into the hindbrain region or peritoneal cavity of 1-3 d old larvae (Chao et al., 
2010). Therefore, we decided to inject Aspergillus spores directly into the hindbrain region or 
peritoneal cavity of larvae. Unfortunately, we did not find any microinjection facilities in a 
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Biosafety level-2 lab. This is why I could not continue this experiment. But we are still 
looking for such as microinjection facilities. 
Appendix B: Molecular biology, microscopic and microbiological techniques used in the 
thesis  
1. Protein extraction and purification 
1. 1. Total Protein Extraction 
1. Grow A. nidulans conidia in liquid complex media (CM) for 20 h.  
2. Collect mycelia from liquid cultures by filtration through Miracloth paper 
3. Wash mycelia with distilled water, dry on paper towels and ground to a powder with 
mortar and pestle in liquid nitrogen.  
4. Resuspend the ground mycelium and boil in the urea/SDS buffer (1% SDS, 9 M urea, 
25 mM Tris-HCl (pH 6.8), 1 mM EDTA, and 0.7 M 2 mercaptoethanol).  
5. Remove the debris by centrifugation at 13000 x g.  
6. Determine the total protein concentration.  
 
      1.2 SDS and Western blotting 
The acrylamide percentage in SDS PAGE gel depends on the size of the target protein in the 
sample. (Details shown below) 
Acrylamide % M.W. Range 
7% 50 kDa - 500 kDa 
10% 20 kDa - 300 kDa 
12% 10 kDa - 200 kDa 
15% 3 kDa - 100 kDa 
 
 For a 5 ml stacking gel: 
H2O 2.975 ml 
0.5 M Tris-HCl, pH 6.8 1.25 ml 
10% (w/v) SDS 0.05 ml 
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Acrylamide/Bis-acrylamide 
(30%/0.8% w/v) 
0.67 ml 
10% (w/v) ammonium persulfate (AP) 0.05 ml 
TEMED 0.005 ml 
 
 For a 10ml separating gel: 
Acylamide percentage 6% 8% 10% 12% 15% 
H2O 5.2ml 4.6ml 3.8ml 3.2ml 2.2ml 
Acrylamide/Bis-acrylamide 
(30%/0.8% w/v) 
2ml 2.6ml 3.4ml 4ml 5ml 
1.5M Tris(pH=8.8) 2.6ml 2.6ml 2.6ml 2.6ml 2.6ml 
10% (w/v)SDS 0.1ml 0.1ml 0.1ml 0.1ml 0.1ml 
10% (w/v) ammonium 
persulfate (AP) 
100μl 100μl 100μl 100μl 100μl 
TEMED 10μl 10μl 10μl 10μl 10μl 
Note: AP and TEMED must be added right before each use. 
 5X Sample buffer (loading buffer): 
10% w/v SDS 
10 mM Dithiothreitol, or beta-mercapto-ethanol 
20 % v/v Glycerol 
0.2 M Tris-HCl, pH 6.8 
0.05% w/v Bromophenolblue 
 1x Running Buffer: 
25 mM Tris-HCl 
200 mM Glycine 
0.1% (w/v) SDS 
 
 
1.2 SDS PAGE Protocol: 
1. Make the separating gel:  
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1. Set the casting frames (clamp two glass plates in the casting frames) on the casting 
stands.  
2. Prepare the gel solution (as described above) in a separate small beaker.  
3. Swirl the solution gently but thoroughly.  
4. Pipet appropriate amount of separating gel solution (listed above) into the gap between 
the glass plates. 
5. To make the top of the separating gel be horizontal, fill in water (either isopropanol) 
into the gap until a overflow.  
6. Wait for 20-30min to let it gelate. 
2. Make the stacking gel: 
1. Discard the water and you can see separating gel left.  
2. Pipet in stacking gel until an overflow. Insert the well-forming comb without trapping 
air under the teeth. Wait for 20-30 min to let it solidifies. 
3. Prepare the samples: 
1. Mix your samples with sample buffer (loading buffer). 
2. Heat them in boiling water for 5-10 min.  
3. Load prepared samples into wells and make sure not to overflow. Don't forget loading 
protein marker into the first lane. Then cover the top and connect the anodes. 
4. Set an appropriate volt and run the electrophoresis when everything is done, generally, 
about 1 hour for a 120 V voltage and a 12 % separating gel.  
PAGE Staining Methods 
Coomassie blue staining:  
Staining solution: 
0.3 % Coomassie Brilliant Blue R-250 (w/v) 
45 % methanol (v/v) 
10 % glacial acetic acid (v/v) 
45 % ultrapure water 
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Destaining solution: 
20% methanol (v/v) 
10% glacial acetic acid (v/v) 
70 % ultrapure water 
Procedure: 
1. Immerse the gel with staining solution, and slowly shake it on horizontal rotator for about 
20 30 min. 
2. Immerse the gel in destaining solution and put it on the same shaker for about 20-30min. 
 
Western Blotting: 
1. Soak 2 pads, nitrocellulose membrane and 6 x 3 Whatman paper in 1 x transfer buffer 
for 5-10 min. 
2. Prepare transfer sandwich in the following order: black-face of plastic holder, pre-
soaked pad, pre-soaked 3 x 3 mm Whatman papers, gel, pre-soaked nitrocellulose 
membare, pre-soaked 3 x 3 mm Whatman papers, presoaked pad, white-face of plastic 
holder. 
3. Place the cassette, along with the ice pack, into the electrophoretic cell. The black face 
of the cassette must face the negative electrode (black panel of the transfer container). 
4. Fill the transfer apparatus to the top with the ice-cold 1X transfer buffer. Transfer the 
gel at 80 V for 1. 5 h 
5. Rinse your blot in wash buffer after blotting, add blocking buffer, incubate with gentle 
agitation for 30-60 min at room temperature or overnight at 4 °C, on a shaker. 
6. Pour out the blocking buffer (can be reused), add washing buffer, agitate on a shaker 
for 10 min. Remove washing buffer, repeat two more times. (Can be done with four 
steps of 5 min each) 
7. Add primary antibody solution to blot. Incubate for 2 h to overnight with gentle 
agitation. Pour off primary antibody solution (Can be reused). 
8. Wash 3 x 5 min with TBST 
9. Add secondary antibody solution. Incubate for 1/2 to 1.5 hours with gentle agitation. 
Pour off secondary antibody solution (Can be reused). 
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10. wash 3 x 5 min with TBST 
11. Scan the membrane with the appropriate scanner. 
1.3. TAP protocol 
1. Collect total protein from A. nidulans strains 
2. Incubate crude extract/IgG sepharose mixture on a rotating platform at 4 °C for 2 h.  
3. Pass the mixture through chromatography columns with gravity. IgG sepharose will be 
accumulated at the bottom of the columns.  
4. Wash Sepharose with 2 × 10 mL wash buffer 1 (250 mM NaCl, 40 mM Tris–HCl pH 8.0, 
0.1 % NP-40, 1 mL PMSF, 100 mL DTT) supplemented with ethylene diamine tetra-acetate 
(EDTA)-free protease inhibitor tablets and phosphatase inhibitors, once with 10 mL wash 
buffer 2 (150 mM NaCl, 40 mM Tris–HCl pH 8.0, 0.1 % NP-40, 1 mM PMSF, 1 mM DTT)  
and once with TEV cleavage buffer (TCB) (150 mM NaCl, 40 mM Tris–HCl pH 8.0, 0.1 % 
NP-40, 0.5 mM EDTA, 1 mM PMSF, 1 mM DTT) supplemented with E-64.  
5. Execute TEV protease cleavage reaction by adding 1 mL TCB and 20 µL of AcTEV™ 
enzyme (Invitrogen) and rotating the suspension overnight at 4 °C.  
6. Transfer TEV protease treated suspensions to new column with 300 µL of washed 
calmodulin affinity resin (Stratagene) and 6 mL of calmodulin-binding buffer (CBB).   
7. Close CBB columns and rotate at 4°C for 1 h.  
8. Wash CBB columns  with 3× 1 mL CBB.  
9. Add 2 X 500 µL elution buffer (EB) to the column and collect proteins in 1.5 mL vials.  
10. Perform Trichloroacetic acid (TCA)-precipitation and then load TCA-precipitated proteins 
onto a 10 % polyacrylamide gel, and then stain with Coomassie Brilliant Blue G (Sigma).  
11. Cut the Protein bands and send to the PBI mass spectrometry facility for analysis.  
 
2. DNA extraction, manipulation and PCR  
2.1. Genomic DNA extraction protocol  
1. Inoculate 20 mL liquid CM media in Petri plates with A. nidulans spores; incubate 
overnight at 37ºC. 
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2. Harvest mycelia by filtration through sterile paper towel, squeeze between several layers of 
paper towel to move extra water 
3. Transfer into sterile microfuge tube, freeze in -80 ºC for 30 min then lyophilize overnight. 
4. Break the lyophilized mycelia into fine powder using round toothpick 
5. Transfer 100 μL of fine powder into fresh microfuge tube 
6. Prepare fresh extraction buffer (pH 7.5-8) immediately before use as follow: 
 For 1 mL solution:  
500 mM EDTA   100 μL 
10% SDS    20 μL 
Ultrapure water  880 μL 
 
7. Add 500 μL extraction buffer per tube, Mix vigorously and transfer immediately to 
preheated 68ºC water bath. 
8. Incubate at 68ºC for 10 min meanwhile chill KOAc solution on ice (60 mL 5M potassium 
acetate, 11.5 mL glacial acetic acid, 28.5 mL ultrapure water). 
9. Vortex microfuge tubes briefly, centrifuge 5 min at maximum speed 
10. Transfer supernatant to fresh microfuge tube (using micropipette) 
11. Add 30 μL chilled KOAc solution, leave on ice for 5 min the centrifuge for 5 min 
12. Transfer supernatant into fresh microfuge tube 
13. Add equal volume of phenol:chloroform:isoamyl alcohol using Pasteur pipette 
14. Vortex 30s then microfuge for 2 min. 
15. Transfer the upper layer to a fresh microfuge tube (do not transfer the material at the 
interface). 
16. Add equal volume of chloroform to the partially clean supernatant, vortex for 30s the 
centrifuge for 2 min 
17. Transfer the upper layer to a fresh microfuge tube (do not disturb the interface). 
18. Add 600 μL isopropanol, vortex well, centrifuge for 5 min. 
19. Pour off isopropanol then add 500 μL of 70% ethanol, vortex till the DNA pellet is not 
stuck, centrifuge for 5 min then decant supernatant and let the pellet dry. 
20. Resuspended in 100 μL (containing 5 μl RNAse). May require heating to dissolve 
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21. Run agarose gel to check quality of DNA (sharp band) before proceeding into other steps. 
22. Finally, DNA is cleaned using Qiagen columns before using it in PCR. 
 
2.2. Fusion PCR and Transformation: 
Fusion PCR is widely used to fuse multiple DNA sequences together to generate one 
construct that can be used for gene targeting (gene deletion, replacement, tagging and 
promoter exchange). 
Recipe for fusion PCR 
DNA     1x3 μL 
Primers (10μm)   1x2 μL 
Taq polymerase   0.2 μL 
Buffer (10x)    5 μL 
H2O     39.8 μL 
Total     50 μL 
Fusion products were then transformed into A. nidulans protoplast to target genes by 
homologous recombination. 
 
3. RNA manipulation and qRT-PCR 
3.1. RNA extraction 
1. Inoculate A. nidulans spores in liquid CM media (2x 10
5
 spores/ mL media), incubate at 
37°C with shaking for 16 h 
2. Collect mycelia by centrifugation, remove supernatant and flash froze the pellet in liquid 
nitrogen. Lyophilize the mycelia overnight 
3. Transfer the lyophilized hyphae to RNase free centrifuge tube (start with a similar weight 
for all samples). 
4. Break the mycelia completely into fine powder using a small pestle. 
5. Add 450 μl RLC buffer (to which β-mercaptoethanol was added), vortex vigourously 
6. Transfer the lysate to QIAshredder spin column and centrifuge for 2 min at maximum 
speed. 
7. Transfer the supernatant to a new micro-centrifuge tube without disrupting the pellet 
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8. Add 0.5 volume 100% ethanol and mix immediately by pipetting, transfer directly to 
RNeasy spin column, centrifuge for 15s at 8000 x g, discard the flow-through 
9. Add 700 μl buffer RW1 to the column, close the lid gently and centrifuge for 15 s at 
8000 x g, discard the flow-through. 
10. Add 500 μL buffer RPE to the column, centrifuge for 15s at 8000 x g, and discard the 
flow through. 
11. Add 500 μL buffer RPE to the column, centrifuge for 2 min at 8000 x g, and discard the 
flow through. 
12. Place the column in a new 2 mL collection tube, centrifuge for 1 min at maximum speed 
13. Place the RNeasy column in a new 1.5 micro-centrifuge tube, add 50 μL RNase-free water 
directly to the membrane, centrifuge for 1 min at 8000 x g 
14. The eluted solution contains total RNA, measure the RNA concentration with Nanodrop 
and dilute to the appropriate concentration, aliquot and store in -20 °C. 
 
3.2. gDNA elimination and cDNA synthesis 
Quantitect reverse transcription kit (Qiagen) was used to remove gDNA contamination and 
synthesize DNA first strand. This protocol is optimized to be used for up to 1 μg RNA. RNA 
should be diluted up to 500 ng / μL. 
 
For gDNA elimination follow the following steps 
1. Thaw template RNA, gDNA Wipeout buffer and RNase-free water on ice 
2. Prepare genomic DNA elimination reaction on ice as follow gDNA Wipeout buffer 7x 2 μL 
Template RNA (500 ng/μl)   2 μL 
RNase-free water    10μL 
Total      14 μL 
3. Incubate for 2-3 min at 42°C, then place immediately on ice 
For reverse transcription (cDNA synthesis) follow the following steps 
4. Thaw Quantiscript Reverse Transcriptase, Quantiscript RT buffer and RT primer Mix on 
ice. 
5. Prepare the reverse-transcription master mix as follow 
Quantiscript Reverse Transcriptase   1 μL 
 163 
 
Quantiscript RT buffer 5x    4 μL 
RT primer Mix     1 μL 
RNA from step 3     14 μL 
Total       20 μL 
6. Incubate for 15-30 min at 42 °C. 
7. Incubate at 95 °C for 3 min to inactivate the reverse transcriptase. 
8. Measure the cDNA concentration, dilute as required (e.g. 1:10), aliquot and store in -20 °C, 
this cDNA can be used for qRT-PCR or cloning. 
 
3.3. qRT-PCR procedure 
QuantiTect SYBR Green kit (Qiagen) and IQ cycler (BioRad) were used for performing 
qRT-PCR. We determined the relative expression of targeted genes using actin as a reference 
gene and ΔΔct to calculate the fold change in gene expression. 
Procedure 
1) Thaw QuantiTect SYBR Green PCR Master Mix, template cDNA, primers and nuclease-
free water on ice. 
2) The following recipe is used for 1 reaction 
QuantiTect SYBR Green PCR Master Mix (2X)  10 μL 
Primers (10 μm)      2x0.3 μL 
cDNA        3 μL 
Nuclease free-water      6.4 μL 
Total        20 μL 
3) For each gene (Actin or ugmA) multiply the above recipe by 10 to make a cocktail for 10 
reactions (3 technical replicates, 3 No template control). 
4) Mix all the ingredients (except cDNA) and divide equally into 3 tubes (A, B, C). 
5) Add 10 μL cDNA to tube A (wild type) and B (mutant) and 10 μL water to tube C. 
6) Mix and dispense 20 μL in the bottom of each well (of the 96-well plate). 
7) Place the plastic film over the plate and carefully seal firmly, clean the surface with Kim 
wipes before putting in the IQ cycler. 
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4. DNA cloning, bacterial transformation, site directed mutagenesis 
4.1. Cloning using restriction digest and ligation 
1) The DNA fragment (insert) and the cloning plasmid (vector) should be cut using the same 
restriction enzymes to generate compatible ends. 
2) Set up the following reaction mixtures 
Test         Negative control 
           Vector    DNA 5 μL    ultrapure water 5 μL 
Insert DNA   5 μL     - 
5X ligase buffer  4 μL     4 μL 
Water    5 μL     10 μL 
T4DNA ligase  1 μL     1 μL 
3) Leave at room temperature at least for 2 hours or ligate overnight 
4) Transform 10 μl of the rection mix into E. coli comptent cells; shake at 37 °C for 1 hr 
5) Spread 50-100 μl on LB plates + suitable antibiotics; incubate overnight at 37°C 
6) Colonies on test plates can be used for plasmid extraction, negative control plates should 
have no colonies. 
 
4.2. Site directed mutagenesis 
Site-directed mutagenesis is performed using the GENEARTR
R
 site-directed mutagenesis kit 
(life technologies) according to the manufacturer's protocol. An over-expression vector 
pET22b harboring the Afugm gene was used
 
as the template DNA. 
Procedure: 
1. Create the following reaction mixture: 
Component      Volume  
10X AccuPrime™ Pfx Reaction mix   5 μL  
10X Enhancer      5 μL  
Primer mix (10 μM each)    1.5 μL  
Plasmid DNA (20 ng/μL)    1 μL  
DNA Methylase (4 U/μL)    1 μL  
25X SAM       2 μL  
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AccuPrime™ Pfx (2.5 U/μL)    0.4 μL  
PCR water to      50 μL 
2. Perform PCR using the following parameters.* 
Temperature    Duration    Number of Cycles 
37 
o
C     20 min    1 
94
 o
C     2 min 
94
 o
C     20 s 
57
 o
C     30 s     18 cycles** 
68
 o
C     30 s/kb of plasmid 
68
 o
C     5 min     1 
4 oC     forever     1 
3. Set up the recombination reaction: 
Component     Volume  
5X Reaction Buffer    4 μL  
PCR water     10 μL  
PCR sample     4 μL  
10X Enzyme mix    2 μL  
4. Mix well and incubate at room temperature for 10 minutes. 
5. Stop the reaction by adding 1 μL 0.5 M EDTA. Mix well and place the tubes on ice. 
6. Place the tubes on ice and immediately proceed to transformation. 
7. Select Ampicillin-resistant colonies from the LB plates and the specific mutation can 
be verified by DNA sequencing.  
 
4.3. DNA sequencing protocol  
Protocol for sequencing in Dr. Andres Lab 
You can use your plasmid or PCR product for sequencing. It is better to start with the PCR 
product. 
Step One: Cleaning the PCR product (Not needed for extracted plasmid) 
Add following things to a new PCR tube: 
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PCR product    8  μL 
PCR buffer 10x   1  μL 
SAP       0.5 μL 
EXOT     0.05 μL 
*one drop of mineral oil to seal the tube 
Put the tube into PCR machine, run the following PCR program: 
37 
0
C      40 min 
80 
0
C      15 min 
l5 
0
C       hold  
Step Two: Sequencing Reaction:  
Template DNA    1 μL 
ABI 5 x Buffer     0.5 μL 
Primers (only one)    0.1 μL 
RR      0.75 μL 
ultrapure water    up to 5 μL 
*Add one drop of mineral oil to seal the tube. 
It is better to make master mix with RR, primer, ABI -5x buffer and H2O first. Then add 4 μL 
of master mix to 1 μL template DNA.  
Put the tube into PCR machine, run the following program: 
94 
0
C     2 min 
95 
0
C     50 s  
Annealing Temperature  30 s  
60 
0
C     4 min 
15 
0
C    hold 
 
Step Three: Cleaning the Sequencing Reaction tube 
Follow the ABI cleaning process: 
1. Shake the Agencourt Clean SEQ to fully resuspend the magnetic beads before using  
2, Add 8 ul of Agencourt Clean SEQ to each sample. 
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3, Add 31 ul 85% ethanol to each sample, and mix 7 times by pipette. (Or until it becomes 
homogenous) 
4. Place the tube onto an Agencourt SPIRPlate 96R (magnet) for 3-5 min, until the solution 
become clear. 
5. Aspirate the cleared solution (supernatant) from the plate and discard (don't touch the 
brown beads on the tube wall by your tip) 
6. Dispense 100 μL 85% ethanol into each well. Wait at least 30s and completed remove the 
ethanol and discard, repeat once (don't touch the beads on the tube wall by your tip) 
7. Repeat 6 twice 
8. Let the sample air-dry for l0 min (usually 5min is enough in Andres lab) 
10. Transfer 35 ul of solution from each well to a new 96 direct inject plate, use A1-H1 
column first and then A2-H2 (do not touch the beads on the wall and don't bring any bead to 
the 96 well plates). 
11. ***lf your sample number is less than 16. You should fill up other wells in the first two 
columns by water. Because the machine will load l6 samples at one time) 
l2. Put your plate into a cassette; make sure the wells with samples face to the front (the side 
without the notch). 
Step Four: Loading the sample  
l. Turn on the Computer  
2. Turn on the machine; wait for the green light to switch on. 
3. Run the program "3130" on the desktop 
(A panel with 4 items will show on the screen. When all items become green, the panel will 
disappear and a new control panel will show up) 
4. Select "ga3130XL", and then select "plate manager", then at the bottom of the panel to 
build a "New" program. 
5. *wear a glove to touch the machine 
Push "tray" button on the machine. When the tray stop at the front of the machine, open the 
door and put your cassette on the left position. 
6. **check if there is any bubble in the circular system (at the left hand side of machine, start 
from a bottle and end in a glass jar) 
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7. Click "3l30XL", choose "Run Schedule" and "plate view". Find the file with your name and 
choose it. Then click panel A on the screen, the color will turn to green at the panel A place 
Then choose "run view" to see if it shows the right place of your sample on panel A 
8. Click “        ” symbol to run the machine. 
 
5. Immunofluorescence  
Protocol: 
1. Grow Aspergillus nidulans spores on dialysis tubing over night 
2. Cut the dialysis tubing into pieces and transfer into Petri dish 
3. Fix 30-60 min at room temperature in formaldehyde/MBS/P+BS.  
4. Dilute the 10x wash solution P+BS/PIPES into 1x. 
5. Wash the samples 3x 5 min with 1x washing solution. 
6. Block the nonspecific binding with freshly prepared 5 % non-fat milk in P+BS 
solution for 20-30 min. 
7. Dilute the 5 % non-fat milk in P+BS solution into o.5 % non-fat milk in P+BS 
solution. 
8. Dilute the primary antibody at 1:100 dilution in 0.5 % non-fat milk solution 
9. Incubate the sample in dissolved primary antibody for 30-90 min 
10. Wash the samples 3x 5 min with 1x washing solution. 
11. Dissolve the secondary antibody in 0.5 % non-fat milk solution 
12. Incubate the sample with 100 μL fluorescent labelled secondary antibody for 
30-90 min in dark place. 
13. Final wash the samples 3 x 5 min with 1x washing solution. 
14. Then mount the sample on the cover slip and on the slide to see under confocal 
microscope on the same day. 
6. Cell wall extracts preparation protocol.  
1. Grow Aspergillus nidulans strains at 30 oC for 24-48 h on CM + amp.  
2. Inoculate about 105 Spores in 200 mL CM + amp for 48 hours with shaking at 
160 rpm. 
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3. Filter through a #1 Whatman filter  
4. Wash with ddH2O followed by washing with 0.5 M NaCl.  
5. Store at -80 oC for 2-4 hours 
6. Thaw mycelia and wash once with ddH2O followed by washing with 0.5 M NaCl.  
7. Fungal hyphae are broken in Disruption Buffer (DB; 20 mM Tris, 50 mM EDTA, 
pH 8.0) using glass beads and vortex until microscopic examination shows hyphal 
ghosts.  
8. Cell walls are separated by centrifugation at 3000 x g for 10 min.  
9. The pellet containing the cell wall fraction are washed with chilled DB with stirring 
for 4 h at 4 
o
C  
10. Collect the Cell walls by centrifugation at 3000 g for 10 min.  
11. The pellet containing the cell wall fraction are washed with ultrapure water  with 
stirring for 4 h at 4 
o
C  
12. Collect the pellet by vaccum filtration on filter paper. 
13. Place the filter paper, which contains the cell wall material in 50 mL conical flask, 
freeze at -80 for 20 min and then lyophilize overnight. 
Disruption Buffer (DB) for 250 ml;  
20 mM Tris                          0.61 g         
50 mM EDTA, pH 8.0)        4.8 g 
H2O upto             250 mL 
O.5M NaCl buffer: 
NaCl             7.3 g 
H2O upto             250 mL 
 
7. ELISA protocol for Aspergillus nidulans cell wall galactofuranose quantification 
1. Add 100-150 ul of cell wall preparation (Isolated cell walls at 0.5 mg/ml in EPBS (8.2 
mM Na2HPO4, 1.8 mM NaH2PO4.H2O, 140 mM NaCl, pH 7.4) are incubated in 96-
well Immulon 2HB plates) and incubate overnight at 4 
o
C.  
2. Wells are washed three times with ELISA wash buffer (10 mM Tris, 0.05% Tween 20, 
3.1 mM sodium azide, pH 8.0) at room temperature 
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3. Block with ELISA blocking solution (10 mg BSA /ml, 0.02% sodium azide in EPBS) 
for 30 min at room temperature 
4. Wells are washed three times with ELISA wash buffer at room temperature 
5. Incubate L10 (Mouse IgM) antibody for 1 to 2 h. L10 antibodies are diluted 1: 10 with 
ELISA diluent (0.05% Tween 20, 0.02% sodium azide, 10 mg BSA /ml in EPBS) at 
room temperature.  
6. Wells are washed three times with ELISA wash buffer at room temperature 
7. Incubate with alkaline phosphatase-conjugated goat antimouse IgM antibody (Sigma) 
for 1–2 h (diluted 1: 500 in ELISA diluent) at room temperature.  
8. Wells are washed three times with ELISA wash buffer at room temperature 
9. Incubate with phosphatase substrate tablets (Sigma) dissolved in 8.33 ml alkaline 
phosphatase substrate buffer (0.5 mM MgCl2.6H2O, 9.6% diethanolamine, pH 9.6) 
for 30 min at room temperature.  
10. Read absorbance at 405 nm. 
ELISA experiment needs to be performed at least two times. 
 
8. Sample preparation and critical point drying for scanning electron microscope 
(SEM)  
a. Grow on dialysis tube for 3 days at 30 oC. 
b. Soak sample in 8% glutaraldehyde for 1 h  
c. Fix in 8% glutaraldehyde vapour for 1 h  
d. Place samples in -80 oC acetone and place them in -80 oC freezer for 1 h 
e. Put all samples in -20 oC for 1 h  
f. Put all samples in 4 oC for 1 h  
g. Put all samples at room temperature for 1 h 
h. Put sample in critical point dryer in acetone 
i. Let liquid CO2 into chamber 
j. CO2 replace acetone 
k. Raise the temperature to over 31.5 oC 
l. CO2 vaporise and leaves samples 
m. Remove samples from critical point dryer. 
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n. Gold coat the samples and observe under SEM. 
o.  
9. Protocol for transmission electron microscope (TEM) 
Day 1—Preparation 
Grow conidia on sterile dialysis tubing on CM+ medium overnight 
Day 2: Fixation-done in the fume hood  
1. Make 5% glutaraldehyde in 50mM buffer (from 100 mM NaKPO4 pH7.5)  
2. Cut dialysis tubing into ~mm squares 
3. Fix dialysis tubing in glutaraldehyde in 50mM buffer for 1 hour. 
4. Wash 3X15 min 50 mM buffer 
5. Fix 1 hour in 1 % OsO4 in buffer (2O drops of 100 mM NaKPO4 buffer, 16 
drops ultrapure water, 10 drops 1% OsO4) 
6. Wash in graded ethanol series-10 min each in 20 %, 40 %, 60 %, 80 %, and 
100 % ethanol 
7. Transition to dry 100 % acetone 
8. 2X30 min washes in 100 % acetone 
Day 2: Embedding- done in the fume hood 
9. Transition to 1:1 acetone:resin for 1 h. Open the top slightly and leave acetone 
to evaporate slowly overnight. 
10. Transfer to fresh resin on a coated glass slide, topped with a second slide for 4-
5 h in a dessicator. 
Polymerisation: 
11. Polymerize resin at 60 oC for 2 d. 
Staining EM sections: 
Wash and rinse the staining dishes (NO grease) and shake off excess ultrapure water. 
Have two pairs of clean fine-tipped forceps.  
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Have 500 mL ultrapure water (ddHOH) for washing and a beaker to collect used wash water 
Have filter paper triangles for drying 
Uranyl acetate staining - 20 min at room temperature 
1. Fill part of one groove in a staining dish with uranyl acetate (UrAc). The solution 
should have a slightly convex top, so that it will be easy to submerge the grids. 
2. Pick up each grid by its border, holding by the wide part of the edge, and place it into 
the staining solution so it is fully submerged, then release to leave it there. Wipe the 
forceps dry before picking up the next grid. 
3. After 20 min staining in uranyl acetate (precise timing is not critical) transfer each grid 
to water, then rinse each individually for 20-30 s with a gentle stream of dHOH and 
put in fresh ddHOH. 
4. When all grids are rinsed after UrAc, fill the lead citrate channel with lead citrate 
stain. Do not disturb any crystals on the sides of the PbCit container - take stain from 
the middle of the solution, and transfer gently into the lead citrate channel.  
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